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Abstract
This thesis describes stereospecific fluorination reactions, and addresses the synthesis of
fluorosugars. In Chapter 1, the influence of fluorine on the physical properties of organic
molecules, as well as its stereoelectronic effects, are introduced. Furthermore, an overview
of nucleophilic and electrophilic fluorination reactions is given. Chapter 2 describes the
dehydroxyfluorination of allylic alcohol diastereoisomers 155a and 155b, which can
proceed either by direct or allylic fluorination. The regio- and stereo- selectivities were
also assessed. Chapter 3 outline the synthesis of the novel trifluoro D-glucose analogue
193 and trifluoro D-altrose analogue 216.
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The transport of these hexose analogues across the red blood cell membranes was then
explored, to investigate the influence of polarity versus hydrogen bonding ability in
carbohydrate-protein interactions. Chapter 4 describes the development and optimisation
of Bio’s methodology, to promote stereospecific dehydroxyfluorination of benzylic
alcohols (R)-213 and (R)-227 by addition of TMS-amine additives 226 and 229. And
finally Chapter 5 reports the experimental procedures as well as the characterisation and
the crystallographic data of the molecules prepared in this thesis.
1Chapter 1: Fluorine in organic chemistry
1.1) Organofluorine chemistry:
Organofluorine research actively contributes to progress in a broad range of technologies
including applications in medicinal chemistry,1 in soft materials chemistry2 and in the
development of agrochemical products.3 Fluorine is introduced into organic molecules to
modulate their molecular properties, most often by the substitution of hydrogen and/or
oxygen by fluorine. To do this, a broad range of new fluorination reagents and novel
synthetic methodologies have been developed.2 Today organofluorine research still receives
significant attention from both the academic and industrial scientific communities, and the
study of newly generated fluorinated analogues is an important aspect of chemistry research.
1.2) The effect of fluorine on the physical properties of organic molecules:
1.2.1) Electronic effects:
Some of the important effects which arise from the introduction of fluorine into organic
molecules can be rationalised by the principles of molecular orbital theory. For instance the
replacement of hydrogen by a fluorine atom in organic molecules generates HOMO (highest
occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) energy levels
both of which are lower in energy than the analogous hydrocarbon.4 A low HOMO indicates
that the valence electrons (2s and 2p) are more tightly held to the nucleus. As a result, the
electronic polarisability of the fluorinated analogue is reduced. Electronic polarisability can
be assessed by determining the refractive index (nD), a value which is lower in fluorinated
2compounds compared to their non-fluorinated analogues. The limited electronic polarisability
of fluorinated analogues weakens the van der Waals forces,4 which is the basis of many
characteristic properties of fluorinated molecules.
1.2.2) Boiling point:
Generally the boiling point of structurally related compounds depends upon their molecular
weight, the higher the molecular weight, the higher the boiling point. However, this is not
always true for halogenated organic compounds. Fluorination decreases the electronic
polarisability of organic molecules and consequently reduces the van der Waals interactions
which may result in lower boiling points, and as stated above, lower refractive indices. For
instance, a linear correlation is found between the refractive indices and the boiling points.5
1.2.3) Miscibility:
The definition of “fluorous” was described by D. P. Curran in 2002.6 “Fluorous” refers to
highly fluorinated sp3-hybridized moieties such as perfluoroalkanes, and
perfluorotrialkylamine compounds. “Fluorophilic” is used to describe molecules that show an
affinity for fluorous media, whereas “fluorophobic” are molecules that do not (e.g.
hydrocarbons).6 In this regard, the polarity, as well as the electronic polarisability, plays a
central role. In fact, perfluorinated organic compounds are neither soluble in organic solvents,
nor in water. The fluorinated analogues, deficient in electronic polarisability, are unable to
make sufficient van der Waals interactions with neighboring organic solvent molecules,
making them insoluble in organic media.4 In addition, fluorinated analogues cannot establish
3adequate hydrogen bonding with surrounding water molecules and they form weak van der
Waals forces with each other while isolated from water molecules.4
1.2.4) Lipophilicity:
The partition coefficient, log D, is the conventional parameter for measuring the effect of
fluorine substitution on lipophilicity. Log D is defined as the logarithmic coefficient of a
compound’s distribution between octanol and water at a given pH, typically 7.4.7 Fluorine
substitution has multiple effects upon lipophilicity, and no simple rules exist to predict these
effects. A study by H. -J. Böhm8 examined the effects of fluorine substitution, by replacing a
hydrogen atom with fluorine in a series of 293 pairs of structurally related molecules.
For each molecule the log D was determined and the difference between each pair of
fluorinated and non-fluorinated analogues was calculated. The graph in Figure 1.1 illustrates
a Gaussian distribution with a maximum around 160 (number of observations) which
corresponds to a log D difference a little higher than zero. This study also demonstrates that,
on average, the replacement of a hydrogen atom by fluorine enhances the lipophilicity by
approximately 0.25 log units. Log D values below zero indicate that fluorine substitution can
also decrease lipophilicity. In these instances, an oxygen atom is always located near the
fluorine (Figure 1.2).
4Figure 1.1. Log D variation observed after substitution of a hydrogen atom by fluorine.8 H. -J. Böhm, D.
Banner, S. Bendels, M. Kansy, B. Kuhn, K. Müller, U. Obst-Sander, M. Stahl, ChemBioChem, 2004, 5, 637-
643. Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
Figure 1.2. Examples of compounds for which a fluorine substituent decreases log D.8
Conformational analyses and ab initio quantum-chemical calculations of these molecules
revealed that the positioning of the fluorine close to an oxygen atom increases the polarity of
the molecule. This might favour the formation of stronger hydrogen bonding with the
surrounding water molecules. In contrast, most cases reporting a positive Δ log D are
characterised by the presence of one or more basic nitrogens, whose basicity is reduced by
the fluorine electron-withdrawing effect.
51.3) Electronic effects:
1.3.1) Acidity:
Fluorine is the most electronegative element (3.98 on the Pauling scale) in the Periodic
Table.9 This makes the C-F bond extremely polar with a characteristic dipole moment (µ) of
approximately 1.4 D. The introduction of fluorine into a molecule can have a significant
effect on the acidity of the molecule.10 For instance the pKa of a series of organic acids is
reported in Table 1.1.10 The pKa decreases after fluorine introduction due to the inductive
effect. Fluorination also decreases the basicity (pKb) of organic bases as shown in Table 1.2.10
Acid (H) pKa Acid (F) pKa
CH3COOH 4.76 CF3COOH 0.52
C6H5COOH 4.21 C6F5COOH 1.75
CH3CH2OH 15.9 CF3CH2OH 12.4
(CH3)2CHOH 16.1 (CF3)2CHOH 9.3
(CH3)3COH 19.0 (CF3)3COH 5.4
C6H5OH 10.0 C6F5OH 5.5
Table 1.1. Acidities (pKa) of organic acids in comparison with their fluorinated analogues.10
Base (H) pKb Base (F) pKb
CH3CH2NH2 3.3 CF3CH2NH2 8.1
C6H5NH2 9.4 C6F5NH2 14.36
Table 1.2. Basicities (pKb) of organic bases in comparison with their fluorinated analogues.10
6Fluorine also alters the reactivity of charged intermediates. For instance, fluorine can
influence the stability of fluorinated carbocations.11 α-Fluoro substitution of a carbocation
stabilises the positive charge by the mesomeric effect, but destabilises the positive charge by
the inductive effect as shown in Figure 1.3.2 In general, a single fluorine atom will increase
the stability of a carbocation. β-Fluoro substitution destabilises a carbocation by the inductive
effect (Figure 1.3). α-Fluoro substitution of carbanions destabilises the negative charge by an
n-π interaction, whereas β-fluoro substitution stabilises the charge by the inductive effect and
by negative hyperconjugation (Figure 1.4).
Figure 1.3. Influence of fluorine on carbocation stability.2
Figure 1.4. Influence of fluorine on carbanion stability.2
71.3.2) Bond energy and bond length:
As fluorine is the most electronegative atom, the C-F bond is the strongest bond in organic
chemistry (105.4 kcal/mol), making it extremely stable.12 This property confers thermal and
oxidative stability to fluorinated compounds. The length of the C-F bond determines the
strength of the C-F bond, highlighted by the sequence of substituted methanes in Table 1.3.12
Molecule C–F bond length
(Å)
C–F bond strength
(kcal/mol)
CH3F 1.39 107
CH2F2 1.36 109.6
CHF3 1.33 114.6
CF4 1.32 116
Table 1.3. C-F bond length and C-F bond strength in substituted methanes.12
1.4) Stereoelectronic effects in organofluorine molecules:
1.4.1) The size of fluorine and steric effects:
An important property of fluorine is its small size, with a van der Waals radius of 1.47 Å, just
slightly bigger than that of hydrogen (1.20 Å).13 Thus, the replacement of hydrogen by
fluorine is the most conservative, in regards to steric effects, but the most dramatic with
respect to alteration of electronic properties. As the carbon-fluorine bond length (1.39 Å) is
close to that of carbon–oxygen (1.43 Å),13 the replacement of oxygen for fluorine in organic
molecules is the most neutral change in terms of both steric and electronic effects.
81.4.2) Anomeric effect involving n-σ*C-F interactions:
The σ*C-F antibonding orbital, similar to the σ*C-O orbital, can take part in anomeric
stabilisation. A well established example is the “anomeric effect” in carbohydrates.14 When
an electron-withdrawing atom X such as fluorine (or oxygen), is introduced at the anomeric
position the axial orientation is favoured over the equatorial orientation, as shown in Figure
1.5.15 This stabilisation (X = F, 2.8-2.9 kcal/mol)15 takes place involving a favourable n-σ*
interaction between the lone pair n on the oxygen and σ*C-X.
Figure 1.5. Stabilising n-σ* interaction favouring the electronegative substituent in the axial position.15
1.4.3) Organic fluorine as a hydrogen bond acceptor:
Hydrogen bonding plays a fundamental role in nature, shaping the three-dimensional
structures of important macromolecules such as proteins and sugars. It is also involved in
numerous molecular recognition processes. Although inorganic fluoride can behave as a
strong hydrogen bond acceptor,16 the role of organic fluorine in hydrogen bond interactions
is still debatable.4 Firstly, fluorine can behave only as a hydrogen bond acceptor. Moreover,
the hydrogen-bond acceptor ability of organic fluorine is very weak; in fact the low energy of
the HOMO (lone pair) orbital level in organic fluorine makes significant interactions with
proton donors unlikely. An authentic hydrogen bond should involve orbital interactions, with
9the construction of a bond path and exchange of the proton.4 In this sense, hydrogen bonds
are classified as strong (bond energy = 15-30 kcal/mol), medium (4-15 kcal/mol) and weak
(<4 kcal/mol).17 While strong and medium hydrogen bonds have mainly covalent
characteristics, the weak hydrogen bond is principally an electrostatic interaction between the
proton and the negative charge on the heteroatom.4 These weak hydrogen bonds include O-
H···F-C, N-H···F-C and C-H···F-C interactions, which are best described as a charge-dipole
interactions between the δ+ charge of the hydrogen and the lone pair of electrons of the
fluorine.18 The intensity of such interactions is mainly dependant upon the chemical
surroundings. Organic fluorine can also stabilise some molecular conformations by
intramolecular hydrogen bonding. A well-known example is the intramolecular hydrogen
bonding in β-fluorinated alcohols (see section 1.4.4.2). Experimental observations of fluorine
hydrogen bond interactions, are quite rare, and up until now, only one measurement of H-F
spin-spin coupling by 19F NMR and 1H NMR has been recorded, found in compound 1 shown
in Figure 1.6.19
F
OH
JH-F = 6.6 Hz
1
Figure 1.6. 1H NMR of 1 shows spin-spin coupling between the phenol proton and the organic fluorine.19
An important example of intramolecular hydrogen bond in pharmaceutical chemistry is
observed in the two isomers of 2-fluoro 2 and 6-fluoronorepinephrine 3 (Figure 1.7).20 In
10
these examples, fluorine stabilises two different conformations by intramolecular hydrogen
bonding with the aliphatic hydroxyl group, and this results in different biological activities.
Figure 1.7. Stabilisation of two different conformations of 2 and 3 by intramolecular hydrogen bonds with
organic fluorine.20
The C-H···F-C interaction is weak and essentially electrostatic in nature. The interaction is
involved in crystal packing. For instance, the crystal packing of fluorobenzenes in contrast to
the corresponding chloro-, bromo- and iodo- analogues, seems to be stabilised by C-H···F-C
interactions, rather than F-F contacts as shown in Figure 1.8.21
Figure 1.8. C-H···F-C electrostatic interactions rather than F-F interactions occur in fluorobenzenes.21
The hydrogen bond distances involved are long and in the region of 2.47-2.65 Å, thus it
would be expected that the interactions are very weak. However, throughout a crystal lattice
they contribute significantly to overall stabilisation.
11
1.4.4) Effect of fluorine on molecular conformation:
1.4.4.1) Fluorine gauche effect:
The gauche effect was first described by Wolfe as “a tendency to adopt that structure which
has the maximum number of gauche interactions between the adjacent electron pairs and/or
polar bond”.22 For example, when two fluorines are placed vicinal to each other in a
hydrocarbon motif, a gauche rather than an anti conformation is preferred. The well-known
example is 1,2-difluoroethane, where the gauche conformer 4a is more stable than the anti
conformer 4b by around 0.8 kcal/mol (Figure 1.9).12
Figure 1.9. The gauche conformer 4a is lower in energy than the anti conformer 4b in 1,2-difluoroethane.12
Currently there are two main explanations for the gauche effect: the “hyperconjugative
stabilisation” theory proposed by P. Rablen23 and the “bent-bond” theory suggested by K. B.
Wiberg.24 The hyperconjugation model in 1,2-difluoroethane argues a stabilising interaction
between the σC-H orbital (HOMO) and the vicinal σ*C-F orbital (LUMO) as shown in Figure
1.10.
12
Figure 1.10. Representation of hyperconjugative stabilisation in 1,2-difluoroethane, σC-H → σ*C-F.23
The σC-H orbital is a better electron donor than the σC-F orbital, and the σ*C-F orbital is a better
electron acceptor than the σ*C-H orbital. Only the gauche conformer possesses the correct
geometry between the σC-H orbital and the σ*C-F orbital (antiperiplanar) to allow this
stabilising interaction. Conversely, no hyperconjugation can take place in the anti conformer.
Wibergs “bent-bond” theory24 was proposed to explain the energy difference between the
gauche and the anti conformer in 1,2-difluoroethane. This theory suggests that due to the
strong electronegativity of the fluorine atom, overlap between the sp3 orbitals along the C-C
bond is reduced as a result of the C-C bond bending towards the fluorine (Figure 1.11).
However, in the anti conformer the C-C orbitals are bent in opposite directions and
consequently there is poor overlap, whereas in the gauche conformer the orbitals are bent in
the same direction resulting in a better overlap.
Figure 1.11. 1,2–Difluoroethane, bond overlap in the anti conformer 4b and gauche conformer 4a.24
Wiberg also used charge density difference maps24,25 to explain the higher stability of the cis
isomer 5a over the trans isomer 5b (by 1 kcal/mol) in 1,2 difluoroethene. The electron
density maps (Figure 1.12) show that the σ bond electron density is higher in the region of
13
fluorine due to its high electronegativity. Electron density maps revealed a stronger overlap
of the C-C orbitals in the cis isomer due to the C-C bond bending towards the fluorines, and a
poorer overlap in the trans conformer as the C-C bond is bent in the opposite direction.
Figure 1.12. Wiberg electron density maps of the σ bonds of cis-1,2-difluoroethene 5a (left) and trans-1,2-
difluoroethene 5b (right).24 Reprinted with permission of K. B. Wiberg, Acc. Chem. Res., 1996, 29, 229-234.
Copyright 1996 American Chemical Society.
1.4.4.2) An electrostatic gauche effect:
A preferential gauche conformation is favoured over an anti conformation in β-
fluoroalcohols.26,27 2-Fluoroethanol has been explored by Density Functional Theory (DFT).
Calculations were performed to assess the conformational relationship between the C-F and
the C-O bond. It was found that the gauche conformer 6a is stabilised by 2.0 kcal/mol over
the anti conformer 6b as shown in Figure 1.13. However, this stabilisation is mostly due to an
intramolecular O-H···F hydrogen bond and not a stereoelectronic effect. In fact, the gauche
structure 7a, which is deficient in intramolecular hydrogen bond, is stabilised over the anti
F
H
F
H
5a cis
F
H
H
F
5b t rans
14
conformer 7b by only 0.1 kcal/mol. Therefore the gauche preference in 2-fluoroethanol is
almost entirely due to intramolecular O-H···F hydrogen bonding.
Figure 1.13. Calculated conformations for 2-fluoroethanol.26, 27
The same type of studies have also been performed in molecules where the hydroxyl group is
protonated as shown in Figure 1.14. The positive charge on the oxygen increases the
polarisation of the C-O bond which should result in a stronger stereoelectronic effect. In this
case the gauche conformer 8a which takes account of hydrogen bonding, is lower in energy
than its anti structure 8b by 7.2 kcal/mol. The calculated gauche structure 9a which lacks an
intramolecular hydrogen bond, is stabilised over its anti conformer 9b by 4.4 kcal/mol which
is almost four times the stereoelectronic gauche stabilisation in 1,2-difluoroethane. It was
concluded that the stabilisation due to intramolecular hydrogen bond is around 2.6 kcal/mol
which is similar to that found for the non-protonated fluoroalcohols.26,27
15
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Figure 1.14. Calculated energy difference in different conformations in protonated 2-fluoroethanol.26, 27
D. Y. Buissonneaud et al.28 carried out density functional theory (DFT) calculations28 to
examine the relative energies of the gauche and anti conformers of β-substituted α-
fluoroethanes (F-CH2CH2-X), where substituent X can be F (4), NH3+ (10), OCOH (11), NO2
(12), NHCHO (13), N3 (14), NCO (15), CH=NH (16), NCS (17), CH=C=CH2 (18), CH3 (19),
CH=CH2 (20), NC (21), CN (22) and CHO (23) and CCH (24). Gauche preferences for 1,2-
difluoroethane (4) are attributable to hyperconjugative interactions (σC-H → σ*C-F) and for β-
fluoroethylammonium (10) they are caused by a charge-dipole interaction.29 For the
remaining compounds, preferences for gauche or anti conformers were established by
analysing hyperconjugative, steric and electrostatic contributions. To achieve this, full
rotational energy profiles were obtained by progressive rotation around the FC-CX bond. For
compounds 11, 12, 13, 14 and 15, the gauche conformer is favoured over the anti. For
instance, the gauche conformation in 15 is adopted as a result of an electrostatic interaction
between the electropositive carbon (in substituent NCO) and F, as well as hyperconjugative
σC-H → σ*C-N interaction (Figure 1.15).28 Furthermore, the most stable gauche conformation
is the one with the C-F bond and isocyanate group co-aligned, a result of repulsion between
the lone pair of electrons of the nitrogen and F.
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Figure 1.15. Rotational energy profiles of gauche and anti conformers of 15.28 Reprinted from D. Y.
Buissonneaud, T. V. Mourik, D. O. Hagan, Tetrahedron, 2010, 66, 2196-2202., Copyright 2010, with
permission from Elsevier.
The preference to adopt a gauche conformation in compounds 16-20 is weak. For instance
the hyperconjugative interaction (σC-H → σ*C-X) in 17 (X = NCS) is weaker compared to 15
(X = NCO), as the C-N bond in the isothiocyanate group is less polarised. Compounds 21 (X
= NC), 22 (X = CN), 23 (X = CHO) and 24 (X = CCH) prefer to adopt an anti conformation.
For instance an anti conformation in 23 is preferred because of a stabilising antiparallel
dipolar C=Oδ-····δ+HFCδ- interaction. In 24, a repulsion between the sp hybridised C≡CH 
substituent and p orbitals of the fluorine disfavours the gauche conformation (Figure 1.16).28
Figure 1.16. The anti conformer is lower in energy than the gauche conformer in 24.28
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1.4.4.3) 1,3-Fluorine-fluorine repulsion:
Sun et al.30 carried out ab initio calculations to examine the energy of different conformations of
1,3-difluoropropane. Four different conformations named CG, AG, AA and G’G’ were explored,
and the conformational energy was found to increase in the order GG < AG < AA < GG’ as
shown in Figure 1.17.
Figure 1.17. Energy of different conformations of 1,3-difluoropropane.30
Two σC-H/σ*C-F stabilising interactions occur in the GG conformer, whereas in GA and AA
there are one and no σC-H/σ*C-F interactions respectively. Although the GG’ conformer has two
σC-H/σ*C-F interactions, it is the less stable. Sun et al.,30 suggested that a 1,3-repulsive difluoro
interaction, calculated at 3.33 kcal/mol destabilises the GG’ conformation. This repulsive
interaction was also observed in multivicinal hexafluoroalkanes synthesised by L. Hunter31
shown in Figure 1.18. The 1,3-repulsive difluoro interaction induces a helical arrangement of
the C-F bonds in the all syn compound 25, but not in the syn-anti-syn-anti-syn compound 26
where a zigzag conformation is favoured (Figure 1.19) .
FF
F
F
F
F
F
F
F
F
F
F
25
26
Figure 1.18. All syn compound 25 and syn-anti-syn-anti-syn compound 26.31
Figure 1.19. X-ray structures of 25 and 26.31 L. Hun
Int. Ed., 2009, 48, 5457-5460. Copyright Wiley
permission.
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broad topic, the most established monofluorination methods are reviewed and are classified
below as nucleophilic and electrophilic fluorination methods.2
1.5.1.1) Nucleophilic fluorination:
Amongst the selective direct fluorination methodologies, the preparation of mono-fluorinated
compounds by nucleophilic fluorination plays a central role, particularly in industrial
chemistry, for the preparation of fine chemicals.2 The main problem associated with
nucleophilic fluorination is the poor nucleophilicity of fluoride. In fact, fluoride ion is an
excellent hydrogen-bond acceptor as it is the smallest anion with the highest negative charge
density and lowest polarisability. Therefore, the use of protic solvents, which are of course
hydrogen bond donors, is not useful, as fluoride is strongly solvated. Fluoride is a much
better nucleophile in polar aprotic solvents such as dimethylformamide (DMF) and
acetonitrile (CH3CN). There are several sources of fluoride suitable for nucleophilic
fluorination reactions.
Popular choices involve metallic fluorides such as potassium fluoride (KF), sodium fluoride
(NaF), cesium fluoride (CsF), silver fluoride (AgF) as well as ammonium fluorides such as
tetrabutylammonium fluoride (TBAF) and tetrabutylammonium dihydrogen trifluoride
(TBATF).32 For these reagents, the nucleophilicity of fluoride is affected by the reaction
conditions, predominantly by interaction with the solvent and the positively charged metal.
Use of ammonium fluorides, like TBAF and TBATF (Figure 1.20), provides an effective way
of increasing the nucleophilicity of fluoride. These reagents decrease fluoride interactions
with metal ions due to the presence of large lipophilic cations. As a result, the nucleophilicity
of the fluoride is enhanced.33
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Figure 1.20. Molecular structures of TBAF and TBATF.32
Furthermore, crown ethers have been used to increase the nucleophilicity of fluoride, as they
bind the metal cations.33 The poor nucleophilicity of fluoride is not the only issue associated
with nucleophilic fluorination reactions. A further problem is that the fluoride ion is also a
strong base, which can result in deprotonation and therefore elimination before, during or
after the fluorination step. For instance, an elimination reaction occurs during the
dehydroxyfluorination of alcohol 27 with diethylaminosulfur trifluoride (DAST), due to the
presence of fluoride ions (Scheme 1.1).41 This becomes an issue, particularly when the
desired process involves a nucleophilic SN2 reaction.34
Scheme 1.1. DAST-mediated dehydroxyfluorination of 29.41
Fluoride is a poor leaving group (order of nucleofugicity I- > Br- > Cl- > F-) in aliphatic
nucleophilic substitution reactions as the C-F bond is very strong. The Finkelstein exchange
reaction used for the synthesis of alkyl fluorides35 takes advantage of the limited
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nucleofugicity of fluoride and the lower boiling point of fluoroaliphatic molecules. In this
reaction an alkyl tosylate 30 is reacted with KF with heating, and the resultant alkyl fluoride
31 is isolated by distillation during the course of the reaction (Scheme 1.2).
Scheme 1.2. Finkelstein exchange of tosylates 30 by fluoride.35
Hydrogen fluoride (HF) is no longer used as a source of fluoride ions due to its corrosive
nature and high toxicity. Reagents that are both safer and easier to handle have been prepared
by combining HF with amines. The first amine-hydrogen fluoride reagent prepared was
pyridinium poly(hydrogen fluoride) known as Olah’s Reagent.36 It is a complex composed by
70% HF and 30% pyridine, which can etch glass similar to anhydrous HF. It was found that
the nucleophilicity of the fluoride could be improved by increasing the percentage of the
amine. This resulted in the preparation of the more neutral Et3N·3HF,37 which does not etch
glass. These types of reagent normally require an activated substrate. For instance, Olah’s
reagent was successfully used for the introduction of fluorine at the anomeric position in the
synthesis of 33 as shown in Scheme 1.3.38 The reaction proceeded via a stabilised
oxocarbenium ion as shown in Scheme 1.4.38
Scheme 1.3. Preparation of 33 using Olah’s reagent.38
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Scheme 1.4. Stabilised oxocarbenium ion formed in the synthesis of 33.38
Amongst the nucleophilic fluorination methodologies, the dehydroxyfluorination of alcohols,
where a hydroxyl group is converted to fluorine, plays an important role. This can be
achieved either by a two-step activation-fluorination procedure or by a direct
dehydroxyfluorination.34 In the first case, initially the OH group is activated by forming a
good leaving group, such as triflate or a mesylate, which is isolated and followed by direct
displacement with fluoride. An example of this type of synthesis is shown in Scheme 1.5. The
triflate derivative 35 is isolated and then reacted with TBAF to generate the enantiopure
vicinal difluoride 36.39
Scheme 1.5. Preparation of the activated diol 35 and subsequent nucleophilic fluorination.39
In the second case, the substitution of OH for F is achieved in a one-step procedure. One of
the first reagents used for this type of reaction was sulfur tetrafluoride (SF4).40 As shown in
Scheme 1.6, alcohol 37 is converted to unstable intermediate 38 and then immediate fluoride
displacement generates alkyl fluoride 39, HF and sulfonyl fluoride.2
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Scheme 1.6. Dehydroxyfluorination of 37 using SF4.2
SF4 is a very toxic gas, thus not easy to handle. Therefore, analogues have been prepared by
replacing one fluorine atom with a dialkylamino group (Scheme 1.7), eg. DuPont generated
diethylaminosulfur trifluoride (DAST), which is a more user friendly form of SF4 that
became commercially available in the 1980’s.41
Scheme 1.7. Preparation of DAST.41
The mechanism of action of DAST is similar to that for SF4. The hydroxyl group of alcohol
40 is transformed into a good leaving group by nucleophilic attack of the oxygen to the sulfur
of DAST, to generate the unstable intermediate 41. This is followed by displacement by
fluoride to generate 42 (Scheme 1.8).42
Scheme 1.8. Mechanism of a DAST-mediated dehydroxyfluorination reaction.42
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Dehydroxyfluorination of n-octanol 43 with DAST generated the corresponding fluoride 44
(Scheme 1.9).41
Scheme 1.9. Dehydroxyfluorination of n-octanol 43 using DAST.41
However, DAST is less reactive than SF4 due to the inductive effect and steric hindrance of
the dialkylamino moiety. For instance, dehydroxyfluorination of ribose derivative 45, as
shown in Scheme 1.10, failed using DAST although use of the two-step activation-
fluorination method with Tf2O and TBAF was successful.43
Scheme 1.10. Unsuccessful dehydroxyfluorination of 45 using DAST, and successful two-step activation-
fluorination generating product 47..43
A kinetic resolution using a chiral amine to generate DAST analogue (S)-2-
(methoxymethyl)pyrrolidin-1-ylsulfur trifluoride 49 has been reported (Scheme 1.11),44
however, this was not very successful and gave a product 50 in only 8% ee along with 2-
octene 51.
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Scheme 1.11. A poor kinetic resolution using the chiral DAST analogue 49.44
Heating of DAST above 50 °C can lead to violent explosions, particularly on a larger scale,
as the sulfur-nitrogen bond is not stable. The reagent [bis(2-methoxyethyl)amino]sulfur
trifluoride (DeoxofluorTM) has emerged45 as a second generation DAST reagent (Figure 1.21)
that is proving to have widespread utility, as it is more thermally stable and less hazardous
than DAST for large scale conversions. This stability is attributed to the coordination
between the ether oxygen and sulfur.46 Other reagents such as Ishikawa’s reagent
(F3CCHFCF2NEt2)47 and Yarovenko’s reagent (ClCHFCF2NEt2)48 (Figure 1.21) have been
explored in dehydroxyfluorination reactions, but have not been widely used. Most recently,
1,1,2,2-tetrafluoro-N-N-dimethylethylamine (TFEDMA)49 (Figure 1.21) was introduced as a
commercially available reagent; the scope and limitations of this reagent are still emerging. A
new fluorinating reagent developed in 2008, with high stability and ease of handling, 4-tert-
butyl-2,6-dimethylphenylsulfur trifluoride (FLUOLEADTM),50 is also an alternative to current
fluorinating reagents (Figure 1.21).
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Figure 1.21. Dehydroxyfluorination reagents DeoxofluorTM, TFEDMA, Ishikawa’s and Yarovenko’s reagents,
and FluoleadTM 45-49
Nucleophilic fluorination is also an important methodology for epoxide ring opening for the
preparation of fluorohydrins, important building blocks in organofluorine chemistry.51
Although many reagents and reaction conditions have been developed,51 the nucleophilic ring
opening of epoxides very often requires harsh reaction conditions and long reaction times due
to the poor nucleophilicity of fluoride and its potential to behave as a strong base.34 Ring
opening can occur via SN2 or SN1 mechanisms. The most frequently used nucleophilic
reagents for the ring opening of epoxides are KF, CsF, potassium hydrogen fluoride (KHF2),
TBAF, TBATF, tetrafluorosilane (SiF4) , boron trifluoride etherate (BF3·OEt2) as well as a
combination of HF-amine adducts, such as triethylamine trihydrofluoride (Et3N·3HF) and
Olah’s reagent (Py·9HF).51
The influence of the type of fluoride source using amine/HF adducts on the regioselectivity of
ring opening, particularly of terminal epoxides, was investigated by G. Haufe et al.,51 with
ethyl 10,11-epoxyundecanoate 52 as the model substrate (Scheme 1.12). Use of pyridine/HF
mixtures in ring opening of 52 (Scheme 1.12, Table 1.4) with a lower level of HF altered the
product distribution towards the fluorination at the primary position generating 54.51 A
similar study was performed by ring opening of 52 with Et3N·3HF (Scheme 1.12, Table 1.5)
and different equivalents of a second amine, as shown in Table 1.5. It is clear that increasing
the level of amine increased the product distribution in favour of fluorination at the primary
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position generating 54 (Table 1.5). A 45:55 mixture of 53:54 was obtained using neat
Et3N·3HF.
Scheme 1.12. Product ratios of fluorohydrins 53 and 54 formed in ring opening of 52 with different types of
fluoride source.51
Table 1.4. Product ratios of fluorohydrins 53 and 54 formed in ring opening of 52 with different pyridine/HF
mixtures in CH2Cl2 at RT.51
a Not determined.
Table 1.5. Effect of added amines on product ratios of fluorohydrins 53 and 54 formed in ring opening of 52
with neat Et3N·3HF, heating at 100 °C for 36 h.51
Entry HF (wt.%)
Product ratio
(53:54)
Conversion
GC (%)
Combined isolated yield
(%)
1 65 92:8 >99 83
2 60 83:17 >99 79
3 50 74:26 >99 74
4 40 55:45 5 NDa
5 30 50:50 2 NDa
Entry Amine
Et3N·3HF
(neat)/second
amine ratio
Product
ratio
(53:54)
Conversion
(by GC, %)
Combined
isolated yield (%)
1 none - 45:55 >99 77
2 C6H5CH2NH2 1:1.5 25:75 ND <2
3 (c-C6H11)2NH 1:1 20:80 96 23
4 i-Pr2NH 1:1.2 18:82 97 23
5 Et3N 1:2 24:76 82 44
6 i-Pr2Et3N 1:1 25:75 98 54
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Potassium hydrogen difluoride (KHF2) is a good nucleophilic source of fluoride. A
comparison between the epoxide ring opening of 55 using Py·9HF and the more neutral
KHF2 in the presence of a crown ether is summarised in Scheme 1.13,51 and shows that
KHF2, as opposed to Py·9HF, favours fluorination at the primary position over the secondary
position.
Scheme 1.13. Ring opening of 55 with Py·9HF and KHF2.51
It is concluded that acidic complexes like pyridine/HF mixtures favour a SN1 process, as the
first step is the protonation of the oxygen, followed by fluoride attack at the most stable
carbocationic centre (secondary position) as shown in Scheme 1.14, (a).52,53 Conversely, the
SN2 mechanism is favoured by more neutral reagents such as Et3N·3HF and KHF2, as the ring
opening occurs via attack at the less hindered position (primary position) of the epoxide as
shown in Scheme 1.14 (b).54 In fact, Py·9HF prepared by Olah in 197855 is a 70:30 mixture of
hydrogen fluoride and pyridine (in molar ratio 9:1 favouring the HF), therefore it is more
acidic than Et3N·3HF which has a molar ratio of HF to amine of around 3:1.
a) b)
Scheme 1.14. (a) Representation of (a) an SN1 mechanism52,53 and (b) an SN2 mechanism54 occurring at the
epoxide opening with fluoride ion.
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The regio- and stereo- selective outcome is not only influenced by the type of fluoride source,
but also the nature of substituents present on the epoxide. The reaction pathway is controlled
by the presence of electron-donating or electron-withdrawing groups on the epoxide ring. For
instance the presence of phthalimide (electron-withdrawing) at the β position to the epoxide 
ring in compound 58 (Scheme 1.15) strongly destabilises the formation of a carbocationic
intermediate at the secondary position,51 thus fluoride ion attack, when using Py·9HF, occurs
preferentially at the primary position over the secondary position, generating 60 and 59 in a
85:15 ratio.51 The presence of electron-withdrawing groups at the β position to the epoxide
ring in compound 61 such as 4- and 5- nitroimidazoles again disfavours formation of a
carbocationic intermediate at the secondary carbon, which further promotes fluoride ion
attack at the primary position favouring the formation of 63 over 62 (Scheme 1.15).51
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Scheme 1.15. Epoxide opening reactions of 58 and 61 with Py·HF.51
The combination of TBATF and a catalytic amount of KHF2 under solid-liquid phase transfer
catalysis has been used by Landini et al.56 for the ring opening of enantiopure (+)-(2R)-
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[(triphenylmethoxy)methyl]oxirane 64 (Scheme 1.16). The reaction generated (R)-65 as the
major product. TBATF can also be used alone as shown in Scheme 1.17, and generated
fluorohydrin 67 with good regioselectivity (25:1) after reaction with 66.57 TBAF in THF was
used for epoxide ring opening of 68 as shown in Scheme 1.18.58 Sharpless et al. demonstrated
that TBAF was also suitable for ring opening of cyclic sulfates.59 This strategy was used by
Hunter et al. as a method for the stereospecific opening of 70 (Scheme 1.19) to generate
fluorohydrin 71.60
Scheme 1.16. Epoxide opening of 64 with TBATF and a catalytic amount of KHF2.56
Scheme 1.17. Epoxide opening of 66 with TBATF.57
Scheme 1.18. Epoxide opening of 68 with TBAF.58
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Scheme 1.19. Ring opening of cyclic sulfate 70 and subsequent hydrolysis to 71.60
Other approaches have been explored to develop new methods for the preparation of
enantiopure fluorohydrins. Haufe et al.61,62 explored the catalytic enantioselective
nucleophilic ring opening of meso and racemic epoxides using a Jacobsen’s (salen) complex.
This involved using the (S,S)-(+)-(salen)chromium chloride complex 72 as a catalyst (Figure
1.22) in association with a nucleophilic source of fluorine. For instance, when cyclohexene
oxide 73 was reacted with 1 equivalent of TBATF, 20 mol% of catalyst 72 and 20 mol% of
AgF in Et2O at RT for 140 h, the product (R,R)-(-)-2-fluorocyclohexanol 74 was generated in
67% ee and 42% yield along with the side-product chlorohydrin 75 (Scheme 1.20).
Figure 1.22. Jacobsen’s enantiopure (salen)chromium chloride complex 72.62
Scheme 1.20. Catalytic enantioselective nucleophilic ring opening of meso 73.62
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Reaction of racemic styrene oxide 76 with 1.5 equivalents of AgF and 50 mol% of catalyst 72
at 50 °C for 5 h in CH3CN generated the fluorohydrin 77 in 74% ee and 43% yield (Scheme
1.21).
Scheme 1.21. Catalytic enantioselective nucleophilic ring opening of racemic-76.62
1.5.1.2) Electrophilic fluorination:
Electrophilic fluorination involves reagents containing an “F+” equivalent, which is then
attacked by a nucleophile. As a result, the “F+” is transferred to the reactant. Despite
elemental fluorine (F2) being a highly toxic and aggressive reagent due to the low F-F bond
energy (36.6 kcal/mol), it has been used as an electrophilic fluorinating reagent. A successful
example of the use of elemental fluorine as an electrophilic is found in the synthesis of 5-
fluorouracil 80 by reaction of 78 with dilute F2 in an inert gas such as N2. This reaction is still
used in industry to produce 80 which is an important chemotherapeutic reagent (Scheme
1.22).63
Scheme 1.22. Industrial preparation of 5-fluorouracil 80.61 Scheme adapted from P. D. Schuman et al.63
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However, the difficulty in handling F2 and sometimes its lack of selectivity led to the
introduction of more refined reagents. Hypofluorites, also called “OF” reagents, are
characterised by the activation of fluorine by oxygen. Examples of this class are CH3COOF,64
CF3COOF65 and CF3OF.66 However, many of these reagents are strong oxidising agents and
suffer from a lack of selectivity which lead to unwanted side-products.67 Significant progress
came with the synthesis of less reactive N-F reagents. The fluorinating strength of this type of
reagent is decreased compared to the “OF” reagents, as the N-F bond is stronger than the O-F
bond, and this decreases the electrophilicity of the fluorine, enabling more controlled
fluorinations to be performed. Also, the strength of the N-F bond can be further modulated by
the introduction of electron-donating or withdrawing substituents on the nitrogen. Important
reagents of this class are SelectfluorTM and N-fluorosulfonamides. SelectfluorTM (Figure 1.23)
is a very stable and versatile electrophilic fluorinating reagent that was developed by Banks et
al. 68,69 in 1988.
Figure 1.23. Electrophilic fluorination reagent Selectfluor.68,69
The utility of the N-fluorosulfonamides as electrophilic reagents for the fluorination of
carbanions was first demonstrated by Barnette.70 An important reagent of this category is the
N-fluorobenzenesulfonimide (NFSI) shown in Figure 1.24.
Figure 1.24. Electrophilic fluorination reagent NFSI .70
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Stereoselective preparation of α-fluorinated carbonyl compounds by asymmetric
fluorination71 emerged as a result of the extensive development of electrophilic reagents. The
first example of an enantioselective fluorination reaction was reported by Differding and
Lang72 in 1988 by the use of the N-fluorocamphorsultams 81 and 82 (Figure 1.25).
81 R = H
82 R = CH3
S
N
R
O O
F
Figure 1.25. Electrophilic fluorination reagents N-fluorocamphorsultams 81 and 82.72
Enantioselective electrophilic fluorination using N-fluoro quaternary ammonium salts of
cinchona alkaloids was developed by Cahard73 and Shibata74 in parallel in 2000. This
followed the pioneering work of Banks et al.,75 who reported the quantitative conversion of
SelectfluorTM and quinuiclidine 83 to N-fluoro quinuclidine 84 (Scheme 1.23).
Scheme 1.23. Preparation of N-fluoro quinuclidine 84.75
For instance, Cahard et al.73 synthesised the N-fluoro quaternary ammonium salt of cinchona
alkaloid 86 by a transfer fluorination reaction between SelectfluorTM and cinchonidine 85
(Scheme 1.24). Cinchona alkaloid 86 was then used for the fluorination of the sodium enolate
of 2-methyl-1-tetralone 87 to generate 88 in 80% yield and 56% ee. (Scheme 1.25).
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Scheme 1.24. Preparation of the N-fluoro quaternary ammonium salt of cinchona alkaloid 86.73
Scheme 1.25. Electrophilic fluorination of the sodium enolate of 87.73
Togni and Hintermann in 200076 reported the first catalytic enantioselective electrophilic
fluorination of a β-ketoester by the use of chiral titanium-based Lewis acids catalysts. This
finding followed observations that substoichiometric amounts of a Lewis acid might catalyse
the enolisation reaction.77 After extended screening, the best results were found with
SelectfluorTM and a titanium taddolate complex (R)-89 or (R)-90 (Figure 1.26), an example is
reported in Scheme 1.26.
Figure 1.26. Chiral titanium-based Lewis acids catalysts (R)-89 and (R)-90.76
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Scheme 1.26. Enantioselective electrophilic fluorination of 91 by the use of chiral catalysts (R)-89 and (R)-90.76
Another important result in this context was reported in 2005 by Shibata et al.,78 who
demonstrated that chiral NiII or ZnII complexes of the ligand phenyl-bis(oxazoline) (R,R)-93
(Figure 1.27) can catalyse the enantioselective asymmetric fluorination of β-ketoesters with
NFSI to generate products with excellent enantioselectivities. For instance, treatment of the
non symmetrical malonate ester 94 as shown in Scheme 1.27 generated the α-fluoro-β-
ketoester 95 in good yields (up to 95%) and very good enantiopurities (up to 99% ee).78
O
O
N N
O
PhPh
(R,R)-93
Figure 1.27. Ligand phenyl-bis(oxazoline) (R,R)-93.78
Scheme 1.27. Catalyitic asymmetric fluorination of nonsymmetrical malonate esters 94.78
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1.6) Polar hydrophobicity:
1.6.1) The “hydrophobic effect” of fluorinated compounds:
As previously discussed (see section 1.2.3), perfluorinated compounds and their analogous
hydrocarbons are hydrophobic, thus are not miscible in water.79 The exact nature of the
hydrophobic interactions is still debatable.80 However, the hydrophobic effect is an important
aspect to take into consideration when a fluorinated molecule is biologically active. The
entropy of the binding of a hydrophobic substrate such as a hydrocarbon or a fluorocarbon to
a physiological receptor, due to liberation of water by desolvation, is high and positive. Thus,
the hydrophobic effect is exploited for the synthesis of more potent enzyme inhibitors.81 For
instance Whitesides et al.,82 synthesised inhibitors of carbonic anhydrase (Figure 1.28), and
reported that the binding was directly proportional to their hydrophobic surface. However
higher affinities were observed for the fluorocarbons, due to the larger hydrophobic surface
areas compared to the hydrocarbon analogues.
1.6.2) Fluorosugars and polar hydrophobicity:
The C-F bond can take part in electrostatic (dipole-dipole or point-dipole) interactions, which
are weakened in the presence of polar heteroatom solvents.83 However, the C-F bond cannot
take part in dipole-induced dipole, ion-induced dipole and dispersion interactions, due to its
low polarisability.83 Various studies84 have reported that favourable dipolar C-F···M
interactions, where M is a metal cation, occur in preorganised systems such as macrocyclic
fluorinated ligands. The synergy between hydrophobic effects, and the ability of the C-F
bond to interact with dipoles or positive ions, is named “polar hydrophobicity”,83 and has
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been largely exploited in protein-ligand interactions. In this respect, the replacement of
hydrophilic groups (OH) by polar hydrophobic groups (CF2) in a sugar is thought to be a
general strategy to enhance its binding to a physiological receptor.85
1.7) Aims and objectives:
This chapter introduced the concept of fluorine in organic molecules, and methods to
introduce fluorine. This thesis now describes research addressing studies on
dehydroxyfluorination reactions, and appropriate reagents, and describes the synthesis of two
trifluoro D-hexose sugar analogues.
Chapter 2 explores allylic fluorination as a key aspect of the trifluoro D-hexose sugar
analogue syntheses, and Chapter 3 then describes the syntheses of the final sugars and their
transmembrane transport studies using red blood cells. Chapter 4 investigates the
methodology for promoting SN2 rather than SN1 reactions processes in
dehydroxyfluorination, in order to mediate highly stereospecific fluorination reactions.
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Chapter 2: Synthesis of allylic fluorides by dehydroxyfluorination
of allylic alcohols with a range of reagents
2.1) Introduction:
2.1.1) The importance of the allylic fluoride motif:
Allylic fluorides are a key functional group. They are found in fluorinated analogues of
important biological molecules and they can be subject to various synthetic transformations.1
For instance an allylic fluoride motif is contained in the fluorinated Vitamin D analogue Ro
26-9228 96, which was developed by Hoffmann-La Roche, and found to be more
pharmacologically active than the natural analogue calcitriol 97 (Figure 2.1).2,3
Figure 2.1. Ro 26-9228 96 and calcitriol 97.2,3
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The analogues prostacyclin, 7-F-PGI2 98 and 5-F-PGI2 99 (Figure 2.2) are allylic fluorides
which have been developed to increase the metabolic stability of the parent prostacyclin PGI2
100.4
Figure 2.2. Allylic fluorides 7-F-PGI2 98, 5-F-PGI2 99 and PGI2 100.4
An allylic fluoride motif is present in the fluorinated fatty acid 101, prepared by Yamamoto
et al.,5 to increase the antidiabetic effect of the natural analogue fatty acid docosahexaenoic
acid 102 (DHA) (Figure 2.3).
Figure 2.3. The fluorinated fatty acid 101 and docosahexaenoic acid (DHA) 102.5
The anti-asthmatic and anti-dermatosis fluticasone propionate 103 also contains an allylic
fluoride motif (Figure 2.4).6
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Figure 2.4. The anti-asthmatic and anti-dermatosis, fluticasone propionate 103.6
Allylic fluoride motifs, either racemic or enantiomerically enriched, are attractive building
blocks in organofluorine chemistry.1 For example Grée et al.7 reported the epoxidation of
allylic fluoride 104 using m-CPBA (Scheme 2.1), whereby the fluoro-epoxides 105 and 106
are generated as a 1:1 diastereomeric mixture. Conversely the m-CPBA epoxidation of the
analogous non fluorinated allylic alcohol of 104 proceeds with high diastereoselectivity,8
demonstrating the importance of hydrogen bonding to achieve high selectivity in these type
of reactions.
Scheme 2.1. Epoxidation of the allylic fluoride 104 using m-CPBA.7
Dollé et al.9 documented the predominant substitution of the tosyl group on allylic fluoride
107 by nucleophilic attack by 108 (Scheme 2.2) clearly because the tosyl group is more
polarisable than fluorine.
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Scheme 2.2 Nucleophilic substitution of the tosyl group on the allylic fluoride 107.9
Davis et al.10 demonstrated that diol 111 is generated as a single diastereoisomer after
Sharpless dihydroxylation of allylic fluoride 110 using AD-mix-β (Scheme 2.3).
Scheme 2.3 Sharpless dihydroxylation of 110 to generate 111.10
Matsuda et al.11 described the dihydroxylation of allylic fluoride 112 by the use of potassium
permanganate (KMnO4) to generate the corresponding diol (Scheme 2.4), followed by
oxidative cleavage with sodium metaperiodate (NaIO4) to furnish aldehyde 113.
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Scheme 2.4 Dihydroxylation and oxidative cleavage of 112 to generate aldehyde 113.11
Hunter et al.12 reported the self-metathesis reaction of the enantiomerically enriched allylic
fluoride 114 (Scheme 2.5). This reaction generated a statistical 8:4:1 mixture of (S,S), (R,R)
and (R,S) stereoisomers. The major isomer (S,S) 115 (98% ee) was isolated by column
chromatography in 69% yield.
Scheme 2.5. Self-metathesis reaction of allylic fluoride 114.12
2.1.2) Regio- and stereo- selective dehydroxyfluorination of allylic alcohols:
Dehydroxyfluorination of an enantiomerically pure allylic alcohol to an enantiomerically
pure allylic fluorine product is attractive. However reaction of allylic alcohols with
dehydroxyfluorination reagents such as diethylaminosulfur trifluoride (DAST) can progress
by SN2, SN2’, SNi’ or SN1 reaction courses,1 and as a result a poor level of regio- and stereo-
selectivity is frequently observed (Scheme 2.6).
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Scheme 2.6 Possible mechanisms in the dehydroxyfluorination of allylic alcohols mediated by DAST.1
The first allylic shift observed using DAST as a dehydroxyfluorination reagent was reported
by Middleton13 (Scheme 2.7), whereby dehydroxyfluorination of crotyl alcohol 116 in
diglyme gave a mixture of 117 and 118 in a 28:72 ratio. Changing the solvent to the more
apolar isooctane only had a small influence on the outcome (ratio 36:64).
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Scheme 2.7. Fluorination of allylic alcohol 116 using DAST reported by Middleton.13
The ratio of products of direct versus allylic fluorination is extremely substrate dependent. A
detailed study on this subject has been carried out by A. Grée et al.14 They repeated the
experiment shown in Scheme 2.7 using CH2Cl2 as a solvent, whereby dehydroxyfluorination
of 116 generated 117 and 118 in 1:3 ratio (Scheme 2.8), a regioselective outcome very
similar to Middleton’s result. Furthermore when the hydrogen α to the OH was replaced by
an isopropyl group (compound 119) (Scheme 2.8), the ratio of the direct (compound 120)
versus allylic fluorination (compound 121) increased from 1:3 to 2:3, thus alkyl groups had a
modest effect on the regioselective outcome.
Scheme 2.8. Dehydroxyfluorination of 116 and 119 using DAST in CH2Cl2.14
The regioselectivity changes dramatically when R is a phenyl group. For instance
dehydroxyfluorination of 122 with DAST gave exclusively the most conjugated product 124,
and the same product is generated entirely from 123 (Scheme 2.9).14
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Scheme 2.9. Dehydroxyfluorination of 122 and 123 using DAST generated 124, exclusively.14
However the formation of the most conjugated system is not always favoured. For instance
dehydroxyfluorination of allylic alcohol 125 (Scheme 2.10) using DAST gave preferably the
least conjugated secondary fluoride 126 over the more conjugated primary fluoride 127.14 In
general the formation of secondary fluorides is preferred over primary fluorides, and this
generally overcomes the formation of the most conjugated product,14 with the exception of
allylic alcohols conjugated with electron-withdrawing groups. For instance the DAST-
mediated dehydroxyfluorination (Scheme 2.11) of 128 (R = Me) gave mainly the secondary
fluoride 129 over the primary fluoride 130 (9:1 ratio), however dehydroxyfluorination of 131
(R = CO2Me) using DAST (Scheme 2.11) generated a 1:4 ratio of primary fluoride 133
versus secondary fluoride 132.14
Scheme 2.10. Dehydroxyfluorination of 125 using DAST gave preferably 126 over 127.14
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Scheme 2.11. Dehydroxyfluorination of 128 and 131 using DAST.14
De Jonghe et al.15 reported that dehydroxyfluorination of N-Boc-protected sphinghosine
using DAST occurred with modest regio- and stereo- selectivity. For instance treatment of
134 with DAST at -78 °C gave allylic fluorides 135 and 136 and oxazolidinone 137 (Scheme
2.12). Treatment of N-acyl-protected allylic alcohol 138 generated allylic fluorides 139 and
140 as well as oxazoline 141 (Scheme 2.13). Both of the products generated by direct
substitution of OH by F (135 and 139) were formed in favour of the threo diastereoisomer,
however no preference was shown for products 136 and 140 generated by allylic
transposition.
Scheme 2.12 Dehydroxyfluorination of 134 reported by De Jonghe et al.15
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Scheme 2.13 Dehydroxyfluorination of 138 reported by De Jonghe et al.15
To date, only a few examples of the dehydroxyfluorination of allylic alcohols using reagents
other than DAST have been reported. For instance, Middleton13 reported a similar level of
allylic transposition in comparison to that using DAST (Scheme 2.7), when 116 (Scheme
2.14) was subjected to reaction with DeoxofluorTM.
Scheme 2.14 Dehydroxyfluorination of 116 using DeoxofluorTM reported by Middleton.13
Reaction of 145 with Yarovenko’s reagent (Scheme 2.15) generated a 1:4 mixture of
regioisomers, 146 and 147 (a and b). The product 146, generated by direct substitution by
fluoride, was isolated as a single stereoisomer by column chromatography, and was assumed
to be generated through an SN2 reaction mechanism. The mixture 147 (a and b), generated by
allylic substitution by fluoride, was isolated as a 1:1 diastereomeric mixture.16
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Scheme 2.15. Dehydroxyfluorination of 145 using Yarovenko’s reagent.16
Dollé et al.17 reported the preparation of 149 by fluorination of the tosylate 148 with TBAF
(Scheme 2.16). Monosubstitution of the tosyl group by fluoride generated 149 in 30% yield.
Scheme 2.16. Fluorination of the tosylate 148 by treatment with TBAF.17
2.2) Aims and objectives:
For the synthetic programme aimed at the synthesis of trifluorosugars, presented later in this
thesis (Chapter 3), we required to fluorinate the diastereoisomers of allylic alcohol 155 (a and
b) for conversion to 156 (a and b) as illustrated in Scheme 2.17. However fluorination can
proceed either by direct substitution of OH for F to give 156, or by an allylic substitution
reaction to generate product 157. Furthermore for each reaction course there are two
stereochemical outcomes, thus diastereoisomers 155a and 155b can potentially generate a
mixture of four products, 156a/156b, and/or 157a/157b (Scheme 2.17). However the
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outcomes of the regio- and stereo- selectivity of fluorination of 155a and 155b may be
influenced depending on the fluorination reagent used. In order to enhance direct substitution
over allylic substitution, fluorination of 155a/155b was screened with various reagents
including DAST, DeoxofluorTM, TFEDMA, FluoleadTM and perfluorobutansulfonyl fluoride
(PBSF) in combination with Et3N·3HF (Figure 2.5).18
Scheme 2.17. Diastereoisomers 155a and 155b can generate four different isomeric products, as a result of
dehydroxyfluorination progressing either by direct or allylic fluorination.
Figure 2.5. Dehydroxyfluorination reagents DAST, DeoxofluorTM, TFEDMA, FluoleadTM and PBSF.
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It was envisaged that starting materials 155a and 155b could be prepared in four steps
following the synthetic route outlined in Scheme 2.18. Acetonide protection of D-mannitol
150 followed by oxidative cleavage of the resultant protected D-mannitol 151 would generate
aldehyde 152. Then an anti and a syn addition of aldehyde 152 to benzyl propargyl ether 153
would generate propargylic alcohols 154a and 154b, respectively. Reduction of propargylic
alcohols 154a (anti) and 154b (syn) would furnish the desired substrates 155a (anti) and
155b (syn), respectively (Scheme 2.18).
Scheme 2.18. Envisaged preparation of required substrates 155a and 155b.
2.3) Results and discussion:
2.3.1) Synthesis of 1,2:5,6-di-O-isopropylidene-D-mannitol 151:
1,2:5,6-Di-O-isopropylidene-D-mannitol 151 was prepared by reacting commercially
available D-mannitol 150 with acetone and anhydrous zinc chloride (ZnCl2) (Scheme 2.19),19
HO
OH
OH
OHOH
OH O
O
O
O
OH
OH
CHO
O
O
O
O OBn
OH
O
O
OBn
OH
O
O OBn
OH
O
O
OBn
OH
155a154a
154b 155b
OBn
150 151 152
153
58
a method developed by Baer20 and later optimised by Tipson and Cohen.21 This procedure
generated a complex mixture of mono-, di- and tri- acetals. Recrystallisation from a hot
solution of CHCl3/heptane gave 151 in 52% yield.
Scheme 2.19. Acetonide protection of D-mannitol 150 .19-21
Kuszmann et al.19 reported that the acetonation procedures using 2-methoxypropene and p-
toluenesulfonic acid in DMF, and the one using 2,2-dimethoxypropane, 1,2-dimethoxyethane
and tin(II) chloride, give a more complex mixture of acetals than reported in the literature.
Therefore these two methods were not attempted. Kuszmann et al.19 also stated that that
acetonation of D-mannitol 150 using acetone and zinc chloride (Scheme 2.19) is
recommended because of easy isolation and high conversion to product 151.
2.3.2) Preparation of protected glyceraldehyde 152:
Glycol cleavage of diol 151 using sodium metaperiodate (NaIO4) in CH2Cl2 in the presence
of NaHCO3 (aq),22,23 generated aldehyde 152 (Scheme 2.20) in 67% yield. The CH2Cl2
solvent was removed by distillation at atmospheric pressure, and aldehyde 152 was then
purified by fractional distillation through a Vigreux column. The [α]D of 152, after
distillation, was found to be consistent with literature values, and was a good indication that
racemisation had not occurred during the distillation process.
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Scheme 2.20. Glycol cleavage of 151.22
Protected glyceraldehyde 152 is volatile and unstable and rapidly undergoes polymerisation
at RT or lower.22 However the polymer can be cracked upon redistillation. Furthermore it is
reported that the enantiopurity of 152 is unaffected by repeated pyrolysis of the polymer and
distillation.22
2.3.3) Preparation of benzyl propargyl ether 153:
Benzyl propargyl ether 153 was prepared in good yield starting from commercially available
propargyl alcohol and benzyl bromide upon deprotonation of the alcohol with NaH in DMF
(Scheme 2.21).24
Scheme 2.21. Synthesis of benzyl propargyl ether 153.24
2.3.4) Preparation of propargylic alcohols 154a and 154b:
Mixtures of diastereoisomers 154a and 154b (Scheme 2.18) were prepared but with different
diastereoisomeric biases. The syn addition of lithium acetylide derived from 153 to freshly
prepared aldehyde 152 was first carried out under conditions planned to promote chelation-
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control25 as illustrated in Scheme 2.22. This generated 154b as the major isomer, but with
very low diastereoselectivity (9% de, determined by chiral GC-FID). The syn addition is
consistent with a chelation transition state in which nucleophilic attack26 occurs from the less
hindered face as indicated by the arrow in Figure 2.6.
Scheme 2.22. Syn addition of lithium acetylide of 153 to freshly prepared aldehyde 152.25
Figure 2.6. Chelation transition state leading preferentially to 154b.26
Attempts to increase the diastereomeric excess (% de) of the syn adduct 154b by following a
syn-selective addition in the presence of anhydrous zinc bromide (ZnBr2), described by
Mead,27 was also explored but without success (Scheme 2.23). Slow addition of a solution of
n-BuLi in hexane via cannula, to a solution of 153 in dry diethyl ether at -78 °C, resulted in
the formation of a precipitate. The solubility of n-BuLi was not improved even when the
addition was performed at 0 °C and using a larger amount of diethyl ether. A lack of
solubility of anhydrous ZnBr2 in diethyl ether was also observed. Therefore syn-selective
addition described by Mead27 was not further attempted.
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Scheme 2.23. Attempt to improve the % de of 154b using ZnCl2.27
An analogous reaction was carried out under non-chelation conditions using titanium tri-
isopropoxychloride, to favour anti-selective addition28 as illustrated in Scheme 2.24. This
gave 154a in a much higher diastereoisomeric excess (62% de, determined by chiral GC-
FID). The anti addition is consistent with a non-chelation transition state in which
nucleophilic attack28 occurs from the less hindered face as indicated by the arrow in Figure
2.7.
Scheme 2.24. Anti addition of lithium acetylide of 153 to freshly prepared aldehyde 152.28
O
O
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H
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Figure 2.7. Non-chelation transition state leading preferentially to 154a.28
The relative stereochemistry of diastereoisomers 154a and 154b was assigned by preparing
the dinitrobenzoyl ester derivatives as illustrated in Scheme 2.25. Treatment of 154a (62%
de) with 3,5-dinitrobenzoyl chloride in pyridine generated a mixture of diastereoisomers 158
(a and b) as a crystalline solid. The esters were recrystallised from absolute ethanol, and the
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relative stereochemistry of the major isomer 158a, originating from 154a, was determined by
X-ray structure analysis (Figure 2.8). The corresponding X-ray structure revealed an anti
relationship between the C-O bond of the ester group and the vicinal acetonide ether C-O
bond in stereoisomer 158a.
Scheme 2.25. Preparation of the dinitrobenzoyl ester derivative 158a (single isomer).
Figure 2.8. X-Ray structure of 158a.
2.3.5) Preparation of allylic alcohols 155a and 155b:
The diastereoisomeric mixtures of 154a/154b were then transformed separately by
propargylic reduction to the corresponding allylic alcohols 155a/155b using LiAlH429 as
illustrated in Scheme 2.26. These allylic alcohol reductions gave exclusively the E-olefins, as
expected. Although after 2 h, t.l.c analysis indicated complete consumption of the starting
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material, allylic alcohols 155a and 155b were obtained in only poor yield (respectively 55%
and 45%) after purification by column chromatography.
Scheme 2.26. Reduction of propargylic alcohols 154a and 154b by using LiAlH4 in n-hexane.29
When reduction was initially performed by treating 154a/154b with 2 equiv. of LiAlH4 in
THF, t.l.c analysis showed that the allylic alcohols were formed together with a large amount
of an unidentified side-product. Replacement of THF with the less polar solvent hexane, and
using only 1.3 equiv. of LiAlH4, generated less side-product. Furthermore the yield of allylic
alcohol formation was notably improved by replacing LiAlH4 with Red-Al® (Figure 2.9).30
Slow addition of 2 equiv. of Red-Al® (70% wt. in toluene) to a solution of 154a/154b in THF
at 0 °C generated 155a/155b in 90-95% yield, and this became the method of choice.
Figure 2.9. Structure of Red-Al®.30
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2.3.6) Dehydroxyfluorination attempts of allylic alcohols 155a/155b:
With the allylic alcohol diastereomeric mixtures 155a/155b in hand, the fluorination step was
explored. Accordingly, dehydroxyfluorination was conducted by treating the product mixture
155a/155b with 1.5 equiv. of DeoxofluorTM at RT for 1 h. The reaction was poorly regio- and
stereo- selective as it generated a mixture of four fluorinated products. The 19F{1H}-NMR of
the product mixture had four signals at -183.0, -183.4, -184.1 and -187.5 ppm (Figure 2.10).
Figure 2.10. 19F{1H}-NMR spectrum of the product mixture after dehydroxyfluorination of 155a/155b .
Identification of the individual fluorinated products was required. T.l.c analysis of the
product mixture showed two adjacent spots of unequal intensity. Two rounds of column
chromatography successfully separated these fractions from any unreacted starting material.
Subsequent NMR analysis and mass spectrometry indicated that the minor fraction was 156a
generated by direct substitution of OH by F, whereas the major fraction contained both
157a/157b, diastereoisomers generated by allylic substitution of OH by F. Diastereoisomer
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156b, generated by direct substitution of OH by F, was also present in this major fraction
(Scheme 2.27). Compounds 156b, 157a and 157b could not be further separated by
chromatography.
Scheme 2.27. Fluorination of allylic alcohols 155a/155b gave 156a and an inseparable mixture of isomers
156b/157a/157b.
1H-NMR analysis of 156a (Figure 2.11) showed signals at 4.16 ppm and 4.88 ppm that were
assigned to protons H1 and H2 respectively of 156a. The 1H- 1H COSY spectrum (Figure
2.12) has dashed lines highlighting 3JH1-H2 crosspeaks. This established that 156a resulted
from the direct substitution of OH by F. The 19F{1H}-NMR spectrum (Figure 2.13) of 156a
has a signal at -187.9 ppm corresponding to a single fluorine.
O
O
F
OBn
O
O
OH
OBn
O
O
OBn+
F
156a155a/155b
O
O
F
OBn +
156b 157a, 157b
major fraction
(inseparable mixture after
column chromatography )
minor fraction
(single isomer af ter
column chromatography)
DeoxofluorTM,
CH2Cl2, RT
66
Figure 2.11. 1H-NMR spectrum of 156a highlighting H1 and H2 signals.
Figure 2.12. 1H-1H COSY-NMR spectrum of 156a showing 3JH1-H2 crosspeaks .
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Figure 2.13. 19F{1H}-NMR spectrum of 156a.
The 1H-NMR spectrum (Figure 2.14) of the major fraction is clearly more complex, and has
signals at 5.12 ppm and 4.54 ppm that are assigned to protons H4 and H1 respectively in the
product mixture of 157a/157b. The signal at 4.87 ppm is assigned to proton H2‘ in product
156b. The 1H-1H COSY spectrum (Figure 2.15) has dashed lines highlighting 3JH1-H2, 3JH3-H4
crosspeaks but significantly there are no crosspeaks between H4 and H1. This confirms that
157a/157b are products resulting from the allylic substitution of OH by F.
O
O
F
OBn
156a
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Figure 2.14. 1H-NMR spectrum of the inseparable mixture of 156b/157a/157b.
Figure 2.15. 1H-1H COSY-NMR spectrum of the inseparable mixture of 156b/157a/157b.
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Analyisis of the 19F-HMQC spectrum of the inseparable mixture 156b/157a/157b (Figure
2.16) has dashed lines highlighting 2JH4-F and 2JH2‘-F crosspeaks which allow individual
assignment of the 19F resonances to products 156b, 157a and 157b. The 19F{1H}-NMR
spectrum (Figure 2.17) of the minor fraction has signals at -183.0 ppm, -183.4 ppm and -
184.1 ppm corresponding respectively to product 156b, 157a and 157b.
Figure 2.16. 19F-HMQC spectrum of the inseparable mixture of 156b/157a/157b.
Figure 2.17. 19F{1H}-NMR spectrum of the inseparable mixture of 156a/157a/157b.
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The influence of the reagent (Figure 2.18) was investigated in the dehydroxyfluorination of
155a/155b. The resultant ratios of products 156a/156b and 157a/157b were determined by
19F-NMR in the product mixture and the results are summarised in Scheme 2.28 and Table
2.1. The consumption of starting material was followed by t.l.c. Reactions using FluoleadTM
and TFEDMA were performed in polyethylene flasks as these reagents were found to etch the
glass. Reactions employing DeoxofluorTM and DAST were conveniently carried out in
standard laboratory glassware. Furthermore all of the reactions (see Paragraph 5.3, Chapter 5)
were performed under anhydrous conditions to avoid the in situ generation of HF. All
reactions gave very modest regio- and stereo- selectivity. A very low conversion was
obtained at -78°C with DAST, DeoxofluorTM and TFEDMA, and conversion was only
moderately improved at 0°C. Thus for these three reagents, warmer reactions temperatures
were necessary (see conditions in Table 2.1). Although the yields were not determined, the
reaction of FluoleadTM at 0 oC proved efficient in terms of conversion, but gave a similar
overall product profile to the other more established reagents that were investigated.
Figure 2.18. Dehydroxyfluorination reagents DAST, DeoxofluorTM, TFEDMA, FluoleadTM and PBSF.
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Scheme 2.28. Fluorination of allylic alcohol 155a/155b gave 156a and the inseparable mixture of isomers
156b/157a/157b.
Fluorinating
agent
Temp.
Major allylic
alcohol
substrate,
de %
Ratioa
156a/156b/157a/157b
Yield, %b
156a (156b/157a/157b)
TFEDMA RT 155a, 75% 2.0/1.0/2.9/4.2 11 44
DAST RT 155a, 75% 1.5/1.0/2.2/2.7 11 45
DeoxofluorTM 55 °C 155a, 75% 1.2/1.0/1.7/3.7 9 48
TFEDMA RT 155b, 17% 2.5/1.0/3.7/3.9 13 46
DAST RT 155b, 17% 1.5/1.0/2.1/2.2 12 44
DeoxofluorTM 55 °C 155b, 17% 1.5/1.0/2.6/2.7 10 44
FluoleadTM 0 °Cc
155a/155b
dr 1:1
1.9/1.0/2.6/2.8 NDc NDc
a Ratio in the crude mixture determined by 19F-NMR.
b Determined after two rounds of chromatography.
c ND-not determined. Product ratios determined by 19F-NMR only, although the conversion was high.
Table 2.1 Influence of the dehydroxyfluorinating agent on direct or allylic fluorination of 155a/155b in CH2Cl2
as a solvent.
The fluorination of 155a/155b with 1.1 equiv. of perfluorobutansulfonyl fluoride (PBSF) in
combination with Et3N·3HF (1.1 equiv.) and 3.3 equiv. of Et3N (3.3 equiv.)18 was found to
be very unreactive. T.l.c analysis indicated a very low conversion even after prolonged
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heating and the use of a large excess of reagent. Therefore this reagent was not explored
further. The relative stereochemistry of products 156a, 156b, 157a and 157b required to be
assigned. The configuration of isomer 156a was determined after conducting a Sharpless
dihydroxylation.31 Accordingly 156a as a single stereoisomer was reacted with AD-mix-β in
t-BuOH/H2O (Scheme 2.29) to favour the formation of diol 159. The reaction was stirred for
3 days at RT. 19F{1H}-NMR analysis of the product mixture showed the presence of three
fluorinated products, together with a significant amount of unreacted starting material. The
major fluorinated product was isolated by column chromatography as a white solid (single
stereoisomer). Recrystallisation from diethyl ether afforded 159 as a crystalline compound
suitable for X-ray structure analysis. The resultant structure (Figure 2.19) clearly shows that
there is an anti relationship between the C-F bond and the vicinal acetonide ether C-O bond
in stereoisomer 159.
Scheme 2.29. Synthesis of 159 using a Sharpless dihydroxylation reaction.31
Figure 2.19. X-ray structure of 159 used to determine the relative stereochemistry of 156a.
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To complete the stereochemical analysis of the fluorination reaction of 155a/155b, the
diastereoisomer preference for the allylic substituted products 157a/157b was also explored. A
TFEDMA reaction on 155a (75% de) generated a diastereoisomeric mixture of
156b/157a/157b in the ratio 0.3/0.7/1.0 (determined by 19F-NMR). The relative
stereochemistry of 157a/157b was determined after a Sharpless dihydroxylation31 of the
inseparable mixture of 156b/157a/157b. Accordingly the mixture of 156b/157a/157b was
treated with AD-mix-β in t-BuOH/H2O to favour the formation of a mixture of diols
160a/160b (Scheme 2.30).
O
O
OBn
FOH
OH
1:0.7 diastereomeric
mixture favouring 160b
160a/160b 60%
O
O
OBn
F
O
O
F
OBn +
156b 157a, 157b
inseparable mixture by
silica gel chromatography
i) AD-mix-, t-BuOH/H2O,
0 °C then RT, 3 days
ii) Column chromatography
Scheme 2.30. Preparation of the mixture of diols 160a/160b.
19F{1H}-NMR of the product mixture indicated that the Sharpless dihydroxylation had
proceeded with high diastereoselectivity. Chromatography gave a 1:0.7 diastereoisomeric
mixture of diols favouring 160b.32 Separation of the corresponding diol derived from 156b was
unsuccessful. The vicinal diols 160a and 160b were then converted to their corresponding
cyclic sulfates using the Sharpless protocol (Scheme 2.31).33 Thus 160b/160a (dr 1:0.7) was
treated with SOCl2 and pyridine to generate a mixture of cyclic sulfites 161. The resulting
mixture of cyclic sulfites 161 was directly oxidised without isolation.
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Oxidation used RuO4 (NaIO4 and catalytic amount of RuCl3) in MeCN-H2O generated the
desired cyclic sulfates 162b and 162a in 1:0.7 diastereomeric ratio. The two diastereoisomers
were successfully separated by flash chromatography (162b in 61% yield, 162a in 27% yield).
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160b/160a, dr 1: 0.7
SOCl2, pyridine
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O O
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O O
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O
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O O
F
S
O O
+
162b 61%
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1 0.7
NaIO4, RuCl3, MeCN,
H2O, 0 °C
CH2Cl2, 0 °C
Scheme 2.31. Preparation of cyclic sulfates 162a and 162b by the Sharpless protocol.33
The minor isomer 162a was crystallised in Et2O and a suitable crystal was subjected to X-ray
structure analysis. The corresponding X-ray derived structure is illustrated in Figure 2.20 and
confirms the stereochemistry as shown. By inference the major isomer formed in the allylic
fluorination reaction of 155a (de 75%) is 157b (Figure 2.21).
Figure 2.20. X-ray structure establishes the absolute configuration of 162a.
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Figure 2.21. Structure of major isomer formed in the allylic fluorination reaction of 155a (de 75%)
2.4) Conclusions:
In this Chapter the dehydroxyfluorination on substrate 155a/155b was investigated with a
range of reagents, which can proceed either by direct or allylic substitution. The
stereochemical preference of direct substitution by fluoride and allylic fluorination were
assessed by determining X-ray structures of suitable product derivatives. None of the reagents
proved to be regio- or stereo- selective, however in all of the reactions the allylic fluorination
products 157 (a and b) prevailed over the direct fluorination products 156 (a and b). In the case
of direct substitution, the major isomer was 156a for all of the reagents explored in spite of the
stereochemical bias of both starting diastereoisomer mixtures of 155a/155b. Furthermore 155a
(75% de) generates a fluorinated product with retention of configuration (156a), therefore an
SN1 pathway is proposed for the dehydroxyfluorination of 155a/155b.
Most likely the reaction proceeds via a carbocation intermediate (shown in Scheme 2.32 for
the reaction using TFEDMA), stabilised by transposition of the allylic double bond, which
favours the formation of 157a/157b over 156a/156b. Furthermore, steric and electronic effects
related to the acetonide and its ether oxygen induces fluoride attack to a specific face of the
carbocation intermediate, favouring the formation of 156a over 156b. Allylic fluorination
displayed a much reduced facial bias consistent with the proposed mechanistic pathway, thus
the formation of 157b is favoured over 157a.
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Scheme 2.32. Proposed mechanism for the dehydroxyfluorination of allylic alcohol 155a/155b.
Product 156a was used in the synthesis of trifluoro D-hexose glucose analogue 193 and
trifluoro D-hexose altrose analogue 216 (Scheme 2.33), and this is discussed in Chapter 3.
Scheme 2.33. Allylic fluoride 156a is the key intermediate for the synthesis of trifluoro D-glucose analogue 193
and trifluoro D-altrose analogue 216.
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Chapter 3. Synthesis of trifluoro D-hexose sugar analogues and
assessment of their erythrocyte transmembrane transport
3.1) Introduction:
3.1.1) Fluorosugars:
Over the last 15 years, the interest of the scientific community in the synthesis of
fluorinated carbohydrates has increased steadily.1,2 This is due to the possibility of
modulating their physicochemical properties by the selective introduction of fluorine. The
replacement of OH by fluorine in a sugar can alter the hydrophilic/lipophilic balance,
change the adsorption, modify the hydrogen bonding capacity as well as affect the
receptor binding ability of those sugars.1 Furthermore a fluorine motif in a sugar offers a
sensor to investigate carbohydrate metabolism and protein-carbohydrate interactions.3,4,5
In particular 19F is a NMR active nucleus6 which allows generation of 19F-NMR spectra
without a background signal. Also, 18F is positron-emitting isotope, and 18F-labelled
sugars are important compounds for positron emission tomography (PET) in the clinic.7
Glycosyl fluorides are used as glycosyl donors in chemical and enzymatic glycosylation
reactions, furthermore they can be important substrates or inhibitors in enzymatic
reactions.1
This chapter focuses on deoxyfluoro sugar analogues obtained by fluorination of non-
glycosydic positions.1 The substitution of a single OH by fluorine in a sugar removes the
hydrogen bonding donor capacity at that site because there is no hydrogen, but it retains
the weak hydrogen bonding acceptor ability and the C-O/C-F polarity. Furthermore, the
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substitution of OH (van der Waals radius around 1.57 Å) by F (van der Waals radius
around 1.47 Å) has a negligible steric effect. Therefore monosubstituted deoxyfluoro
sugars, such as the 2-deoxy-2-fluoro-D-glucose analogue 163 and 3-deoxy-3-fluoro-D-
glucose analogue 164 (Figure 3.1), have become particularly attractive in assessing the
influence of polarity versus hydrogen bonding ability in transport and binding studies.8
Figure 3.1. 2-Deoxy-2-fluoro-D-glucose analogue 163 and 3-deoxy-3-fluoro-D-glucose analogue 164.8
Examination of the literature reveals that deoxyfluoro sugars with more than one fluorine
are less common, for instance, there are only a few examples of deoxyfluoro hexoses with
two fluorines replacing secondary alcohols eg. 165 and 166 (Figure 3.2).9,10 Attention has
focused on much more highly fluorinated sugar analogues, particularly on deoxyfluoro
sugars containing an internal perfluoroalkylidene fragment (IPF).1
For instance DiMagno et al.11 prepared the hexafluorohexose analogue 167 (Figure 3.2) to
introduce the concept of “polar hydrophobicity”,12 which finds its fundamentals in the
positive variation of entropy associated with the liberation of water by desolvation of a
solute, occurring, for instance, when a hydrophobic molecule binds to a protein receptor.
Thus, the replacement of hydrophilic OH groups with hydrophobic substituents such as
CF2 will increase the entropy of binding, as a hydrophobic molecule is more easily
desolvated when transported to the receptor, increasing the molecular recognition of the
transporter protein as a result. In parallel, advantageous electrostatic interactions occur in
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proximity of the receptor, between the C-F bonds and polar charged centres of the
protein. The transport of 167 across the red blood cell membranes was explored by 19F-
NMR and 2D 19F EXSY-NMR.11 This study has opened the way to the preparation of
further IPF containing sugars. Linclau et al.13,14 developed methodologies for the
enantioselective synthesis of the tetrafluorinated ribose derivative 168 and for the
synthesis of the tetrafluoropyranose analogue 169, as well as the tetrafluorinated D-
glucose analogue 170 and D-galactose analogue 17115 (Figure 3.2). Gouverneur et al.16
have reported the synthesis of the tetrafluorofuranose derivative 172 (Figure 3.2) for
incorporation into enantioenriched tetrafluorinated aryl-C-nucleosides.
Figure 3.2. Some examples of relevant fluorinated carbohydrates analogues 165-167, 169-172, and
derivative 168.9- 15
Interestingly, the synthetic methodologies adopted by DiMagno et al.,11 Linclau et.
al.,13,15 and Gouverneur et al.16 followed the building block approach,1 which involves the
preparation of a fluorinated non-sugar scaffold that can be transformed into a deoxyfluoro
sugar. For example Linclau et al.14 synthesised 169 in 5 steps starting from the fluorinated
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scaffold 173 (Scheme 3.1). A Sharpless dihydroxylation of 173 generated 174, which was
then monofunctionalised by regioselective formation of the primary benzyl ether 175.
Formylation of 175 gave 176 and this was followed by lithiation to 177 in situ, via a
bromine-lithium exchange, and subsequent anionic cyclisation furnishing 168. Finally
deprotection of the benzyl group of 168 generated the tetrafluoropyranose analogue 169.
CF2CF2Br
K2OsO4·2 H2O (2 mol%), (DHQ)2PYR (2 mol%),
K3Fe(CN)6
(DHQ = dihydroquininyl, PYR = pyrimidine)
i) Bu2SnO, toluene, reflux, 24 h DCC, DMAP, HCOOH
OBn
CF2CF2Br
OH
OH
CF2CF2Br
OH
OBn
CF2CF2Br
O
CHO
OBn
CF2CF2Li
O
CHOMeLi (1 equiv)
F2C CF2
O
OBn
OH
168 78%
C
F2
CF2
O
HO
OH
169 98%
Pd(OH)2/C, H2
174 96%, 81% ee173
175 97% 176 95%
177
K2CO3, t-BuOH, H2O, 4 °C, 9 d
ii) BnBr, Bu4NI, reflux, 16 h CH2Cl2, RT, 16 h
THF, -78 °C, 3 h EtOAc, RT, 4 h
Scheme 3.1. Preparation of 169 via a building block approach.1,14
The synthesis of deoxyfluoro sugars from fluorinated building blocks differs from the
more popular replacement of an OH group with fluorine directly on a carbohydrate
precursor.2 In this manner, Sarda et al.17 reported the synthesis of diacetylated trifluoro D-
galactose analogue 178 (Scheme 3.2) and D-glucose analogue 179 (Scheme 3.3).
Compounds 178 and 179 are diastereoisomers that differ only in their configuration at C4.
Synthesis of 178 started from p-toluene-sulfonate 180 (Scheme 3.2). Treatment of 18018
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with sodium methoxide (NaOMe) generated epoxide 181. Epoxide ring opening of 181
with KHF2 in boiling ethylene glycol gave fluorohydrin 182 as the main product.
Fluorohydrin 182 was then subjected to dehydroxyfluorination, which took place with
retention of configuration, to give 183. Debenzylation of 183 followed by
dehydroxyfluorination, with an inversion of configuration afforded 185. Treatment of 185
with a mixture of acetic anhydride (Ac2O) and sulfuric acid (H2SO4) gave the diacetylated
D-galactose 178 (Scheme 3.2).
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KHF2 DAST
O O
OBn
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F
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O O
OBn
OH
F
O OF
F
F
OF
F
OAc
OAc
F
181 182
183 70% 185 72%
178 75%
O O
OBn
OH
OTs
180
NaOMe
H2, Pd/C O
O
OH
F
F
PhMe, (CH2OH)2, 
EtOAc, RT PhMe, 
Ac2O, H2SO4
RT
184 96%
Scheme 3.2. Preparation of D-galactose trifluoro sugar precursor 178.17,18
Synthesis of the diacetylated D-glucose analogue 179 was achieved starting from
intermediate 184 (Scheme 3.3). The configuration at C4 of 184 was inverted by preparing
triflate 186, followed by treatment with sodium benzoate (PhCO2Na) which generated
187. Methanolysis of ester 187 gave alcohol 188. Dehydroxyfluorination of 188 took
place with an inversion of configuration, to generate 189, which was reacted with a
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mixture of Ac2O and H2SO4 to give 179 (Scheme 3.3). Sarda et al.17 did not explain why
dehydroxyfluorination using DAST occurred with an inversion of configuration in some
cases and with a retention in other cases. Furthermore, the diacetylated analogues 178 and
179 were never hydrolysed to explore the physical or biological properties of the free
carbohydrates.
Scheme 3.3. Preparation of D-glucose trifluoro sugar precursor 179.17
3.1.2) The Human Facilitative Glucose Transporter (Glut1):
Human erythrocytes (red blood cells) are recognised to have a transport capability for D-
glucose across their cell membranes.19 This is carried out by the Human Facilitative
Glucose Transporter (Glut1), which is a protein of the glucose transporter facilitator
family.19 These proteins are not associated with ATP hydrolysis.20 Their transport,
through a process of facilitated diffusion is specific for the D-enantiomer of glucose. Thus
D-glucose is transported depending on its chemical gradient inside or outside the cell.20
Although no crystal structure of Glut1 has been obtained, two three-dimensional models
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namely Glut1A and Glut1B have been predicted19 based on the crystal structures of the
two homologous proteins GlpT21 and LacY22, respectively.
Glut1 is a transmembrane protein composed of 492 residues19 characterised by a channel
across the protein connecting the intra- and extra- cellular environments. Glut1 is
composed by twelve transmembrane helices divided into two 6-helical domains by a large
intracellular loop between H6 and H7, as illustrated in Figure 3.3 (a). The extracellular
side and the cytoplasmic view of the protein are shown in Figure 3.3 (b) and (c)
respectively.19 Key amino acid residues which line the walls of the channel have also
been identified.
Figure 3.3. Representations of Glut1.19 (a) Side view showing the relative positions of the helices; Glut 1
measures ~35.6 x 26.3 Å viewed from the top, and 46.2 x 27.2 Å from the bottom. Its height is ~61 Å. (b)
View from the extracellular side showing the 12 transmembrane helices; (c) Cytoplasmic view. Reprinted
from A. Salas-Burgos, P. Iserovich, F. Zuniga, J. C. Vera, J. Fischbarg, Biophys. J., 2004, 87, 2990-2999.,
Copyright 2004, with permission from Elsevier.
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3.1.3) Erythrocyte transmembrane transport of fluorosugars:
Fluorosugars, such as the 3-deoxy-3-fluoro-D-glucose analogue 164 (Figure 3.1), have
been studied with Glut1. G. J Riley and N. F. Taylor,23 using an optical method developed
by A. K. Sen and W. F. Widdas,24 were the first to discover that 164 can cross the
membrane of red blood cells via Glut1. The Vmax of the transport of D-glucose, 3-deoxy-
3-fluoro-D-glucose analogue 164 and 3-deoxy-D-glucose analogue 190 (Figure 3.4) were
found to be very similar when Glut1 was saturated with each of these sugars.23
O
OHHO
OH
OH
190
O
OHHO
F
OH
OH
164
Figure 3.4. 3-deoxy-3-fluoro-D-glucose analogue 164 and 3 deoxy-D-glucose analogue 190.22
Kuchel et al.25 observed that the 19F-NMR spectrum of 164 in a red blood cell suspension
displayed four resonances, as a result of the intra- and extra- cellular populations of the α-
and β- anomers. The intracellular resonances were broader and were found to be shifted
downfielded compared to the extracellular signals. This experiment was consistent with
previous work reported by R. E London and S. A. Gabel,26 whereby the 19F signals of
trifluoroacetamide and trifluoroacetate were found to resolve intra- and extra- cellular
when suspended in human red blood cells.
They suggested27 that the chemical shift difference may be due to the different level of
binding interactions between the intra- and extra- cellular enviroments, as well as high
intracellular viscosity. Kuchel et al.25 reported that the exchange rate of the α- and β-
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anomers of 164 across red blood cell membranes can be determined by a 19F-NMR spin-
transfer technique. Furthermore, Kuchel et al.25 revealed that the exchange of 164 across
red blood cell membrane was reduced by glucose-transport inhibitors such as phloretin
and cytochalasin B,28,29 reinforcing Riley and Taylor’s studies30 whereby the transport of
164 involves Glut1 and is not simply due to diffusion. London et al.8 described the
erythrocyte transmembrane transport of the sugar analogues 163 and 164 (Figure 3.1) as
well as the 4-deoxyfluoro-D-glucose 191 and 6-deoxyfluoro-D-glucose 192 (Figure 3.5)
using a combination of 1D 19F-NMR and 2D 19F-NMR EXSY experiments. The 2D 19F-
NMR EXSY experiment detects correlations between the 19F-NMR shifts of intra- and
extra- cellular enviroments, the intensities of which correlates to the exchange rate across
the membrane.
Figure 3.5 4-Deoxyfluoro glucose 191 and 6-deoxyfluoro glucose 192.8
Although the presence of fluorine in sugars generally inhibits metabolism,8 the 19F-NMR
spectrum of 164 showed, in addition to its intra- and extra- cellular resonances, extra
signals corresponding to metabolites of 164. One of these was identified as the 3-fluoro-
3-deoxygluconate and/or its 6-phosphate ester (only intracellular), and also 3-
fluorosorbitol (intra- and extra- cellular). Also the 19F-NMR spectrum of 163 showed an
additional signal corresponding to the 2-fluoro-2-deoxygluconate and/or its 6-phosphate.8
The formation of these metabolites is slow, thus no interference with the transmembrane
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study was observed. For each of the analogues 163, 164, 191 and 192 there were no cross-
peaks associated with / anomer interconversion in the 2D 19F-NMR EXSY spectrum.
The efflux rate constants (kef) of 163, 164, 191 and 192 were determined either by 1D 19F-
NMR and 2D 19F-NMR EXSY experiments, and the average values are shown in Table
3.1. The 2-deoxy-2-fluoro-D-glucose 163 and 3-deoxy-3-fluoro-D-glucose 164 were
found to cross the erythrocyte membrane at similar rates to glucose, however 4-
deoxyfluoro-D-glucose 191 and 6-deoxyfluoro-D-glucose 192 were found to be
transported more slowly.8 Furthermore the α-anomers were all more rapidly transported
than the β-anomers,8 similarly to D-glucose itself.31 However the α- and β- anomers of
163 and 164 were transported at rates only slightly in favour of the α-anomer, whereas
this difference was much bigger for 191 and 192.
Analogue kef (s-1)
163 (α-anomer) 1.29 ±0.31
163 (β-anomer) 1.21±0.22
164 (α-anomer) 1.35±0.32
164 (β-anomer) 1.04±0.23
191 (α-anomer) 0.77±0.16
191 (β-anomer) 0.30±0.09
192 (α-anomer) 0.72±0.21
192 (β-anomer) 0.44±0.20
Table 3.1. Measured kef for the transport of 163, 164, 191 and 192 across the red blood cell membranes.8
This data suggest that the transport rates of monosubstituted deoxyfluoro sugar analogues
across the red blood cell membranes are not dramatically affected by replacement of one
OH by F at individual positions.11 Conversely changing the configuration of a single
O
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hydroxyl group on glucose has a dramatic impact on the tranport rates. For instance D-
galactose is transported nearly 10 times slower than D-glucose across the red blood cell
membrane.32
DiMagno et al.11 carried out transmembrane transport studies of the highly fluorinated
hexose analogue 167 (Figure 3.2) in red blood cells also by the use of 2D 19F EXSY-
NMR. It was found that 167 is transported 10 times faster than 3-deoxy-3-fluoro-D-
glucose 164,11 most probably due to a higher affinity to the relevant membrane protein,
and the α-anomer is more rapidly transported than the β-anomer.11 No cross peaks
associated with / anomer interconversion were observed, indicating that the rate of this
phenomenon is slow. Also, there was no formation of metabolites observed. Replacement
of OH by F can increase the lipophilicity of molecules,33,34 and this can enhance the rate
of transport across the membrane by simple diffusion. Thus, DiMagno et al.11 performed a
series of experiments to demonstrate that the improved transport of 167 compared to 164
across the red blood cell membranes was due to an increased binding to the Glut1
transporter, and not diffusion. For instance, when the potent glucose-transport inhibitor
phloretin28 was added, the exchange rate was reduced by a factor of three.
3.2) Aims and objectives:
The focus of this research was to explore a stereoselective synthesis to the trideoxy-
trifluoro D-glucose analogue 193 (Figure 3.6). This would be the first example of a
trifluorohexose in the literature.
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Figure 3.6. Trideoxy-trifluoro D-glucose analogue 193.
It was envisaged that 193 could be prepared starting from intermediate 156a (see
preparation in Chapter 2) following the synthetic route outlined in Scheme 3.4. A key
aspect of this approach involves the synthesis of the vicinal trifluoro motif 197, which
could then be converted to aldehyde 198 by oxidation. Acetonide cleavage of 198 would
then generate 193 by an intramolecular cyclisation (Scheme 3.4). It was anticipated that
this novel D-glucose analogue could be then explored for its ability to cross red blood cell
membranes, in order to compare it with D-glucose. This could give some insight into the
role of C-F bonds as C-OH mimics, and the importance of hydrogen bonding in the
process.
Scheme 3.4. Proposed route to the trifluorohexose 193.
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3.3) Results and discussion:
3.3.1) Synthesis of D-glucose analogue 193 and D-altrose analogue 216:
3.3.1.1) Introduction of the second fluorine:
The synthesis of allyl fluoride 156a was discussed in Chapter 2. This was used as a
starting point for the synthesis of 193 and 199. Epoxidation of 156a using m-CPBA35 in
CH2Cl2 generated an inseparable mixture of fluoro-epoxides 194a/194b (dr 1:0.7,
determined by 19F-NMR) (Scheme 3.5).
Scheme 3.5. Synthesis of epoxide isomers 194a/194b.
With the diastereomeric mixture of fluoro-epoxides 194a/194b in hand, an epoxide ring
opening reaction was then explored. Initially the mixture of 194a/194b was reacted with
Et3N·3HF (8.0 eq) in dry chloroform at RT. The reaction was slow and even after 3 days
at 70 °C, t.l.c analysis of the product mixture still indicated the presence of unreacted
starting material. 19F{1H}-NMR of the product mixture at this stage showed a complex
pattern of fluorine signals (Figure 3.7), and clear identification of the individual
fluorinated products was required.
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Figure 3.7. 19F{1H}-NMR spectrum of the product mixture after epoxide ring opening of the inseparable
mixture of 194a/194b.
Chromatography successfully separated four fractions from unreacted starting material
194a/194b. Subsequent structure analysis by NMR and mass spectrometry indicated that
the two major components were 195a and 195b generated via an SN2 pathway by fluoride
ion attack at the less hindered β-position of the epoxide (Scheme 3.6 and Table 3.1).
Compounds 195a and 195b could be separated by chromatography.
A minor component contained an inseparable mixture of diastereoisomers 199a/199b
(Scheme 3.6 and Table 3.1), which was presumably generated by fluoride attack at the
more hindered position (α-position) of the epoxide. A fraction containing 200a/200b
(Scheme 3.6 and Table 3.1) was also isolated, which are products of acetonide cleavage.
These could not be separated from each other by chromatography. Epoxide ring opening
of 194a/194b was also attempted by reaction with TBATF36,37 and KHF2,36,37 however
these attempts did not appreciably improve the outcome of the reaction. BF3·Et2O (33
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mol%) in CH2Cl2 was also explored.38 It proved to be very reactive even at low
temperature (-78 °C), but it mainly resulted in the cleavage of the acetonide protecting
group. Therefore Et3N·3HF became the reagent of choice for the epoxide ring opening
reaction of 194a/194b. The reaction shown in Scheme 3.6 was therefore further
developed and optimised. The goal was to reduce the cleavage of the acetonide protecting
group (acid-labile) which generated side-products 200a and 200b, and also to shorten the
reaction time.
The use of protic solvents was avoided as they diminish the nucleophilicity of fluoride
ions. When epoxide ring opening of 194a/194b was carried out with additional Et3N,
integration of the signals at -217.0 and -202.7 ppm (corresponding to 200a and 200b, see
Table 3.2) in the 19F{1H}-NMR spectrum of the product mixture indicated a remarkable
reduction of the acetonide cleavage side-reaction. Also, the reaction time was
significantly reduced when performed under microwave (MW) irradiation.39 Furthermore,
a temperature gradient was found to be necessary to prevent the acetonide cleavage under
MW conditions.
Scheme 3.6. Epoxide ring opening of 194a/194b with Et3N·3HF generated a complex mixture of products
195a, 195b, 199a, 199b, 200a and 200b.
*Probable structure based on partial purification/characterisation.
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Product
19F{1H}-NMR chemical shifts (ppm) JF-F (Hz)
F F JF-F
194a -199.1 - -
194b -200.8 - -
195a -196.8 -200.3 -
195b -194.7 -211.5 3.0
199a -211.6 -212.2 9.0
199b -201.2 -202.9 12.0
200a -217.0 - -
200b -202.8 - -
Table 3.2. 19F-NMR chemical shifts (ppm) of products 194a, 194b, 199a, 199b, 200a and 200b and JF-F
coupling constants of products 195a, 195b, 199a and 199b.
The optimised method of choice for ring opening of 194a/194b is illustrated in Scheme
3.7. Although fluorohydrins 195a and 195b were not crystalline materials, the
stereoselectivity of this reaction was determined by X-ray crystallographic analysis of the
final products 193 and 199. Increasing the Et3N (2.15 eq) (Scheme 3.7) required a longer
reaction time (21 h under MW). Although t.l.c analysis of the product mixture showed
high consumption of the starting material, the fluorohydrins 195a, 195b, 199a and 199b
were obtained in low yields (Scheme 3.7). Furthermore, the 19F{1H}-NMR spectrum of
the product mixture indicated that this reaction generated a mixture of isomers of
195a:195b:199a:199b in a ratio of 0.7:1.0:0.2:0.3. This suggests that fluoride attack
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preferentially occured at the less hindered β-position over the α-position. The reason for
this is probably due to the strong electron-withdrawing effect of the vicinal fluorine,
which strengthens the Cα-O epoxide bond and promotes fluoride ion attack at the β-
position.40
Scheme 3.7. Optimised conditions for epoxide ring opening. The yields (%) were recorded after two
rounds of chromatography.
Epoxide ring opening of 194a/194b proved to be even slower when carried out on a larger
scale (1 g). A consistent cleavage of the acetonide protecting group occurred when the
reaction was forced to go to completion by extending the reaction time. Therefore, these
reactions were carried out repeatedly on a smaller scale (around 500 mg), and products
were accumulated.
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3.3.1.2) Introduction of the third fluorine:
Fluorohydrins 195a and 195b were used individually for their conversion to the
corresponding trifluoro D-hexose analogues. Treatment of 195a or 195b with
DeoxofluorTM41 generated trifluoroacetal 196 (Scheme 3.8) and 201 (Scheme 3.9)
respectively. After 14 h at RT, for dehydroxyfluorination of either 195a and 195b, the
19F{1H}-NMR spectrum of the product mixture showed complete consumption of the
starting material and generation of the corresponding trifluoroacetal product as a single
diastereoisomer.
Scheme 3.8. Dehydroxyfluorination of 195a generated 196.
Scheme 3.9. Dehydroxyfluorination of 195b generated 201.
3.3.1.3) Debenzylation of trifluoroacetals 196 and 201:
The next step required the debenzylation of the trifluoroacetals 196 and 201. Catalytic
hydrogenolysis under a hydrogen atmosphere was initially attempted on both compounds
196 (Scheme 3.10) and 201 (Scheme 3.11). Different catalysts and a range of reaction
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conditions were explored. Surprisingly the standard hydrogenation conditions for
debenzylation failed, even under a hydrogen pressure of 15 atm. The results are
summarised in Table 3.3. Starting material was recovered (entries 1 and 2 in Table 3.3) or
was only partially consumed (entry 3 in Table 3.3). It was not clear why this approach
failed, perhaps due to some sulfur residues from the preceding DeoxofluorTM reaction,
however the origin of this remain unclear.
Scheme 3.10. Unsuccessful debenzylation reaction of 196 by hydrogenolysis, using the conditions reported
in Table 3.3.
Scheme 3.11. Unsuccessful debenzylation reaction of 201 by hydrogenolysis, using the conditions reported
in Table 3.3.
Entry Catalyst Solvent
Molar
concentration
(196 or 201)
Pressure
(atm.)
Temp.
(°C)
Time
(h)
1 Pd/C (10 mol%) MeOH 0.02 1 23 18
2 Pd(OH)2 (10 mol%) EtOAc 0.06 1 23 18
3 Pd/C (20 mol%) THF 0.02 15 60 18
Table 3.3. Attempts at the debenzylation of 196 and 201 by catalytic hydrogenolysis.
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When trifluoroacetal 196 was treated with BCl3 (1M in CH2Cl2) at -78 °C, there was no
reaction even after 2.5 h, however, increasing the reaction temperature to 0 °C resulted in
a partial cleavage of both the benzyl and acetonide protecting groups. It was clear that a
method to selectively deprotect the benzyl ether was necessary.
In the event, chemoselective deprotection of the benzyl ether was accomplished by a
method described by Adinolfi et al.42 Treatment of 196 (Scheme 3.12) and 201 (Scheme
3.13) with sodium bromate (NaBrO3) and sodium dithionite (Na2S2O4) under a two-phase
solvent system (EtOAc/H2O) generated 197 and 202 respectively. After 1 h at RT, for
debenzylation of either 196 and 201, the 19F{1H}-NMR spectrum of the product mixture
indicated complete consumption of the starting material and generation of the
corresponding alcohol product as a single diastereoisomer.
Scheme 3.12. Debenzylation reaction of 196.
Scheme 3.13. Debenzylation reaction of 201.
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3.3.1.4) Oxidation and intramolecular cyclisation:
The final steps of the synthesis involved oxidation of trifluoroalcohol 197 to the
correspondent aldehyde 198 using the Dess-Martin periodinane reagent43 (Scheme 3.14).
The resultant α-fluoroaldehyde 198 was unstable, thus it was not isolated and was
immediately subjected to acetonide cleavage with anhydrous SnCl2 in CH2Cl2.44 This was
followed by a spontaneous intramolecular cyclisation which generated the target D-
glucose analogue 193. 19F-NMR indicated that 193 was generated as a mixture of
anomers as expected (Scheme 3.14).
Scheme 3.14. Final steps for the preparation of the D-glucose analogue 193.
The free sugar 193 is a white crystalline solid and a suitable crystal was subjected to X-
ray structure analysis to confirm the relative and absolute stereochemistry. The resultant
structure is shown in Figure 3.8. The stereochemistry is as anticipated and consistent with
the expected configuration of each C-F bond forming reaction through the synthesis. The
structure of the resultant β-anomer of 193 is shown in Figure 3.8.
Figure 3.8. X-ray crystal structure of the D-glucose analogue 193 (β-anomer).
193
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In a similar manner, trifluoroalcohol 202 was oxidised and subjected to acetonide
cleavage to generate the target D-altrose analogue 216, also as a mixture of anomers
(Scheme 3.15).
Scheme 3.15. Final steps for the preparation of the D-altrose analogue 216.
Likewise a suitable crystal of hexose 216 was subjected to X-ray structure analysis and
the resultant β-anomer is shown in Figure 3.9. Again, the structure confirms the expected
stereochemistry, consistent with the anticipated stereochemical course of the various C-F
bond forming reactions during the synthesis.
Figure 3.9. X-ray crystal structure of the D-altrose analogue 216 (β-anomer).
In both of the X-ray structures of the trifluorosugars 193 and 216, the crystal packing
revealed a partitioning of the oxygens/hydroxyls from the fluoromethylene residues, an
intermolecular pattern most probably imposed by the stronger hydrogen bonding
interactions between the oxygen atoms and hydroxyl groups. This can be seen in Figure
3.10 for the D-glucose analogue 193 where the shortest intermolecular O--H and F--H
216
F
O
F
FOH
HO
interactions are 1.74 and 2.43 Å respectively, and in Figure 3.11 for the D-altrose
analogue 216 where the shortest intermolecular O--H and F--H interactions are 1.82 and
2.42 Å respectively.O/OH
interfaceCH/CFFigure 3.10. Molecular packing of analogue 193 (β-anomer).
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Figure 3.11. Molecular packing of analogue 216 (β-anomer).
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3.3.1.5) NMR analysis of D-glucose analogue 193 and D-altrose analogue 216:
NMR analysis provides 19F chemical shifts as well as 19F-1H, 19F-13C and 19F-19F coupling
constants as parameters to obtain structural information.6 However, the presence of three
vicinal fluorines in 193 and 216 generated a complex 1D spectrum. As a result, an
unambigous assignment of all the 1H, 13C and 19F signals was not possible due to
extensive overlap of the NMR resonances. In these cases, carrying out 2D NMR analyses
such as 1H-19F HMBC and 19F-19F COSY as well as 1D analysis such as 1H{19F}-NMR,
was essential to assist confident signal assignments.
In order to assign the specific anomers in the CDCl3 solutions of 193 and 216, a series of
1D and 2D NMR experiments was carried out. The 1H-NMR spectrum of 193 (Figure
3.12) shows two doublet of doublets assigned to H1 (α or β), one at 5.48 ppm displaying
coupling constants of 3.7 and 3.1 Hz, and one at 4.91 ppm displaying coupling constants
of 7.6 and 3.1 Hz. The 1H{19F}-NMR spectrum of 193 in CDCl3 allowed discrimination
between the 3JH-H and 3JH-F coupling constants. The spectrum (Figure 3.13) shows two
doublets at 5.48 ppm and 4.91 ppm displaying 3JH-H coupling constants of 3.7 and 7.6 Hz
respectively. The larger 3JH-H coupling constant of 7.6 Hz is indicative of a trans-diaxial
relationship between the protons H1 and H2, thus the signal at 4.91 ppm was assigned to
the β-anomer. By inference, the signal at 5.48 ppm was assigned to the α-anomer.
Integration of these signals indicated that the anomers were present in a ratio of 1:0.2
(α:β) (Figure 3.13).
Figure 3.12. 1H-NMR spectrum of 193 in CDCl3.
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The 1H,19F-HMBC spectrum of 193 in CDCl3 allowed an assignment of F2α and F2β. The
spectrum (Figure 3.14) shows 3JH1α-F2α and 3JH1β-F2β crosspeaks which enabled an
assignment of the doublet of doublets at -199.9 ppm and -200.5 ppm to F2α and F2β,
respectively.
Figure 3.14.
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93 in CDCl3 (Figure 3.15) allowed assignment of F3α/F3β
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ppm was assigned to F4α and the doublet of doublets at -201.2 ppm to F4β (Figure 3.15).
The anomeric ratio of 193 tends towards 1:1 by increasing the polarity of the solvent
(Figure 3.16), furthermore a significant change in the 19F- chemical shifts are observed.
Figure 3.15. 19F{1H}-NMR spectrum of 193 in CDCl3.
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The 1H-NMR spectrum (Figure 3.17, section a) of 216 in CDCl3 shows a doublet of
doublets at 5.32 ppm, displaying both large and small coupling constants of 11.1 and 1.6
Hz, allowing assignment to H1 (α or β). Although the accurate measurement of the
coupling constants for the resonance at 5.19 ppm (assigned to the other anomeric proton
H1) was not achievable due to overlapping of signals, a large coupling constant of
approximately 17 Hz was estimated. This coupling constant is lost in the 1H{19F}-NMR
spectrum (Figure 3.17, section b), thus the larger coupling constant of 17 Hz is indicative
of a trans-diaxial relationship between H1β and F2β, whereas the smaller coupling constant
(11.1 Hz) is indicative of an axial-equatorial relationship between H1α and F2α. Thus the
signals at 5.32 and 5.19 ppm were assigned to H1α and H1β, respectively. Also, the
integration of these signals shows a ratio of 0.8:1 corresponding to the ratio of the α- and
β- anomers respectively.
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and 2D NMR experiments was carried out. The 1H{19F}-NMR analysis of 193 in D2O
buffer allowed assignment of H1 in each anomer. The spectrum (Figure 3.19) shows two
doublets assigned to H1 (α or β), one at 5.50 ppm displaying a 3JH-H coupling constant of
3.8 Hz, and one at 5.00 ppm displaying coupling constant of 8.2 Hz. The larger 3JH-H
coupling constant is indicative of a trans-diaxial relationship between the H1 and H2
protons, thus the signals at 5.00 ppm and 5.50 ppm were assigned to the β- and α-
anomers, respectively. Integration of these signals indicated that the anomers are present
in 1:0.9 ratio (α:β).
Figure 3.19. 1H{19F}-NMR spectrum of 193 in D2O-Tris-HEPES buffer.
The 1H,19F-HMBC spectrum of 193 in D2O-Tris-HEPES buffer in Figure 3.20 shows
3JH1α-F2 and 3JH1β-F2 crosspeaks which enabled assignment of the doublets at -199.4 ppm
and -200.7 ppm to F2α and F2β, respectively.
H1α H1β
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Figure 3.20. 1H,19F-HMBC spectrum of 193 in D2O-Tris-HEPES recorded at 37 °C.
The use of 1H-NMR (Figure 3.21, section a) and 1H{19F}-NMR (Figure 3.21, section b)
spectra to assign H1 to the corresponding anomers (α or β) of 216 in D2O-Tris-HEPES
was not achievable, due to overlap of H1 (α and β) and H3 (Figure 3.21). To overcome this
obstacle, the 1D gradient NOESY spectra was recorded in D2O-Tris-HEPES buffer
(Figure 3.22). The spectrum shows an NOE between H5 (4.39 ppm) and a H6 proton
(Figure 3.22, section a), and also between H5 (4.13 ppm) and both H6 and H1 protons
(Figure 3.22, section b). This enabled assignment of the resonance at 4.39 ppm to H5 and
that at 4.13 ppm to H5.
Figure 3.21. (a) 1H-NMR and (b) 1H{19F}-NMR spectra of 216 in D2O-Tris-HEPES.
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Figure 3.22. 1D gradient NOESY spectra of 216 in D2O-Tris-HEPES: spectrum (a) shows NOE between
H5 at 4.39 ppm and H6; spectrum (b) shows NOE between H5 at 4.13 ppm and H6 and H1.
The 1H,19F-HMBC spectrum of 216 in D2O-Tris-HEPES buffer was recorded in order to
assign F2, F3 and F4 to the corresponding anomers. The spectrum (Figure 3.23) shows
3JH5α-F4α, 4JH5α-F3α crosspeaks which enabled an assignment of the signals at -212.0 ppm
and -207.3 ppm to F3α and F4α respectively, and 3JH5β-F4β and 4JH5β-F3β (-214.3 ppm and -
213.2 ppm) to F3β and F4β respectively. F2 resonances (α and β) were assigned using
19F,19F-COSY (not shown).
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Figure 3.23. 1H,19F-HMBC spectrum of 216 in D2O-Tris-HEPES buffer.
step of the erythrocyte transmembrane transport study required the preparation
nsion of 193 and red blood cells in D2O buffer. The experiment with 216 was
in parallel. Human red blood cells were obtained from First Link (UK) Ltd.
n blood was centrifuged (4000 rpm, 5 min) and the plasma and supernatant
arded. The cells were then washed four times in three volumes of saline buffer
ontaining 123 mM NaCl, 15 mM Tris-HEPES and 5 mM ascorbic acid
y filtered through sterile filters Nalgene 0.20 µm cellulose acetate membranes),
each wash the supernatant was removed and the cells were collected by
tion. The red blood cells were then transferred to an Eppendorf tube and diluted
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deoxyhemoglobin which can broaden the NMR resonances. The sample was sealed and
was ready to be analysed by 2D 19F EXSY-NMR spectroscopy. A control experiment
consisted of the 1F{1H}-NMR spectra of 193 in D2O-Tris-HEPES buffer, recorded at 37
°C. This showed six resonances (Figure 3.24, section a) corresponding to the α- and β-
anomers as previously assigned.
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Figure 3.25. 19F{1H}-NMR spectrum (470.4 MHz) of 193 in the presence of erythrocytes suspended in
D2O-Tris-HEPES buffer at 37 °C, showed additional signals corresponding to metabolite formation.
OF
F
F
OH
204
O
Figure 3.26. Putative metabolite generated by oxidation of 193 at the anomeric position.
London et al.8 evaluated the human erythrocyte transmembrane transport of the 3-deoxy-
3-fluoro-D-glucose 164, and showed transport ability similar to that of the D-glucose. The
corresponding kef is reported in Table 3.4. This experiment was now repeated, and the
resulting kef (Table 3.4) found to be in good agreement with the literature.8 The D-glucose
193 and D-altrose 216 analogues cross the human erythtrocyte membrane less efficiently
when compared to 164, but 193 was transported better (~70% efficiency) than 216.
Additional signals
corresponding to metabolite
formation
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Furthermore, for 193 there is a marked preference for transport of the α-anomer over the
β-anomer. Conversely, for 216, transport is slow and there is no obvious preference for a
particular anomer.
kef [s-1]
-anomer -anomer
164 (3-F-D-glucose)a 1.35±0.32 1.04±0.23
164 (3-F-D-glucose)b 1.38±0.02 1.01±0.08
193 (D-glucose)b 0.97±0.21 0.22±0.07
216 (D-altrose)b 0.33±0.07 0.40±0.05
aData from the literature.8
bData reproduced in this work.
Table 3.4. Efflux rate constants for 164, 193 and 216 across erythrocyte cell membranes measured by 2D
19F EXSY-NMR. The values reported are averages from different 19F resonances and mixing times. Errors
are standard deviations.
3.4) Conclusion:
Two fully deprotected trifluoro D-hexose analogues 193 and 216 (Figure 3.27), were
successfully synthesised and characterised.
Figure 3.27. D-glucose analogue 193 and D-altrose analogue 216.
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Transmembrane studies provided efflux rate constants (kef), indicating that the Glut1
transmembrane protein can recognise and selectively transport these analogues. The study
suggested, that Glut1 can recognise the stereogenicity associated with the C-F bonds, and
favours the glucose over the altrose analogue as expected. This raises the possibility that
recognition occurs through dipolar interactions rather than hydrogen bonding.
Furthermore, a clear distinction between the transport of the α- and β- anomers of 193
was observed, similar to the 3-deoxy-3-fluoro-D-glucose analogue 164 and also D-glucose
itself.
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Chapter 4. Stereospecific dehydroxyfluorination of enantiopure
benzylic alcohols with TMS-amine additives
4.1) Introduction:
4.1.1) Strategies in stereospecific nucleophilic fluorination of alcohols:
Over the last 20 years a large number of reagents have been developed for the incorporation
of stereogenic C-F bonds into organic molecules, and in this context, catalytic asymmetric
fluorinations have attracted a lot of attention.1 The stereospecific conversion of an
enantiomerically pure alcohol to its corresponding fluoride, with high stereointegrity, can
also be very attractive, due to the relative easy of access to enantiopure alcohols as starting
materials. SN2 reactions are required, however, there are frequently side-reactions associated
with such dehydroxyfluorinations; for instance, the fluorination (Scheme 4.1) can follow an
SN1 reaction course (racemisation), or proceed with retention of configuration (anchimeric
assistance), as well as generate elimination or rearrangement products.2 The outcome depends
on the nature of the alcohol, the reaction conditions (temperature and solvent) and the type of
dehydroxyfluorinating reagent used (nature of the leaving group).2
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Scheme 4.1. The dehydroxyfluorination reaction of an enantiopure alcohol can follow different reaction
pathways.2
Particularly, the stereospecific conversion of an enantiomerically pure benzylic alcohol to the
corresponding benzylic fluoride with high stereochemical integrity (SN2 reaction) is a major
challenge, due to competing SN1 reactions. Such reactions can be achieved either by
nucleophilic fluorination of e.g. tosylates or mesylates, or by a direct dehydroxyfluorination
of the alcohol (see Paragraph 1.5.1, Chapter 1). For instance, the tosylate derivative (R)-205
of (R)-2-octanol has been subjected to nucleophilic fluorination, by the use of several
nucleophilic sources of fluoride under different conditions, to generate (S)-2-fluorooctane
206 and 1-octene (Table 4.1).3,4,5 The best % ee (100%) was obtained by reaction of (R)-205
with the methyl tri-n-butylfluorophosphorane (n-Bu3PMeF), although the yield was low.
Tetrabutylammonium fluoride (TBAF) generated (S)-206 in 54% yield and 96% ee.
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C6H13
OTs
(R)-205 (S)-206
reagent
C6H13
F
+ C6H13
Reagent (S)-206a 1-octenea (S)-206b [α]D20 % ee of (S)-206
KF 50 50 31 13.5 91
n-Bu3PMeF 40 60 15 14.8 100
TBAF 58 33 54 14.2 96
a Ratios by GC; b Isolated yields.
Table 4.1. Nucleophilic fluorination of the tosylate (R)-205 by the use of several nucleophilic sources of
fluoride.2-5
A systematic study was carried out exploring nucleophilic fluorination of a series of
sulfonates (R)-207 by reaction with metal fluorides (MF) such as cesium (CsF) or potassium
fluoride (KF) in different solvents (Table 4.2). This generated (S)-208, and alcohol (R)-209 as
a side-product (Table 4.2).6 Yields of this reaction were higher using CsF instead of KF.
Furthermore, the presence of R1 electron withdrawing groups proved necessary to favour the
formation of 208 over the generation of side-product alcohol (R)-209.
Due to the low solubility of (R)-207 with R1 = CN and R1 = CO2Et in polar solvents, which
results in lower yields, the use of N-methylformamide (MFA) is preferred over DMF or
formamide (FA). In most of the fluorination reactions attempted,6 product (S)-208 was
generated with high stereospecificity (SN2 mechanism), in spite of the fact that an SN1
mechanism is generally favoured for a benzylic substrate.6
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R1
MF
(equiv.)
solvent
T
(°C)
Time
(h)
Yield of (S)-208
(%)
% ee of (S)-208
CN CsF (4) MFA 60 4 81 96.0
CN CsF(4) DMF 60 4 60 NDa
CO2Et CsF(4) MFA 60 1 46 73.0
NO2 CsF(2) MFA 100 0.5 73 NDa
NO2 CsF(8) MFA 100 0.5 75 91.4
NO2 CsF(16) FA 60 1 62 NDa
NO2 KF(8) FA 60 8 25 NDa
Table 4.2. Selected examples of nucleophilic fluorinations of the mesylate (R)-207.6
a Not detemined.
When the mesylate derivative (S)-210 was treated with 4 equiv. of CsF in MFA, only the
formation of racemic-211 was observed (Scheme 4.2).6 The racemisation process is most
likely due to α-deprotonation by basic fluoride (also favoured by the presence of the electron
withdrawing ester function), as the 1H-NMR analysis showed disappearance of the benzylic
proton signal of (S)-210 in d7-DMF/D2O after addition of CsF.
Scheme 4.2. Nucleophilic fluorination of the mesylate (S)-210 with CsF gave a racemic product.6
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An alternative strategy involves direct dehydroxyfluorination of alcohols (see chapter 1).
Several examples are reported in the literature.2 For instance, direct dehydroxyfluorination of
(R)-2-octanol 212 was carried out by the use of the Yarovensko’s reagent (ClCHFCF2NEt2),
DAST and phenyltetrafluorophosphorane (PhPF4), which generated (S)-206 and octene
(Table 4.32,3). It is interesting to compare these results with those reported in Table 4.1. The
best dehydroxyfluorination reagent in terms of stereospecificity was DAST, although the
yield was low due to substantial elimination to generate octene.
C6H13
OH
(R)-212 (S)-206
C6H13
F
+ C6H13
Fluorinating
reagent
Reagent
(S)-206
(%)
1-octene
(%)
Isolated yield of
(S)-206 (%)
% ee of (S)-206
ClCHFCF2NEt2 78 22 40 88
DAST 48 52 23 98
PhPF4 58 42 11 69
Table 4.3. Examples of dehydroxyfluorination reactions of (R)-212.3
(R)-1-Phenylethanol 213 reacts with N,N-diethyl-1,1,2,3,3,3-hexafluoropropaneamine
(Ishikawa’s reagent) to generate (1-fluoroethyl)benzene 214. Oxidation by the action of
RuCl3/KIO4 (Scheme 4.5) generated carboxylic acid 215.7 The acid was then derivatised by
coupling to (R)-methyl mandelate in N,N'-dicyclohexylcarbodiimide (DCC) and 4-
dimethylaminopyridine (DMAP) to generate ester 217 (Scheme 4.3). 1H-NMR analysis
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revealed product 217 in 55% de, presumably in favour of the diastereoisomer with the
inverted configuration. Thus at least a 55% ee was assigned to the enantiopurity of 2-
fluorobenzene 214.
Ph
OH
Ph
F
(R)-213 214 50%
RuCl3/KIO4
F
215
DCC, DMAP
217 55% de
O
HO
F
O
O
Ph
O
MeO
N
F F
F
CF3
(Ishikawa's
reagent)
Ph
OH
(R)-216
O
OMe
Et2O, reflux
Scheme 4.3. Dehydroxyfluorination of (R)-213 and subsequent derivatisation to 217.7
The dehydroxyfluorination reaction of (R)-ethyl mandelate 218 with the Ishikawa’s reagent
generated ethyl 2-fluoro-2-phenylacetate 211 in 66% yield (Scheme 4.4).8 Reduction of 211
with LiAlH4 generated alcohol 220, which was then coupled with the Mosher reagent (R)-α-
methoxy-α-trifluoromethylphenylacetic acid (R)-MPTA 221, to give the corresponding ester
222 in 74% de, presumably in favour of the inverted product. Thus, at least a 74% ee was
assigned to the enantiopurity of 211.
Ph
OH
CO2Et Ph
F
CO2Et
(R)-218
Ishikawa's
reagent
211 66%
LiAlH4
Ph
F
CH2OH
220
Ph
F
222 74 %de
O
O
Ph
F3C OCH3
HO
O
Ph
F3C OCH3
221
pyridine
Scheme 4.4. Fluorination of (R)-218 and subsequent derivatisation to 222.8
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4.1.2) Bio’s TMS-amine additive approach:
In 2008, in a medicinal chemistry program aimed at the preparation of a N-methyl-D-
aspartate (NMDA) antagonist analogue, Bio et al.9 investigated the stereospecificity of the
DAST- and DeoxofluorTM-mediated dehydroxyfluorination reactions of two ortho-
fluorobenzylic alcohols (S)-223a and (S)-223b (Table 4.4). For instance reaction of (S)-223a
with DeoxofluorTM (Entry 1, Table 4.4) and DAST (Entry 2, Table 4.4) in CH2Cl2 generated
(R)-224a in 50% ee and 38% ee respectively, with configurational inversion.
A considerable improvement in the stereospecificity of this reaction was achieved when
alcohol (S)-223a was added to a solution of DAST and N-(trimethylsilyl)diethylamine 225
(Figure 4.1) in CH2Cl2, to provide (S)-224a in 99% ee (Entry 3, Table 4.4). However this also
gave a substantial amount of elimination product. Replacement of DAST and additive 225
with DeoxofluorTM and N-(trimethylsilyl)morpholine 226 (Figure 4.1) significantly reduced
the elimination side-reaction, allowing the reaction to be performed at 0 °C instead of -70 °C,
with negligible loss of stereospecificity (Entry 4, Table 4.4).9
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F
O
NHR
OH F
O
NHR
F
(S)-223a R = Cbz
(S)-223b R = Boc
Dehydroxyf luorination
(R)-224a R = Cbz
(R)-224b R = Boc
-70 °C
Entry Solvent
Fluorinating reagent
(equiv.) Additive
% ee of
(R)-224a or (R)-224b
1 CH2Cl2 DeoxofluorTM none 50
2 CH2Cl2 DAST none 38
3 CH2Cl2 DAST 225 99
4 toluenea DeoxofluorTM 226 96
a Reaction performed at 0 °C.
Table 4.4. Stereospecificity of dehydroxyfluorination reactions of (S)-223a and (S)-223b under various
conditions.
N TMS O N SiMe3
N-(trimethylsilyl)morpholineN-(trimethylsilyl)diethylamine
226225
Figure 4.1. Additives 225 and 226.
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4.2) Aims and objectives:
Encouraged by the results obtained by Bio et al.,9 it became an objective to apply this
methodology to the benzylic dehydroxyfluorination reaction of more challenging substrates,
such as benzylic alcohols without fluorine at the ortho-aryl position. The presence of the
ortho fluorine destabilises the benzylic carbocation intermediate, and promotes inversion
(SN2). It was envisaged that benzylic alcohol substrates (R)-1-phenylethanol 213 and methyl
(R)-(-)-mandelate 227 (Figure 4.2) would present more challenging substrates as they are
more prone to SN1 reaction courses. In this study, Bio’s methodology9 is applied to benzylic
dehydroxyfluorination reactions of (R)-213 (Scheme 4.5) and (R)-227 (Scheme 4.6), to
generate (S)-(1-fluoroethyl)benzene 214 and (S)-methyl 2-fluoro-2-phenylacetate 228
respectively.
OH OH
CO2Me
(R)-213 (R)-227
Figure 4.2. Benzylic alcohol substrates (R)-213 and (R)-227.
OH F
(R)-213
Fluorinating reagent /
TMS-amine additive
(S)-214
Scheme 4.5 Envisaged stereospecific benzylic dehydroxyfluorination of (R)-213.
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(R)-227 (S)-228
OH
CO2Me
F
CO2Me
Fluorinating reagent /
TMS-amine additive
Scheme 4.6 Envisaged stereospecific benzylic dehydroxyfluorination of (R)-227.
Without any TMS amine, reactions of (R)-213 and (R)-227 with 1.1 equiv. of DAST in
CH2Cl2 gave the corresponding benzylic fluorides in 7% ee and 8% ee respectively, thus
there was considerable room for improvement.
4.3) Results and discussion:
4.3.1) Stereospecific benzylic dehydroxyfluorination of (R)-213:
To provide a framework for this study, the dehydroxyfluorination reaction of alcohol (R)-213
was explored with four dehydroxyfluorination reagents (see Paragraph 5.4, Chapter 5):
FluoleadTM, TFEDMA, DeoxofluorTM and DAST (Figure 4.3). At the beginning of this study,
an analytical method to determine the enantiopurity of the fluorinated product 213 was
necessary. Attempts to determine the enantiomeric ratios by 19F-NMR analysis with the chiral
adducting reagent (+)-methyl D-lactate and by 1H-NMR analysis with lanthanide shift
reagents proved unsuccessful. Also an assessment of the enantiomeric purities by chiral
HPLC also failed, as separation of the enantiomers could not be achieved, despite exploring a
range of different columns and conditions. Separation of the enantiomers of 214 by chiral GC
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was successful (Figure 4.4). Therefore, the % ee’s of benzylic fluoride 214 were determined
by chiral-phase GC-MS, directly on the product mixture (see Paragraph 5.5, Chapter 5).
Figure 4.3. Dehydroxyfluorination reagents employed in this study.
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Figure 4.4. Chiral-phase GC chromatogram of racemic-214: temperature-gradient oven (80 °C for 30 min),
250 °C injector temperature, 100:1 split ratio, 0.9 ml/min flow, He carrier gas, BetadexTM 120 fused silica
capillary column (30 m x 0.25 mm i.d., 0.25 µm film thickness), MS (EI) detection.
Treatment of (R)-213 with 1.1 equiv. of each fluorinating reagent in CH2Cl2, either at -78°C
or RT, led to product 214 of very low enantiopurity (Table 4.5). DeoxofluorTM proved to be
the best reagent in terms of stereospecificity (Entry 3, Table 4.5). When the reaction with (R)-
F
(S)-214
F
(R)-214
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213 was carried out at -78 °C, there was no improvement of % ee. This was the case for all
four dehydroxyfluorination reagents.
Fluorinating reagent
(1.1 equiv.)
(R)-213
1.0 equiv., 0.20 M
CH2Cl2, 15 hours
OH F
(S)-214
Entry Fluorinating reagent(1.1 equiv.)
% ee of (S)-214
(-78 °C)
% ee of (S)-214
(RT)
1 FluoleadTM 0 0
2 TFEDMA 3 0
3 DeoxofluorTM 13 13
4 DAST 7 7
Table 4.5. Stereospecificity of dehydroxyfluorination reactions of (R)-213.
The next stage of the study involved exploring the use of the TMS-amine additives 226 and
229 (Figure 4.5) to assess if they could be added to improve the enantiopurity of product 214.
Figure 4.5. TMS-amine additives 226 and 229 used in this study.
Reactions were performed either at -78 °C or RT by addition of a solution of (R)-213 in
CH2Cl2 to a solution of a 1.1 equiv. of a preformed 1:1 fluorination reagent:TMS-amine
adduct in CH2Cl2 (Table 4.6). Moderate to good % ee’s (52-74) were obtained in all cases.
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No significant difference was observed for the enantiopurity of the products either at -78 °C
or RT. Fluorination of (R)-213 with TFEDMA and either additives 226 or 229 proceeded
with very low conversion (Entries 3 and 4, Table 4.6), thus TFEDMA was not explored
further. Also fluorination of (R)-213 with FluoleadTM and either 226 or 229 gave a very low
conversion at -78 °C. However t.l.c analysis indicated a good conversion to product 214
when the reaction was performed at RT (Entries 1 and 2, Table 4.6). The best outcome in
terms of enantiopurity was generated by the reaction of (R)-213 with 1.1 equiv. of a 1:1
DAST:226 adduct (Entry 7, Table 4.6).
OH FFluorinating reagent (1.1 equiv.) /
additive (1.1 equiv.)
CH2Cl2, 15 hours
(S)-214
1.0 eq., 0.20M
(R)-213
Entry
Fluorinating reagent
(1.1 equiv.)
Additive
(1.1 equiv.)
% ee of (S)-214
(-78 °C)
% ee of (S)-214
(RT)
1 FluoleadTM 226 Low conversion 57
2 FluoleadTM 229 Low conversion 56
3 TFEDMA 226 Low conversion Low conversion
4 TFEDMA 229 Low conversion Low conversion
5 DeoxofluorTM 226 56 58
6 DeoxofluorTM 229 65 66
7 DAST 226 72 74
8 DAST 229 52 54
Table 4.6. Enantiomeric purity of (S)-214 under various conditions.
The effect of varying the number of equiv. of additive was then investigated. The
resulting % ee’s, and selected % conversions determined by GC-FID using n-decane as an
internal standard (see Paragraph 5.5, Chapter 5) are shown in Table 4.7. Changing the
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reaction solvent from CH2Cl2 to toluene did not significantly improve the % ee (Entry 5,
Table 4.7), however CH2Cl2 was preferred due to its higher volatility which simplifies
isolation and purification of products. Generally a substantial improvement of % ee
occurs by addition of 3.3 equiv. of a preformed 1:1 fluorinating reagent:TMS-amine
adduct of either 226 or 229. The most significant improvement was made by addition of
3.3 equiv. of a preformed 1:1 DAST:226. The reaction improved from an almost racemic
product (Entry 4, Table 4.5) to generate (S)-214 in 95% ee with an excellent conversion
(Entry 7, Table 4.7). Reaction with FluoleadTM under similar conditions gave a product
(S)-214 in 92% ee, however the conversion (34%) was modest (Entry 1, Table 4.7).
OH F
(R)-213
Fluorinating reagent / additive
CH2Cl2, 15 hours
(S)-214
1.0 eq., 0.20M
Entry Fluorinating reagent(equiv.) Additive (equiv.)
% ee of (S)-214
(% conv.)
1 FluoleadTM (3.3) 226 (3.3) 92 (34)
2 FluoleadTM (3.3) 229 (3.3) 85
3 DeoxofluorTM (3.3) 226 (3.3) 84 (96)
4 DeoxofluorTM (3.3) 229 (3.3) 59
5 DAST (1.1)a 226 (1.1) 75
6 DAST (2.2) 226 (2.2) 83
7 DAST (3.3) 226 (3.3) 95 (92)
8 DAST (4.4) 226 (4.4) 93
9 DAST (8.8) 226 (8.8) 93
10 DAST (3.3) 229 (3.3) 69
a Reaction performed in toluene.
Table 4.7. The stereospecificity of dehydroxyfluorination of (R)-213 under various conditions.
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The enantiopurity of (S)-214 could not be further improved by the addition of more than
3.3 equiv. (Entries 8 and 9, Table 4.7). A rationale for the improved stereospecificity
using 3.3 eq of adduct is illustrated in Scheme 4.7. Reaction of the first equiv. of 1:1
fluorinating reagent:TMS-amine adduct with the alcohol generates one equiv. of HF,
which may catalize the SN1 process (1). The addition of a second equiv. of adduct will
buffer the HF as hydrogen bifluoride (HF2-), which is a weak nucleophile (2). The
addition of a third equiv. would then generate a free fluoride ion (F-), which is a better
nucleophile than hydrogen bifluoride, and as a result the SN2 mechanism predominates
over the SN1 mechanism (3).
R2NSF3 + TMS-N O + TMS-FR2NSF2-N O
R'-OH R2NSF2-N O+ R2NSF-N O + HF
R 'O
+ HFR2NSF2-N O + HF2R2N=SF-N O
R2NSF2-N O + FR2N=SF-N O
1st equivalent of adduct
2nd equivalent of adduct
3rd equivalent of adduct
promotes
SN1
weak F-
nucleophile
better F -
nucleophile
buffers HF
(1)
(2)
(3)
Scheme 4.7. Rationale for the improved stereospecificity at three equiv. of a preformed 1:1 fluorinating
reagent:TMS-amine adduct.
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4.3.2) Stereospecific benzylic dehydroxyfluorination of (R)-227:
Separation of the enantiomers of 228 by chiral GC was successful (Figure 4.6). Thus, the %
ee’s of benzylic fluoride 228 were determined by chiral-phase GC-MS, directly on the
product mixture (see Paragraph 5.5, Chapter 5).
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Figure 4.6. Chiral-phase GC chromatogram of racemic-228: temperature-gradient oven (start at 110 °C
held for 40 min, then gradient at 20 °C/min to 150 °C held for 15 min), 250 °C injector temperature, 100:1
split ratio, 0.9 ml/min flow, He carrier gas, BetadexTM 120 fused silica capillary column (30 m x 0.25 mm
i.d., 0.25 µm film thickness), MS (EI) detection.
Dehydroxyfluorination of (R)-227 with 1.1 equiv. of each fluorinating reagent in CH2Cl2
either at -78 °C or RT, similarly to that of (R)-213, generated product 228 of low
enantiopurity (Table 4.8). Reactions performed at -78 °C did improve the % ee to some
extent over those at RT (Table 4.8). Product conversion was low even after extended reaction
F
CO2Me
(R)-228
F
CO2Me
(S)-228
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times, and particularly with the reaction of (R)-227 with TFEDMA (Entry 2, Table 4.8).
Accordingly reactions with TFEDMA were not further attempted.
Entry Fluorinating reagent(1.1 equiv.)
% ee of (S)-228
(-78 °C)
% ee of (S)-228
(RT)
1 FluoleadTM 40 3
2 TFEDMA low conversion 12
3 DeoxofluorTM 48 25
4 DAST 19 8
Table 4.8. Stereospecificity of dehydroxyfluorination reactions of (R)-227.
Fluorinations of (R)-227 with 1.1 equiv. of fluorinating reagent:TMS-amine adduct are
shown in Table 4.9. The selected % conversion were determined by GC-FID, using n-
decane as an internal standard (see Paragraph 5.5.2, Chapter 5). Although the reaction
time was extended to 24 h to enhance conversion, FluoleadTM was found to be unreactive
at -78 °C in combination with either 226 or 229 (Entries 1 and 2, Table 4.9). Furthermore
FluoleadTM gave rise to higher % ee’s when 229 is used as an additive at RT (Entry 2,
Table 4.9). It is clear that there is a major improvement in the stereospecificity (up to
99% ee) for DeoxofluorTM (Entries 3 and 4, Table 4.9) and DAST (Entries 5 and 6, Table
4.9) with the addition of either 226 or 229. However, using 226 as an additive,
DeoxoFluorTM (Entry 3, Table 4.9) gave a better conversion than DAST (Entry 5, Table
4.9).
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OH
CO2Me
F
CO2Me
Fluorinating reagent (1.1 equiv.) /
additive (1.1 equiv.)
CH2Cl2, 24 hours
(R)-227
1.0 eq., 0.20M
(S)-228
Entry
Fluorinating
reagent
(1.1 equiv.)
Additive
(1.1 equiv.)
% ee of (S)-228
(-78 °C)
% ee of (S)-228,
RT
(% conv.)
1 FluoleadTM 226 Low conversion 64
2 FluoleadTM 229 Low conversion 89
3 DeoxofluorTM 226 98 99 (51)
4 DeoxofluorTM 229 97 98
5 DAST 226 99 99 (31)
6 DAST 229 98 98
Table 4.9. Enantiomeric purity of (S)-228 under various conditions.
TMS-pyrrolidine 229 proved to be the best additive in combination with 3.3 equiv. of
FluoleadTM (Entry 2, Table 4.10). Increasing the equiv. of adduct again did not further
improve the stereospecificity in the reactions with DeoxofluorTM (Entries 3 and 4, Table
4.10) and DAST (Entries 5, 6 and 7, Table 4.10).
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OH
CO2Me
F
CO2Me
Fluorinating reagent / additive
CH2Cl2, 24 hours
(R)-227
1.0 eq., 0.20M
(S)-228
Entry Fluorinating reagent(equiv.) Additive (equiv.)
% ee of (S)-228
(% conv.)
1 FluoleadTM (3.3) 226 (3.3) 87 (20)
2 FluoleadTM (3.3) 229 (3.3) 94
3 DeoxofluorTM (3.3) 226 (3.3) 98
4 DeoxofluorTM (4.4) 226 (4.4) 98
5 DAST (2.2) 226 (2.2) 98
6 DAST (3.3) 226 (3.3) 97
7 DAST (4.4) 226 (4.4) 97
Table 4.10. The stereospecificity of dehydroxyfluorination reactions of (R)-227 under various conditions.
4.4) Conclusion:
The stereospecific conversion of an enantiomerically pure benzyl alcohol to the
corresponding organic fluoride is a considerable challenge, due to a competing SN1 reaction
course. The methodology developed by Bio et al.9 has successfully been applied to
achieve the highly stereospecific benzylic dehydroxyfluorinations of (R)-213 and (R)-227,
using additives 226 and 229. Addition of one equiv. of a preformed 1:1 fluorinating
reagent:TMS-amine adduct noticeably improved the % ee for the dehydroxyfluorination
of both substrates (R)-213 and (R)-227. However, the best result for substrate (R)-213,
the more challenging in terms of suppressing the SN1 pathway, was obtained using three
equiv. of the adduct. Benzylic fluorides (S)-214 and (S)-228 of up to 95% ee and 99% ee,
respectively, were prepared by the method. The dehydroxyfluorination of (R)-227
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proceeded with the higher stereointegrity (SN2 mechanism) compared to (R)-213,
presumably due to the electron withdrawing effect of the ester function which suppresses
the formation of a benzylic carbocation relative to a methyl group. However, in the case
of (R)-227, reaction conversions were significantly lower, due to the electron-
withdrawing nature of the ester group.
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Chapter 5. Experimental section
5.1) General Procedures:
5.1.1) Reagents and solvents:
All reagents were obtained from commercial sources and were used without further
purification unless otherwise stated. Dry CH2Cl2, ether, THF, hexane and toluene were
obtained from the Solvent Purification System MB SPS-800. Chloroform was dried with
K2CO3, refluxed with Na2SO4, distilled and stored under N2 prior to use. Acetone was dried
with CaSO4, refluxed with CaSO4 , distilled and stored under N2 prior to use.
5.1.2) Reaction conditions:
All moisture sensitive reactions were carried out under a positive pressure of argon or
nitrogen in oven-dried glassware (160 °C). Na2SO4 or MgSO4 were used as a drying agents.
Room temperature (RT) refers to 20 °C. Reaction temperatures of 0 °C were obtained in an
ice/water bath. Reaction temperatures below 0 °C were obtained using either a bath-cooling
apparatus LP Technology RP-100-CD or an acetone-dry ice bath. Reaction reflux conditions
were obtained using an oil bath equipped with a contact thermometer. All microwave-assisted
reactions were performed under sealed vessels (vial size 25 mL) on a Biotage Initiator 2.0
under various temperature gradient conditions, the reaction was monitored by t.l.c. Solvent
evaporations were carried out under reduced pressure on a Büchi rotary evaporator.
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5.1.3) Purification techniques and t.l.c:
Column chromatography was performed using silica gel 60 (40–63 micron). Thin layer
chromatography (t.l.c) was carried out using Macherey-Nagel Polygram Sil G/UV254 plastic
plates; visualisation was achieved by inspection under UV light (255 nm) or by the staining
with a solution of basic potassium permanganate or phosphomolybdic acid.
5.1.4) Nuclear magnetic resonance spectroscopy (NMR):
NMR spectra were recorded on a Bruker AV-300 (1H, 300 MHz; 13C, 75 MHz; 19F, 282
MHz) spectrometer, a Bruker AV-400 (1H, 400 MHz; 13C, 100 MHz; 19F, 376 MHz)
spectrometer or a Bruker AV-500 (1H, 500 MHz; 19F, 470 MHz) spectrometer. 1H and 13C
NMR spectra were calibrated using the residual solvent shift from the deuterated solvent. 19F
NMR spectra were referenced to CFCl3 as the external standard. Chemical shifts are reported
in parts per million (ppm) and coupling constants (J) are given in Hertz (Hz). The
abbreviations for the multiplicity of the proton, carbon and fluorine signals are as follows: s
singlet, d doublet, dd doublet doublets, ddd doublet of doublet of doublets, dddd doublet of
doublet of doublet of doublets, t triplet, dt double of triplets, td triplet of doublets, q quartet,
dq double of quartets, m multiplet, app. apparent and br s broad singlet. When necessary,
resonances were assigned using two-dimensional experiments (COSY, TOCSY, HMBC,
HSQC, NOESY).
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5.1.5) Mass spectrometry:
High and low resolution mass analyses (m/z) were carried out by Mrs Caroline Horsburgh,
and spectra were recorded on a Micromass LCT TOF mass spectrometer using ES ionization
in +ve ion mode. Where this method was inadequate, CI or EI were used using a Micromass
GCT TOF instrument.
5.1.6) Melting point analyses:
Melting points were determined in Pyrex capillaries using a Gallenkamp Griffin
MPA350.BM2.5 melting point apparatus and are uncorrected.
5.1.7) Infrared spectrosopy (IR), polarimetric and X-ray diffraction analyses:
IR spectra were recorded on a Nicolet Avatar 360 FT-IR from a thin film (either neat or
combined with nujol) supported between NaCl plates. Optical rotations [α]D are given in 10-1
deg cm2 g-1 and were measured using a Perkin Elmer Model 341 polarimeter. Single X-ray
diffraction analyses were carried out by Professor Alexandra M. Z. Slawin at the University
of St Andrews.
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5.1.8) Gas Chromatography:
5.1.8.1) GC-MS:
Low resolution GC-MS analyses were carried out using an Agilent 6890 gas chromatograph
coupled to a 5973N mass selective detector in EI mode, with helium as a carrier gas.
Automatic injections using a 7683 series injector were made into both non-chiral and chiral
columns. Chiral separations were achieved with a Supelco BetadexTM 120 fused silica
capillary chiral column (30 m x 0.25 mm i.d., 0.25 µm film thickness). Conditions for the
chiral separation of product 214: oven 80 °C held for 30 min, 250 °C injector temperature,
0.9 mL/min flow. Conditions for the chiral separation of product 228: oven start at 110 °C
held for 40 min, then gradient at 20 °C/min to 150 °C), 250 °C injector temperature, 100:1
split ratio, 0.9 mL/min flow.
5.1.8.2) GC-FID:
GC-FID analyses were carried out using an Agilent 6890 equipped with a flame ionisation
detector, with helium as a carrier gas. Automatic injections using a 6890 series injection were
made into both non-chiral and chiral columns. Non-chiral separations for products 214, 228
and internal standard n-decane were carried out with a Hewlett Packard 1 column (30 m x
0.25 mm i.d, 0.25 µm film thickness): oven start at 50 °C held for 4 min, then gradient at 20
°C/min to 130 °C held for 2 min, then gradient at 20 °C/min to 280 °C, 250 °C injector
temperature, 100:1 split ratio, 1.0 mL/min flow. Chiral separations for products 154a, 154b,
155a and 155b were carried out with a Supelco BetadexTM 225 fused silica capillary chiral
column (60 m x 0.25 mm i.d., 0.25 mm film thickness): oven start at 40 °C held for 15 min,
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then gradient at 0.9 °C/min to 230 °C, 250 °C injector temperature, 100:1 split ratio, 0.9
mL/min flow.
5.1.9) 2D 19F EXSY- NMR spectroscopy:
Human blood was purchased from First Link (UK) Ltd. 3-Deoxy-3-fluoro-D-glucose 164 was
purchased from Apollo Scientific Limited. The human blood was spun down (4000 rpm, 5
min) and the plasma and buffy coat were discarded. The cells were washed four times in 3
volumes of saline buffer solution containing 123 mM NaCl, 15 mM Tris-HEPES and 5 mM
ascorbic acid (the saline buffer solutions were filtered through sterile filters Nalgene 0.20 µm
cellulose acetate membranes before use). After each wash the supernatant was removed and
the cells were collected by centrifugation. The red blood cells were then transferred to an
Eppendorf tube and diluted with one volume of saline buffer containing 123 mM NaCl, 15
mM Tris-HEPES, 5 mM ascorbic acid and 20 mM of fluorinated sugar (final hematocrit 0.5),
carefully mixed and transferred into a WILMAD NMR tube with J Joung valve. A sealed
capillary tube containing D2O was then introduced into the NMR tube to provide deuterium
signal for the NMR lock. A stream of carbon monoxide was bubbled through the cells for 3
min before sealing. Immediately after that the sample was sealed and analysed by NMR.
2D 19F spectra were recorded using Bruker AVANCE 500 MHz spectrometer equipped with
double resonances 19F SEF probe at 310 K. The spectra were acquired using NOESYPH
sequence which was adjusted by adding 1H decoupling for directly detected dimension and
the 1H 180 refocusing pulse in the middle of t1 evolution period to achieve decoupling in the
F1 dimension. Each spectrum was digitised using 1024 points in F2 dimension and 256
points in F1 dimension which was later zero-filled to 1024 points. 8 scans were accumulated
for each increment with interscan delay 2s. Sine squared window multiplication was used for
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all the spectra. Every sample was analysed using at least three different mixing times ranging
from 0 to 800 ms. The program EXSY CALC (Mestrelab Research) was used to analyse
integral intensities of crosspeaks according to a full relaxation matrix analysis.1
5.2) Protocols:
((Prop-2-ynyloxy)methyl)benzene 153:2
Propargyl alcohol (9.0 mL, 154.6 mmol) was added in portions to a suspension of NaH (60%
in mineral oil, 6.80 g, 170.1 mmol) in DMF (150 mL) at 0 °C. After 30 min, benzyl bromide
(20.2 mL, 170.1 mmol) was added and the resultant mixture was stirred at RT overnight. The
mixture was then diluted with EtOAc (300 mL), washed by HCl (1N) (300 mL), and dried
over MgSO4. The EtOAc extract was concentrated in vacuo. The product was purified over
silica gel (8:1 hex:EtOAc → 5:1) to give pure 153 (20.79 g, 95%) as a colourless oil.
δH (400 MHz, CDCl3) 7.42–7.27 (m, 5H), 4.63 (s, 2H), 4.19 (d, J = 2.4 Hz, 2H), 2.49
(t, J = 2.4 Hz, 1H).2
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(1S,2S)-1,2-Bis((R)-2,2-dimethyl-1,3-dioxolan-4-yl)ethane-1,2-diol 151:3,4
Anhydrous ZnCl2 (65.6 g, 0.48 mol) was dissolved in dry acetone (410 mL, 5.5 mol). The
solution was cooled to RT and dry D-Mannitol (41.7 g, 0.229 mol) was added and the solution
stirred for 22 h. Then the reaction was poured into a vigorously stirred (ultra-turax mixer),
and extensively cooled suspension of K2CO3 (66 g) in water (66 mL). The precipitated salts
were filtered off with suction and washed three times with CHCl3. The acetonic filtrates were
combined and evaporated in vacuo to give a white solid (46.8 g). The product was
recrystallised from a hot mixture of CHCl3/heptane (10:1) to give 151 (31.2 g, 52%) as a
white crystalline solid.
Mp = 119–120 °C, lit.5 mp = 120–121 °C; δH (300 MHz, CDCl3) 4.24–4.15 (m, 2H),
4.12 (dd, J = 8.4, 6.3 Hz, 2H), 3.97 (dd, J = 8.4, 5.5 Hz, 2H), 3.79–3.71 (m, 2H), 2.60 (d, J =
6.7 Hz, 2OH), 1.41 (s, 6H), 1.36 (s, 6H); δC (75 MHz, CDCl3) 109.5 (2 x C), 76.4 (2 x CH),
71.4 (2 x CH), 66.9 (2 x CH2), 26.8 (2 x CH3), 25.3 (2 x CH3); MS (ESI, +ve) m/z 285.08
[M+Na]+ (100).
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(R)-2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde 152:6
Sat. aqueous NaHCO3 (2 mL) was added to a stirred solution of 1,2:5,6-di-O-isopropylidene-
D-mannitol 151 (3.3 g, 13 mmol) in CH2Cl2 (30 mL) while maintaining the temperature at 15
°C. Sodium metaperiodate (5.3 g, 25 mmol) was then added over a 20 min period with
vigorous stirring and the reaction was allowed to proceed for 4 h at 15 °C. The solution was
then decanted and the remaining solid was stirred with additional CH2Cl2 (10 mL) for 5 min
and it was again decanted from the solid. The organic solutions were combined and
concentrated in vacuo and then distilled under reduced pressure (67–72 °C, 30 mmHg) giving
the aldehyde 152 as a colourless oil (1.46 g, 67%).
[α]D + 76.2° (c 1.3, benzene), lit.7 [α]D + 73.1° (c 1.3, benzene); δH (300 MHz,
CDCl3) 9.63 (d, J = 1.9 Hz, 1H), 4.31 (ddd, J = 7.3, 4.8, 1.9 Hz, 1H), 4.10 (dd, J = 8.8, 7.3
Hz, 1H), 4.02 (dd, J = 8.8, 4.8 Hz, 1H), 1.41 (s, 3H), 1.34 (s, 3H); δC (75 MHz, CDCl3) 201.8
(CHO), 111.2 (C), 79.8 (CH), 65.5 (CH2), 26.2 (CH3), 25.1 (CH3); MS (CI+) m/z 131.07
[M+H]+ (100); HRMS (CI+) C6H10O3H+ requires m/z 131.0708, found 131.0704.
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(R)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-yn-1-ol 154b:8
nBuLi (1.6 M in n-hexane, 9.6 mL, 15.4 mmol) was added to a stirred solution of benzyl
propargyl ether 153 (2.3 mL, 15.4 mmol) in dry THF (19 mL) at -78 °C. After stirring at -78
°C for 1.5 h , a solution of 152 (1.0 g, 7.7 mmol) in THF (8 mL) was added dropwise to the
mixture and the reaction stirred for 4 h at -78 °C. The reaction was then poured into sat.
aqueous NH4Cl (50 mL) at -78 °C. Water (70 mL) was added and the reaction was extracted
into Et2O (3 x 110 mL). The Et2O extract was successively washed with water and brine, then
dried (MgSO4) and concentrated in vacuo. The product was purified over silica (9:1
hex:EtOAc → 3:1) to give the desired alcohol 154b (1.723 g, 81%, mixture favouring the syn
diastereoisomer) as a clear oil. Chiral-phase GC-FID analysis of the product, tR = 226.0 min
for the minor anti diastereoisomer and tR = 226.6 min for the major syn diastereoisomer,
indicated that the de was 9%.
Data for major diastereoisomer: δH (400 MHz, CDCl3) 7.38–7.26 (m, 5H), 4.58 (s,
2H), 4.37 (dt, J = 8.8, 1.7 Hz, 1H), 4.28–3.86 (m, 5H), 2.70 (br s, OH), 1.46 (s, 3H), 1.38 (s,
3H); δC (100 MHz, CDCl3) 137.3 (C) 128.6 (2 x CH), 128.2 (2 x CH), 128.0 (CH), 110.6 (C),
83.9 (C), 82.3 (C), 78.7 (CH), 71.8 (CH), 66.2 (CH2), 64.3 (CH), 57.4 (CH2), 26.9 (CH3),
25.3 (CH3); MS (ESI, +ve) m/z 299.11 [M+Na]+ (55), 259 [M+H-H2O]+ (100); HRMS (ES+)
C16H20O4Na+ requires m/z 299.1260, found 299.1259.
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(S)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-yn-1-ol 154a:9
n-BuLi (1.6 M in n-hexane, 13.9 mL, 22.2 mmol) was added dropwise to a solution of benzyl
propargyl ether 153 (3.3 mL, 22.2 mmol) in THF (21.0 mL) at -78 °C. After 30 min, ClTi(Oi-
Pr)3 (1M in n-hexane, 41.0 mL, 22.2 mmol) was added and the flask warmed to -60 °C. To
maintain solubility, additional THF (41 mL) was added and the solution was stirred for 90
min prior to re-cooling to -78 °C. Compound 152 (1.44 g, 11.1 mmol) was then added in one
portion and the mixture stirred for 4 h prior to quenching with sat. NH4Cl (70 mL) at -78 °C.
Water (100 mL) was added and the reaction was extracted into Et2O (3 x 150 mL). The
product was purified over silica gel (9:1 hex:EtOAc → 3:1) to give the desired alcohol 154b
(2.52 g, 82%, mixture favouring the anti diastereoisomer) as a clear oil. Chiral-phase GC-
FID analysis of the product, tR = 226.0 min for the major anti diastereoisomer and tR = 226.6
min for the minor syn diastereoisomer, indicated that the de was 62%.
Data for major diastereoisomer: δH (400 MHz, CDCl3) 7.38–7.26 (m, 5H), 4.58 (s,
2H), 4.52 (dt, J = 4.4, 1.7 Hz, 1H), 4.28–3.86 (m, 5H), 2.56 (br s, OH), 1.47 (s, 3H), 1.38 (s,
3H); δC (100 MHz, CDCl3) 137.4 (C), 128.6 (2 x CH), 128.2 (2 x CH), 128.0 (CH), 110.3
(C), 83.9 (C), 82.4 (C), 77.9 (CH), 71.8 (CH), 65.4 (CH2), 62.7 (CH), 57.4 (CH2), 26.5 (CH3),
25.2 (CH3); MS (ESI, +ve) m/z 299.11 [M+Na]+ (55), 259 [M+H-H2O]+ (100); HRMS (ES+)
C16H20O4Na+ requires m/z 299.1260, found 299.1259.
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(S)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-ynyl 3,5-dinitrobenzoate
158a:
O
O OBn
O
O
NO2
158a
NO2
3,5-Dinitrobenzoyl chloride (0.48 g, 2.0 mmol) was added to a solution of alcohol 154a
(0.515 g, 1.8 mmol, de 62%) in dry pyridine (29 mL) at 0 °C. After stirring for 16 h at RT the
reaction was poured into ice-water and extracted into Et2O (3 x 70 mL). The product was
purified over silica gel (9:1 hex:EtOAc → 5:1) to give 158a which was recrystallised from
absolute ethanol (0.59 g, 70%).
Mp 86–88 °C (from EtOH); [α]D + 38.8 (c 0.5, CHCl3); max (NaCl)/cm-1 2923, 1764,
1629, 1545, 1459, 1345, 1273, 1153, 1074, 721; δH (400 MHz, CDCl3) 9.25 (t, 1H, J = 2.1
Hz), 9.21 (d, 2H, J = 2.1 Hz), 7.39–7.27 (m, 5H), 5.88–5.83 (m, 1H), 4.58 (s, 2H), 4.55–4.46
(m, 1H), 4.27–4.15 (m, 4H), 1.38 (s, 3H), 1.39 (s, 3H); δC (100 MHz, CDCl3,) 161.6 (C),
148.9 (2 x C), 137.2 (C), 133.4 (C), 130.1–127.9 (7 x CH), 122.9 (CH), 111.0 (C), 84.9 (C),
79.6 (C), 76.3 (CH), 72.1 (CH2), 66.6 (CH), 65.6 (CH2), 57.3 (CH2), 26.5 (CH3), 25.0 (CH3);
MS (ESI, +ve) m/z 493.06 [M+Na]+ (100); HRMS (ESI, +ve) C23H22N2O9Na+ requires m/z
493.1223, found 493.1218.
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(R,E)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-ol 155b:10
A solution of 154b (1.62 g, 5.9 mmol, 9% de) in n-hexane (6.5 mL) was added to a
suspension of LiAlH4 (0.3 g, 7.6 mmol) in n-hexane (13 mL) at 0 °C. The reaction was
heated under reflux for 2 h and was then quenched by dropwise addition of water (10 mL).
The mixture was filtered and the resultant precipitate was washed with Et20 (3 x 75 mL). The
combined organics were dried (MgSO4) and the product purified over silica gel (9:1
hex:EtOAc → 3:1)  to give alcohol 155b (0.73 g, 45%, mixture favouring the syn
diastereoisomer) as a clear oil. Chiral-phase GC-FID analysis of the product, tR = 221.5 min
for the major syn diastereoisomer and tR = 222.0 min for the minor anti diastereoisomer,
indicated that the de was 17%.
Alternative procedure: Red-Al® (70% w/v in toluene, 3.4 mL, 11.8 mmol) was added slowly
to a solution of 154b (1.62 g, 5.9 mmol, 9% de, syn favour) in THF (6.5 mL) at 0 °C. After
stirring for 1 h at 0 °C, the reaction was quenched with sat. aqueous Rochelle salt and
extracted into Et2O (3 x 30 mL). The combined organics were dried (MgSO4) and the product
purified over silica gel (9:1 hex:EtOAc → 3:1)  to give alcohol 155b (1.46 g, 90%, 17% de,
syn favour) as a clear oil.
Data for major diasteroisomer: δH (400 MHz, CDCl3) 7.38–7.26 (m, 5H), 5.98–
5.89 (m, 1H), 5.78–5.67 (m, 1H), 4.51 (s, 2H), 4.13–3.82 (m 5H), 3.81–3.71 (m, 1H), 2.25 (br
s, OH), 1.45 (s, 3H), 1.36 (s, 3H); δC (100 MHz, CDCl3) 138.2 (C), 130.5 (CH), 130.4 (CH),
153
128.5 (2 x CH), 127.8 (3 x CH), 110.0 (C), 78.8 (CH), 73.4 (CH), 72.4 (CH2), 69.9 (CH2),
66.0 (CH2), 26.9 (CH3), 25.4 (CH3); MS (ESI, +ve) m/z 301.08 [M+Na]+ (100); HRMS
(ES+) C16H22O4Na+ requires m/z 301.1416, found 301.1421.
154
(S,E)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)but-2-en-1-ol 155a:10
A solution of 154a (2.43 g, 8.8 mmol, 62% de) in n-hexane (10 mL) was added to a
suspension of LiAlH4 (0.45 g, 11.9 mmol) in n-hexane (20 mL) at 0 °C. The reaction was
heated under reflux for 2 h and was quenched by dropwise addition of water (15 mL). The
mixture was filtered and the precipitate washed with Et2O (3 x 100 mL). The combined
organics were dried (MgSO4) and evaporated and the product purified over silica gel (9:1
hex:EtOAc → 3:1) to give alcohol 155a (1.35 g, 55%, mixture favouring the anti
diastereoisomer) as a clear oil. Chiral-phase GC-FID analysis of the product, tR = 221.5 min
for the minor syn diastereoisomer and tR = 222.0 min for the major anti diastereoisomer,
indicated that the de was 75%.
Alternative procedure: Red-Al® (70% wt in toluene, 3.4 mL, 11.8 mmol) was added slowly
to a solution of 154a (1.62 g, 5.9 mmol, 62% de, anti favour) in THF (6.5 mL) at 0 °C. After
stirring for 1 h at 0 °C, the reaction was quenched with sat. aqueous Rochelle salt and
extracted into Et2O (3 x 30 mL). The combined organics were dried (MgSO4) and the product
purified over silica gel (9:1 hex:EtOAc → 3:1)  to give alcohol 155a (1.51 g, 93%, 75% de,
anti favour) as a clear oil.
Data for major diastereoisomer: δH (400 MHz, CDCl3) 7.38–7.26 (m, 5H), 5.98–
5.89 (m, 1H), 5.78–5.67 (m, 1H), 4.51 (s, 2H), 4.33–4.27 (m 1H), 4.13–4.07 (m, 1H), 4.05–
4.02 (m, 2H), 3.99–3.87 (m, 2H), 2.25 (br s, OH), 1.44 (s, 3H), 1.36 (s, 3H); δC (100 MHz,
155
CDCl3,) 138.2 (C), 130.4 (CH), 129.4 (CH), 128.5 (2 x CH), 127.9 (2 x CH), 127.8 (CH),
109.5 (C), 78.2 (CH), 71.3 (CH), 72.4 (CH2), 70.1 (CH2), 64.9 (CH2), 26.5 (CH3), 25.2
(CH3); MS (ESI, +ve) m/z 301.08 [M+Na]+ (100); HRMS (ES+) C16H22O4Na+ requires m/z
301.1416, found 301.1421.
156
(R)-4-((S,E)-4-(Benzyloxy)-1-fluorobut-2-enyl)-2,2-dimethyl-1,3-dioxolane 156a and the
inseparable mixture of (R)-4-((R,E)-4-(benzyloxy)-1-fluorobut-2-enyl)-2,2-dimethyl-1,3-
dioxolane 156b, (S)-4-((R,E)-4-(benzyloxy)-3-fluorobut-1-enyl)-2,2-dimethyl-1,3-
dioxolane 157a and (S)-4-((S,E)-4-(benzyloxy)-3-fluorobut-1-enyl)-2,2-dimethyl-1,3-
dioxolane 157b:11
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A solution of allylic alcohol 155a (1.39 g, 5 mmol, 17% de) in CH2Cl2 (10 mL) was added to
a solution of TFEDMA (0.66 mL, 5.5 mmol) in CH2Cl2 (10 mL) at 0 °C in a polythene
vessel. After addition the reaction was stirred for 1 h at RT. The reaction was then worked up
by adding sat. aqueous NaHCO3 solution and the product was extracted into CH2Cl2 (3 x 150
mL). The product was purified over silica gel (6:1→3:1 hex:EtOAc) to give 156a (0.18 g,
13%, single stereoisomer) and the inseparable mixture of isomers 156b/157a/157b (0.64 g,
46%, ratio 0.3/0.7/1.0) as clear oils.
Data for 156a: [α]D -7.6 (c 1.0, CHCl3), max (NaCl)/cm-1 1215, 1115, 1071, 972; δH
(300 MHz, CDCl3) 7.37–7.27 (m, 5H), 6.00 (m, 1H), 5.84 (m, 1H), 4.88 (dm, J = 47.9 Hz,
1H), 4.54 (s, 2H), 4.15 (m, 1H), 4.10 – 4.04 (m, 3H), 3.98 (ddd, J = 8.7, 5.5, 1.1 Hz, 1H),
1.43 (s, 3H), 1.36 (s, 3H); δC (75 MHz, CDCl3) 132.1 (d, J = 11.6 Hz, CH), 138.3 (C), 128.8
(2 x CH), 128.1 (2 x CH), 127.7 (CH), 127.0 (d, J = 18.6 Hz, CH), 120.0 (CH), 109.9 (C),
91.9 (d. J = 173.0 Hz, CH), 76.9 (d, J = 27.7 Hz, CH), 72.8 (CH2), 69.9 (CH2), 65.8 (d. J =
4.2 Hz, CH2), 26.8 (CH3), 25.6 (CH3); δF (282 MHz, CDCl3) -187.5 (dm, J = 47.9 Hz, 1F);
157
δF{H} (282 MHz, CDCl3) -187.5 (s, 1F); MS (ESI, +ve) m/z 303.07 [M+Na]+ (100); HRMS
(ESI, +ve) C16H21FO3Na+ requires m/z 303.1372, found 303.1378.
Data for inseparable mixture of isomers 156b/157a/157b: δH (400 MHz, CDCl3)
7.39–7.26 (m, 15H), 6.06–5.59 (m, 6H), 5.22–4.76 (m, 3H), 4.64–3.52 (m, 21H), 1.36–1.47
(m, 18H); δC (100 MHz, CDCl3) 138.1 (C), 137.8 (2 x C), 133.2 (d, J = 11.2 Hz, CH), 132.1
(d, J = 10.7 Hz, CH), 131.7 (d, J = 10.6 Hz, CH), 128.7–127.7 (17 x CH), 125.8 (d, J = 18.9
Hz, CH), 110.4 (C), 109.7 (2 x C), 92.8 (d, J = 173.6 Hz, CH), 91.6 (d, J = 172.5 Hz, CH),
91.4 (d, J = 172.8 Hz, CH), 76.1–76.0 (3 x CH), 72.6 (3 x CH2), 72.1 (d, J = 23.1 Hz, CH2),
72.0 (d, J = 22.6 Hz, CH2), 69.5 (CH2), 69.4 (2 x CH2), 65.2 (d, J = 5.4 Hz, CH2), 26.7–25.4
(6 x CH3). MS (ESI, +ve) m/z 303.04 [M+Na]+ (100); HRMS (ESI, +ve) C16H21FO3Na+
requires m/z 303.1372, found 303.1375.
Data for 156b: δF (282 MHz, CDCl3) -183.48 (dm, J = 48.3 Hz, 1F); δF{H} (282
MHz, CDCl3) -183.0 (s, 1F).
Data for 157a: δF (282 MHz, CDCl3) -183.4 (m, 1F); δF{H} (282 MHz, CDCl3) -183.4
(s, 1F).
Data for 157b: δF (282 MHz, CDCl3) -184.1 (m, 1F); δF{H} (282 MHz, CDCl3) -
184.1 (s, 1F).
158
(1S,2S,3R)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1-fluorobutane-2,3-diol
159:12
Methanesulfonamide (0.04 g, 0.4 mmol) was added to a solution of AD-mix-β (0.60 g) in
tert-butyl- alcohol (2.3 mL) and water (2.3 mL). A solution of 156a (0.12 g, 0.4 mmol) in
tert-butyl- alcohol (2.3 mL) was then added and the resultant mixture was stirred at 0 °C for 1
h and then at RT for 3 d. Solid Na2SO3 (0.66 g) was added and the mixture stirred for 30 min.
The product was then extracted into Et2O (3 x 20 mL) and the combined organic layers were
washed with 2M KOH (20 mL) and concentrated. The product was purified over silica gel
(9:1 hex:EtOAc → 4:1) and 159 was recrystallised from Et2O (0.05 g, 37%).
Mp 94–96 °C (from Et2O); [α]D +1.9° (c 0.6, CHCl3); max (NaCl)/cm-1 3456, 2727,
1700, 1265, 1225, 1161, 1138, 1115, 1054, 725; δH (400 MHz, CDCl3) 7.40–7.27 (m, 5H),
4.58 (s, 2H), 4.57–4.44 (dm, J = 46.0 Hz, 1H), 4.44–4.37 (m, 1H), 4.14 (ddd, J = 8.7, 6.5,
6.2 Hz, 1H), 4.06 (ddd, J = 8.7, 5.5, 5.3 Hz, 1H), 4.03–3.95 (m, 1H), 3.90 (dddd, J = 11.2,
6.1, 4.7, 1.7 Hz, 1H), 3.65 (d, J = 5.3 Hz, 2H), 3.08 (d, J = 4.7 Hz, 1H), 2.88 (d, J = 5.9 Hz,
1H), 1.44 (s, 3H), 1.37 (s, 3H); δC (100 MHz, CDCl3) 137.7 (C), 128.7 (2 x CH), 128.1 (CH),
128.0 (2 x CH), 110.2 (C), 91.2 (d, J = 176.8 Hz, CH), 74.3 (d, J = 27.3 Hz, CH), 73.8 (CH2),
72.2 (CH2), 71.6 (d, J = 23.3 Hz, CH), 68.4 (d, J = 5.4 Hz, CH), 65.9 (d. J = 4.7 Hz, CH2),
26.5 (CH3), 25.3 (CH3); δF (376 MHz, CDCl3) -198.4 (ddd, J = 46.0, 13.0, 11.2 Hz, 1F); δF{H}
(376 MHz, CDCl3) -198.4 (s, 1F); MS (ESI, +ve) m/z 337.19 [M+Na]+ (100); HRMS (ESI,
+ve) C16H23FO5Na+ requires m/z 337.1427, found 337.1431.
159
(1S,2S,3R)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-fluorobutane-1,2-diol
160a/160b:12
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Methanesulfonamide (0.20 g, 2.2 mmol) was added to a solution of AD-mix-β (3.01 g) in
tert-butyl- alcohol (11.5 mL) and water (11.5 mL). A solution of 156b/157a/157b (0.60 g, 2.2
mmol, ratio 0.3:0.7:1) in tert-butyl- alcohol (11.5 mL) was then added and the resultant
mixture was stirred at 0 °C for 1 h and then at RT for 3 d. Solid Na2SO3 (3.31 g) was added
and the mixture stirred for 30 min. The product was then extracted into Et2O (3 x 100 mL)
and the combined organic layers were washed with 2M KOH (100 mL) and concentrated.
The product was purified over silica gel (9:1 hex:EtOAc → 4:1) to give the desired diols 
160a/160b as a solid (0.41 g, 60%, dr 1:0.7).
δH (300 MHz, CDCl3) 7.42–7.27 (m, 10H), 4.63–4.57 (m, 4H), 4.22–2.45 (m, 20H),
1.42–1.38 (m, 12H); δC (100 MHz, CDCl3) 137.4 (C), 137.3 (C), 128.0 (4 x CH), 128.7 (2 x
CH), 128.2 (4 x CH), 109.5 (C), 109.4 (C), 93.6 (d, J = 174.7 Hz, CH), 90.8 (d, J = 174.6 Hz,
CH), 76.1 (CH), 75.6 (CH), 74.0 (2 x CH2), 71.6 (d, J = 3.8 Hz, CH), 70.4 (d, J = 3.6 Hz,
CH), 69.8 (d, J = 21.0 Hz, CH), 69.6 (d, J = 24.7 Hz, CH), 69.4 (d, J = 22.9 Hz, CH2), 69.2
(d, J = 22.7 Hz, CH2), 67.1 (CH2), 66.8 (CH2), 26.9 (CH3), 26.8 (CH3), 25.4 (CH3), 25.3
(CH3); δF (282 MHz, CDCl3) -194.4 (m, 1F), -200.8 (m, 1F); δF{H} (282 MHz, CDCl3) -194.4
(s, 1F), -200.8 (s, 1F); MS (ESI, +ve) m/z 337.11 [M+Na]+ (100); HRMS (ESI, +ve)
C16H23FO5Na+ requires m/z 337.1427, found 337.1425.
160
(1R,2R,3S)-4-(benzyloxy)-1-((S)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-fluorobutane-
[1,3,2]dioxolane 2,2-dioxide 162a and (1R,2R,3S)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-
dioxolan-4-yl)-3-fluorobutane [1,3,2]dioxolane 2,2-dioxide 162b:13
Thionyl chloride (0.13 mL, 1.7 mmol) was added to a solution of 160a/160b (0.45 g, 1.4
mmol, dr 1:0.7) in CH2Cl2 (65 mL) and pyridine (0.17 mL, 2.1 mmol) and the mixture was
stirred at 0 °C for 30 min. Saturated CuSO4 (aq) (35 mL) was then added and the product
extracted into CH2Cl2 (3 x 70 mL). The organics were dried (MgSO4) and concentrated and
then dissolved in CH3CN (50 mL). The solution was cooled to 0 °C and then NaIO4 (0.76 g,
3.5 mmol), RuCl33H2O (1 mol%) and H2O (35 mL) were added and the heterogenous
mixture was stirred vigorously at 0 °C for 3 h. Et2O (140 mL) was then added and the organic
layer was washed with 5% aqueous NaHCO3 (50 mL) and dried (MgSO4). The product was
purified over silica gel (9:1 hex:EtOAc → 4:1) to give a solid which was then recrystallised 
from Et2O to provide 162a as a white crystalline solid (0.14 g, 27%), and 162b (0.32 g, 61%)
as a clear oil.
Data for 162a: Mp 38–40 °C; [α]D +30.5 (c 0.63, CHCl3); max (NaCl)/cm-1 3090,
3066, 3033, 2990, 1881, 1812, 1734, 1606, 1396, 1261, 1213, 1061, 986, 953, 833; δH (400
MHz, CDCl3) 7.42–7.27 (m, 5H), 5.07–4.76 (m, 3H), 4.62 (d, J = 11.8 Hz, 1H), 4.58 (d, J =
11.8 Hz, 1H), 4.37 (m, 1H), 4.19 (dd, J = 9.6, 6.0 Hz, 1H), 4.07 (d, J = 9.6, 3.1 Hz, 1H),
161
3.89–3.67 (m, 2H), 1.44 (s, 3H), 1.35 (s, 3H); δC (100 MHz, CDCl3) 137.1 (C), 128.8 (2 x
CH), 128.4 (CH), 128.1 (2 x CH), 111.3 (C), 88.1 (d, J = 184.3 Hz, CH), 82.7 (d, J = 18.7
Hz, CH), 79.5 (d, J = 5.4 Hz, CH), 74.8 (CH), 74.1 (CH2), 67.1 (CH2), 67.5 (d, J = 27.6 Hz,
CH2), 26.9 (CH3), 24.9 (CH3); δF (376 MHz, CDCl3) -206.9 (dddd, J = 45.8, 24.6, 18.2, 11.8
Hz, 1F); δF{H} (376 MHz, CDCl3) -206.9 (s, 1F); MS (ESI, +ve) m/z 399.09 [M+Na]+ (100);
HRMS (ESI, +ve) C16H21O7FSNa+ requires m/z 399.0888, found 399.0886.
Data for 162b: [α]D +23.1 (c 1.9, CHCl3); max (NaCl)/cm-1 3090, 3066, 3033, 2990,
1881, 1812, 1734, 1606, 1396, 1261, 1213, 1061, 986, 953, 833; δH (400 MHz, CDCl3) 7.42–
7.28 (m, 5H), 5.16 (ddd, J = 11.0, 6.2, 4.0 Hz, 1H), 4.94 (ddt, J = 46.0, 6.2, 4.1 Hz), 4.83–
4.76 (m, 1H), 4.63 (d, J = 11.9 Hz, 1H), 4.57 (d, J = 11.9 Hz, 1H), 4.43 (ddd, J = 9.5, 6.2, 3.4
Hz, 1H), 4.18 (dd, J = 9.5, 6.2 Hz, 1H), 4.03 (dd, J = 9.5, 3.4 Hz, 1H), 3.84 (ddd, J = 18.0,
11.5, 4.1 Hz, 1H), 3.79 (ddd, J = 27.0, 11.5, 4.1 Hz, 1H), 1.42 (s, 3H), 1.35 (s, 3H); δC (100
MHz, CDCl3) 137.1 (C), 128.7 (2 x CH), 128.3 (CH), 127.9 (2 x CH), 111.2 (C), 89.0 (d, J =
179.6, CH), 81.1 (d, J = 4.1 Hz, CH), 80.2 (d, J = 29.0 Hz, CH), 74.0 (CH2), 73.8 (CH), 67.1
(d, J = 22.6 Hz, CH2), 66.4 (CH2), 26.7 (CH3), 24.9 (CH3); δF (376 MHz, CDCl3) -198.4
(dddd, J = 46.0, 27.0, 18.0, 11.0 Hz, 1F); δF{H} (376 MHz, CDCl3) -198.4 (s, 1F); MS (ESI,
+ve) m/z 399.11 [M+Na]+ (100); HRMS (ESI, +ve) C16H21O7FSNa+ requires m/z 399.0888,
found 399.0890.
162
(R)-4-((R)-(3-(Benzyloxymethyl)oxiran-2-yl)fluoromethyl)-2,2-dimethyl-1,3-dioxolane
194a/194b:14
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m-CPBA (4.99 g, 15.1 mmol) was added to a solution of 156a (2.11 g, 7.5 mmol) in CH2Cl2
(38 mL) at 0 °C. After 1 min the ice/water bath was removed and the solution was stirred for
5 d at RT. The resultant solution was then stirred with a mixture of 10% (w/v) aqueous
Na2SO3 (50 mL) for 15 min and was then washed with sat. aqueous NaHCO3 (50 mL). The
organic layer was dried over Na2SO4 and the product purified over silica gel (9:1→3:1 
hex:EtOAc) to give the inseparable mixture 194a/194b (2.00 g, 89%, dr 1:0.7) as a clear oil.
Data for the diastereomeric mixture: δH (400.13 MHz, CDCl3) 7.42–7.26 (m, 10H),
4.65–4.17 (m, 8H), 4.16–4.08 (m, 2H), 4.06–3.98 (m, 2H), 3.85–3.75 (m, 2H), 3.60–3.46 (m,
2H), 3.38–3.12 (m, 4H), 1.44 (s, 3H), 1.42 (s, 3H), 1.36 (m, 6H); MS (ESI, +ve) m/z 319.02
[M+Na]+ (100); HRMS (ESI, +ve) C16H21FO4Na+ requires m/z 319.1322, found 319.1331.
Data for major diastereoisomer: δC (100 MHz, CDCl3) 137.9 (C), 128.6 (2 x CH), 128.0
(CH), 127.9 (2 x CH), 110.1 (C), 90.8 (d, J = 180.1 Hz, CH), 74.26 (d, J = 29.0 Hz, CH),
73.5 (CH2), 69.4 (CH2), 66.1 (d, J = 2.8 Hz, CH), 54.4–53.3 (m, 2 x CH), 26.7 (CH3), 25.2
(CH3); δF (376 MHz, CDCl3) -201.3 (dm, J = 47.7 Hz, 1F); δF{H} (376 MHz, CDCl3) -201.3
(s, 1F). Data for minor diastereoisomer: δC (100 MHz, CDCl3) 137.8 (C), 128.6 (2 x CH),
128.0 (CH), 127.9 (2 x CH), 110.3 (C), 90.2 (d, J = 178.1 Hz, CH), 74.3 (d, J = 25.7 Hz,
CH), 73.5 (CH2), 69.2 (CH2), 65.7 (d, J = 4.8 Hz, CH), 54.4–53.3 (m, 2 x CH), 26.6 (CH3),
25.3 (CH3); δF (376 MHz, CDCl3) -199.6 (dt, J = 48.0, 12.7 Hz, 1F); δF{H} (376 MHz,
CDCl3) -199.6 (s, 1F).
163
(1S,2R,3R)-4-(Benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1,3-difluorobutan-2-ol
195a and (1S,2S,3S)-4-(benzyloxy)-1-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-1,3-
difluorobutan-2-ol 195b, (4R)-1-(Benzyloxy)-4-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-3,4-
difluorobutan-2-ol 199a/199b, (2R,3R)-3-(3-((benzyloxy)methyl)oxiran-2-yl)-3-
fluoropropane-1,2-diol 200a/200b:15
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A solution of 194a/194b (0.46 g, 1.6 mmol, dr 1:0.7) in dry CHCl3 (5.2 mL) was introduced
in a microwave reaction glass vessel under an atmosphere of argon. Et3N·3HF (2.06 mL, 12.5
mmol) and dry Et3N (0.47 mL, 3.4 mmol) were then added and the reaction was stirred for 2
h at 120 °C under microwave irradiation. After cooling, further Et3N·3HF (2.06 mL, 12.5
mmol) was added and the reaction was stirred for 3 h at 100 °C, for 12 h at 120 °C, for 3 h at
130 °C and for 3 h at 140 °C under microwave irradiation. After cooling the reaction was
concentrated onto silica and subjected to flash chromatography over silica gel (9:1→4:1 
hexane/ethyl acetate) to give separately products 195a (0.08 g, 16%) and 195b (0.14 g, 29%)
as clear oils, and side-products 199a/199b* (0.03 g, 6%, dr 1:0.7) and 200a/200b* (0.03 g,
6%, dr 1:1) as yellow oils.
*Probable structure based on partial purification/characterisation.
Data for 195a: [α]D22 -6.23 (c 1.25 in CHCl3); max (NaCl)/cm-1 3445, 3086, 3058,
3025, 2980, 2936, 1497, 1455, 1410, 1373, 1256, 1217, 1150, 1102, 1063, 845, 738, 699; δH
(400 MHz, CDCl3) 7.42–7.26 (m, 5H), 4.83 (dm, J = 46.4 Hz, 1H), 4.68–4.49 (m, 3H), 4.48–
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4.35 (m, 1H), 4.33–4.17 (m, 1H), 4.17–4.09 (m, 1H), 4.09–4.02 (m, 1H), 3.91–3.87 (m, 1H),
3.84–3.77 (m, 1H), 2.83 (d, J = 4.9 Hz, OH), 1.44 (s, 3H), 1.36 (s, 3H); δC (100 MHz, CDCl3)
137.5 (C), 128.7 (2 x CH), 128.2 (CH), 128.0 (2 x CH), 110.1 (C), 91.7 (dd, J = 176.3, 3.6
Hz, CH), 90.6 (dd, J = 175.2, 6.2 Hz, CH), 73.9 (CH2), 73.8 (d, J = 29.2 Hz, CH), 70.9 (dd, J
= 24.1, 22.2 Hz, CH), 69.3 (d, J = 21.7 Hz, CH2), 66.2 (d, J = 4.4 Hz, CH2), 26.7 (CH3), 25.3
(CH3); δF (376 MHz, CDCl3) -196.8 (dddd, J = 46.4, 27.2, 24.7, 9.4 Hz, F3), -200.3 (ddd, J =
46.5, 14.0, 12.6, F1); δF{H} (376 MHz, CDCl3) -196.8 (s, F3), -200.3 (s, F1); MS (ESI, +ve)
m/z 339.07 [M+Na]+ (100); HRMS (ESI, +ve) C16H22F2O4Na+ requires m/z 339.1384, found
339.1389.
Data for 195b: [α]D22 -8.3 (c 1.25 in CHCl3); max (NaCl)/cm-1 3440, 3087, 3070,
3025, 2986, 2930, 1455, 1373, 1256, 1217, 1069, 842, 738, 699; δH (400 MHz, CDCl3) 7.42–
7.26 (m, 5H), 4.82–4.48 (m, 4H), 4.46–4.33 (m, 1H), 4.23–4.00 (m, 3H), 3.94–3.78 (m, 2H),
2.54 (d, J = 6.2 Hz, OH), 1.42 (s, 3H), 1.37 (s, 3H); δC (100 MHz, CDCl3) 137.5 (C), 128.7 (2
x CH), 128.1 (CH), 128.0 (2 x CH), 110.0 (C), 90.5 (dd, J = 178.1, 2.6 Hz, CH), 89.8 (dd, J =
176.3, 3.7 Hz, CH), 73.9 (CH2), 73.0 (d, J = 29.8 Hz, CH), 69.4 (d, J = 21.0 Hz, CH2), 68.5
(dd, J = 25.9, 17.6 Hz, CH), 66.5 (d, J = 2.7 Hz, CH2), 26.9 (CH3), 25.2 (CH3); δF (376 MHz,
CDCl3) -194.7 (dm, J = 46.8 Hz, F3), -211.5 (dm, J = 46.6 Hz, F1); δF{H}(376 MHz, CDCl3) -
194.7 (d, J = 3.0 Hz, F3), -211.5 (d, J = 3.0 Hz, F1); MS (ESI, +ve) m/z 339.05 [M+Na]+
(100); HRMS (ESI, +ve) C16H22F2O4Na+ requires m/z 339.1384, found 339.1394.
Data for 199a/199b: δH (400 MHz, CDCl3) 7.42–7.26 (m, 10H), 5.16–3.05 (m, 22H),
1.48–1.32 (m, 12H); δF (376 MHz, CDCl3) -201.2 (dm, J = 46.5 Hz, F), -202.9 (m, F), -211.6
(m, F), -212.2 (m, F); δF{H} (376 MHz, CDCl3) -201.2 (d, J = 12.0 Hz, F), -202.9 (d, J = 12.0
Hz, F), -211.6 (d, J = 9.0 Hz, F), -212.2 (d, J = 9.0 Hz, F); MS (ESI, +ve) m/z 339.09
[M+Na]+ (100); HRMS (ESI, +ve) C16H22F2O4Na+ requires m/z 339.1384, found 339.1390.
165
Data for 200a/200b: δF (376 MHz, CDCl3) -217.0 (m, F), -202.8 (m, F); δF{H} (376
MHz, CDCl3) -217.0 (s, F), -202.8 (s, F); MS (ESI, +ve) m/z 279.03 [M+Na]+ (100); HRMS
(ESI, +ve) C13H17FO4Na+ requires m/z 279.1009, found 279.1000.
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(R)-4-((1R,2R,3S)-4-(Benzyloxy)-1,2,3-trifluorobutyl)-2,2-dimethyl-1,3-dioxolane 196:16
O
O
F1
OBn
F2
F3
196
DeoxofluorTM (1.34 mL, 3.2 mmol) was added to a solution of 195a (0.40 g, 1.3 mmol) in dry
CH2Cl2 (25 mL) at 0 ºC. After addition the mixture was heated at reflux (oil bath temperature
70 °C) for 14 h. The reaction was allowed to cool to RT, concentrated onto silica and
subjected to flash chromatography over silica gel (9:1→5:1 hexane/ethyl acetate) to give 196
(0.23 g, 57%) as a yellow oil.
max (NaCl)/cm-1 3033, 2989, 2941, 2868, 1497, 1452, 1382, 1371, 1250, 1216, 1150,
1119, 1071, 839, 741, 699; δH (400 MHz, CDCl3) 7.43–7.27 (m, 5H), 5.18–4.76 (m, 2H),
4.66–4.50 (m, 3H), 4.41–4.30 (m, 1H), 4.23–4.01 (m, 2H), 3.95–3.70 (m, 2H), 1.37 (s, 3H),
1.36 (s, 3H); δC (100 MHz, CDCl3) 137.3 (C), 128.6 (2 x CH), 128.2 (CH), 127.9 (2 x CH),
110.1 (C), 88.5–98.2 (m, 3 x CH), 74.0 (CH2), 72.5 (dd, J = 29.1, 5.0 Hz, CH), 68.5 (dd, J =
21.7, 8.0 Hz, CH2), 66.1 (m, CH) 26.8 (CH3), 25.2 (CH3); δF (376 MHz, CDCl3) -198.3 (dm,
J = 47.3 Hz, F3), -209.4 (dm, J = 46.7 Hz, F1), -214.2 (dm, J = 47.1 Hz, F2); δF{H} (376 MHz,
CDCl3) -198.3 (d, J = 14.2 Hz, F3), -209.4 (d, J = 9.9 Hz, F1), -214.2 (dd, J = 14.2, 9.9 Hz,
F2); MS (ESI, +ve) m/z 340.98 [M+Na]+ (100); HRMS (ESI, +ve) C16H21F3O3Na+ requires
m/z 341.1340, found 341.1334.
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(2S,3R,4R)-4-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,3,4-trifluorobutan-1-ol 197:17
O
O
F1
OH
F2
F3
197
A solution of NaBrO3 (0.1 g, 0.6 mmol) in water (2.1 mL) was added to a solution of 196
(0.07 g, 0.2 mmol) in ethyl acetate (2.9 mL). This mixture was stirred at RT for 10 min and a
solution of Na2S2O4 (0.11 g, 0.5 mmol) in water (4.3 mL ) was added dropwise over 20 min
at RT. The mixture was stirred for 1 h at RT. The mixture was then diluted with EtOAc and
the organic phase was washed with aq. Na2S2O3. The product was purified over silica gel
(9:1→5:1 hexane/ethyl acetate) to give 197 (0.03 g, 53%) as a clear oil.
[α]D22 -20.1 (c 0.57 in CHCl3); max (NaCl)/cm-1 3434, 2986, 2958, 2936, 2896, 1634,
1457, 1385, 1373, 1256, 1222, 1150, 1113, 1066, 1049, 987, 945, 917, 842, 870, 786, 766,
708, 666); δH (400 MHz, CDCl3) 5.13–4.73 (m, 2H), 4.60 (dm, J = 46.7 Hz, 1H), 4.45–4.31
(m, 1H), 4.22–3.79 (m, 4H), 1.91 (t, J = 6.3 Hz, OH), 1.43 (s, 3H), 1.37 (s, 3H); δC (100
MHz, CDCl3) 110.2 (C), 93.3–88.2 (m, 3 x CH), 72.5 (dd, J = 29.0 Hz, 4.9, CH), 66.1 (m,
CH), 61.7 (dd, J = 21.9, 8.1 Hz, CH2) 26.9 (CH3), 25.2 (CH3); δF (376 MHz, CDCl3) -202.0
(dm, J = 47.4 Hz, F3), -209.4 (dm, J = 46.7 Hz, F1), -215.0 (dm, J = 46.5 Hz, F2); δF{H} (376
MHz, CDCl3) -202.0 (d, J = 14.3 Hz, F3), -209.4 (d, J = 9.6 Hz, F1), -215.0 (dd, J = 14.3, 9.6
Hz, F2); MS (ESI, +ve) m/z 251.03 [M+Na]+ (100); HRMS (ESI, +ve) C9H15F3O3Na+
requires m/z 251.0871, found 251.0872.
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(2S,3S,4R)-4-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,3,4-trifluorobutanal 198:18
O
O
F
H
F
F
O
198
A solution of Dess-Martin periodinane reagent (0.13 g, 0.3 mmol) in dry CH2Cl2 (1.1 mL)
was placed in an oven-dried round-bottom flask and stirred at RT for 5 min. Then a solution
of 197 (0.04 g, 0.2 mmol) in dry CH2Cl2 (1.1 mL) was added. After stirring for 40 min at RT,
a mixture of hexane/ethyl acetate (9:1, 5 mL) was added and the resultant suspension was
quickly filtered through a silica plug (2.5 cm) by flushing with 9:1 hexane/ethyl acetate (125
mL). This provided aldehyde 198 (0.04 g) as a yellow oil which was used in the next reaction
without further purification due to its instability.
δF (282 MHz, CDCl3) -204.3 (dd, J = 11.1, 4.8 Hz, 1F), -212.5 (dd, J = 12.8, 11.1 Hz,
1F), -213.5 (dd, J = 12.8, 4.8 Hz, 1F).
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2,3,4-Trideoxy-2,3,4-trifluoro D-glucose 193:19
193
OF4
F3
F2
OH
OH
A mixture of 198 (0.04 g, 0.2 mmol) and anhydrous tin(II) chloride (0.06 g, 0.3 mmol) were
stirred in dry CH2Cl2 (3.9 mL) at RT for 1 h. The undissolved tin(II) chloride was removed
by filtration. Silica gel (1 g) was added to the filtrate. The resultant suspension was
evaporated to dryness and purified over silica gel (9:1→1:9 hexane/ethyl acetate) to give 193
(0.02 g, 58%, as a mixture of α- and β- anomers) as a transparent oil. The product was
recrystallised from CHCl3. The relative stereochemistry of the β-anomer was determined by
X-ray structure analysis. The anomeric ratio was α/β: 1:0.13 determined by 19F{1H}-NMR
(376 MHz, CDCl3), and α/β: 1:0.2 determined by 1H{19F}-NMR (400 MHz, CDCl3).
Data for the anomeric mixture: [α]D22 +40.1 (c 1.15 in d8-THF, 1:1 anomeric ratio);
δH (400 MHz, CDCl3) 5.56–4.78 (m, 4H), 4.77–4.21 (m, 4H), 4.20–3.26 (m, 6H), 3.30 (br s,
OH), 1.78 (br s, OH); MS (ESI, +ve) m/z 208.99 [M+Na]+ (100); HRMS (ESI, +ve)
C6H9F3O3Na+ requires m/z 209.0401, found 209.0405. Data for α-anomer: δC (100 MHz,
CDCl3) 91.5–89.2 (m, 3 x CH), 90.5 (dd, J = 21.1, 9.7 Hz, CH), 88.0 (ddd, J = 192.8, 16.7,
8.1 Hz, CH), 86.6 (ddd, J = 186.0, 18.4, 7.7 Hz, CH), 68.7 (dd, J = 24.3, 6.3 Hz, CH), 60.9
(CH2); δF (376 MHz, CDCl3) -199.9 (dm, J = 51.0 Hz, 1F2), -201.6 (dm, J = 55.0 Hz, 1F3), -
202.0 (dm, J = 49.6, 1F4); δF{H} (376 MHz, CDCl3) -199.9 (dd, J = 12.7, 2.0 Hz, 1F2), -201.6
(dd, J = 13.2, 12.7 Hz, 1F3), -202.0 (dd, J = 13.2, 2.0 Hz, 1F4). Data for β-anomer: Mp
103–105 °C (from CHCl3); δF (376 MHz, CDCl3) -195.8 (dm, J = 52.8 Hz, 1F3), -200.5 (dm,
J = 50.9 Hz, 1F2), -201.2 (dm, J = 50.4 Hz, 1F4); δF{H} (376 MHz, CDCl3) -195.8 (dd, J =
13.2, 12.7 Hz, 1F3), -200.5 (dd, J = 13.2, 2.8 Hz, 1F2), -201.2 (dd, J = 12.7, 2.8 Hz, 1F4).
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(R)-4-((1R,2S,3R)-4-(Benzyloxy)-1,2,3-trifluorobutyl)-2,2-dimethyl-1,3-dioxolane 201:16
O
O
F1
OBn
F2
F3
201
DeoxofluorTM (1.34 mL, 3.2 mmol) was added to a solution of 195b (0.40 g, 1.3 mmol) in
dry CH2Cl2 (25 mL) at 0 ºC. After addition the mixture was heated at reflux (oil bath
temperature 70 °C) for 14 h. The reaction was allowed to cool to RT, concentrated onto silica
and subjected to flash chromatography over silica gel (9:1→5:1 hexane/ethyl acetate) to give 
201 (0.24 g, 60%) as a yellow oil.
max (NaCl)/cm-1 3089, 3058, 3025, 2986, 2930, 2874, 1497, 1455, 1379, 1370, 1259,
1214, 1147, 1108, 1066, 845, 744; δH (400 MHz, CDCl3) 7.43–7.27 (m, 5H), 5.06–4.52 (m,
5H), 4.48–4.36 (m, 1H), 4.15–4.05 (m, 1H), 4.05–3.95 (m, 1H), 3.84–3.72 (m, 2H), 1.39 (s,
3H), 1.36 (s, 3H); δC (100 MHz, CDCl3) 137.4 (C), 128.7 (2 x CH), 128.2 (CH), 128.0 (2 x
CH), 110.1 (C), 91.1–87.8 (m, 3 x CH), 73.8 (CH2), 73.4 (dd, J = 25.1, 3.7 Hz, CH), 67.6 (dd,
J = 25.2, 7.0 Hz, CH2), 65.3 (dd, J = 5.7, 2.9 Hz, CH2) 26.2 (CH3), 25.3 (CH3); δF (376 MHz,
CDCl3) -201.3 (dm, J = 45.9 Hz, F1), -203.3 (dm, J = 47.8 Hz, F3), -213.6 (dm, J = 47.1 Hz,
F2); δF{H} (376 MHz, CDCl3) -201.3 (dd, J = 13.0, 5.7 Hz, F1), -203.3 (dd, J = 10.7, 5.7 Hz,
F3), -213.6 (dd, J = 13.0, 10.7 Hz, F2); MS (ESI, +ve) m/z 341.07 [M+Na]+ (100); HRMS
(ESI, +ve) C16H21F3O3Na+ requires m/z 341.1340, found 341.1344.
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(2R,3S,4R)-4-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,3,4-trifluorobutan-1-ol 202:17
O
O
F1
OH
F2
F3
202
A solution of NaBrO3 (0.1 g, 0.6 mmol) in water (2.1 mL) was added to a solution of 201
(0.07 g, 0.2 mmol) in ethyl acetate (2.9 mL). This mixture was stirred for 10 min at RT and a
solution of Na2S2O4 (0.11 g, 0.5 mmol) in water (4.3 mL ) was added dropwise over 20 min
at RT. The mixture was stirred for 1 h at RT. The mixture was then diluted with EtOAc and
the organic phase was washed with aq. Na2S2O3. The product was purified over silica gel
(9:1→5:1 hexane/ethyl acetate) to give 202 (0.02 g, 51%) as a clear oil.
[α]D22 -4.4 (c 0.39 in CHCl3); max (NaCl)/cm-1 3446, 2986, 2930, 2891, 1636, 1483,
1457, 1382, 1376, 1258, 1211, 1152, 1063, 848); δH (400 MHz, CDCl3) 5.03–4.64 (m, 3H),
4.52–4.36 (dq, J = 15.4, 5.9 Hz, 1H), 4.18–4.10 (m, 1H) , 4.07–4.00 (m, 1H) 3.99–3.84 (m,
2H), 1.97 (t, J = 6.4 Hz, OH), 1.44 (s, 3H), 1.37 (s, 3H); δC (100 MHz, CDCl3) 110.3 (C),
92.0–87.8 (m, 3 x CH), 73.4 (dd, J = 25.3, 4.1 Hz, CH), 65.4 (dd, J = 5.7, 2.9 Hz, CH2), 61.3
(dd, J = 24.4, 7.2 Hz, CH2), 26.3 (CH3), 25.2 (CH3); δF (376 MHz, CDCl3) -201.3 (dm, J =
45.5 Hz, F1), -205.4 (m, F3), -212.8 (dm, J = 47.0 Hz, F2); δF{H} (376 MHz, CDCl3) -201.3
(dd, J = 12.7, 5.9 Hz, F1), -205.4 (dd, J = 10.9, 5.9 Hz, F3), -212.8 (dd, J = 12.7, 10.9 Hz, F2);
MS (ESI, +ve) m/z 251.00 [M+Na]+ (100); HRMS (ESI, +ve) C9H15F3O3Na+ requires m/z
251.0871, found 251.0877.
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(2R,3R,4R)-4-((R)-2,2-Dimethyl-1,3-dioxolan-4-yl)-2,3,4-trifluorobutanal 203:18
O
O
F
H
F
F
O
203
A solution of Dess-Martin periodinane reagent (0.13 g, 0.3 mmol) in dry CH2Cl2 (1.1 mL)
was placed in an oven-dried round-bottom flask and stirred at RT for 5 min. Then a solution
of 202 (0.04 g, 0.2 mmol) in dry CH2Cl2 (1.1 mL) was added. After stirring for 40 min, a
mixture of hexane/ethyl acetate (9:1, 5 mL) was added and the resultant suspension was
quickly filtered through a silica plug (2.5 cm) by flushing with 9:1 hexane/ethyl acetate (125
mL). This provided aldehyde 203 (0.04 g) as a yellow oil which was used in the next reaction
without further purification due to its instability.
δF (282 MHz, CDCl3) -201.5 (dd, J = 13.4, 7.6 Hz, 1F), -210.7 (dd, J = 10.1, 13.4 Hz,
1F), -217.0 (dd, J = 10.1, 7.6 Hz, 1F).
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2,3,4-Trideoxy-2,3,4-trifluoro D-altrose 216:19
O
F
F
OH
216
OH
F
A mixture of 203 (0.04 g, 0.2 mmol) and anhydrous tin(II) chloride (0.06 g, 0.3 mmol) were
stirred in dry CH2Cl2 (3.9 mL) at RT for 1 h. The undissolved tin(II) chloride was removed
by filtration. Silica gel (1 g) was added to the filtrate. The resultant suspension was
evaporated to dryness and purified over silica gel (9:1→1:9 hexane/ethyl acetate) to give 216
(0.01 g, 48%, as a mixture of α- and β- anomers) as a transparent oil. The product was
recrystallised from CHCl3. The relative stereochemistry of the β-anomer was determined by
X-ray structure analysis. The anomeric ratio was α/β: 0.8:1 determined by 19F{1H}-NMR
(376 MHz, CDCl3) and 1H{19F}-NMR (400 MHz, CDCl3).
Data for the anomeric mixture: δH (400 MHz, CDCl3) 5.51–5.02 (m, 4H), 5.00–
4.59 (m, 4H), 4.51–4.33 (m, 1H), 4.09–3.76 (m, 5H), 2.84 (br s, OH); MS (ESI, +ve) m/z
208.98 [M+Na]+ (100); HRMS (ESI, +ve) C6H9F3O3Na+ requires m/z 209.0401, found
209.0403. Data for β-anomer: Mp 78–80 °C (from CHCl3); δC (100 MHz, CDCl3) 91.4 (d, J
= 17.4 Hz, CH), 88.5–81.8 (m, 3 x CH), 72.2 (dd, J = 25.0, 2.8 Hz, CH), 61.4 (CH2); δF (376
MHz, CDCl3) -213.4 (dm, J = 44.4 Hz, 1F), -214.3 (dm, J = 48.8 Hz, 1F), -219.3 (dt, J =
46.5, 17.3 Hz, 1F); δF{H} (376 MHz, CDCl3) -213.4 (d, J = 11.7 Hz, 1F), -214.3 (dd, J = 17.3,
11.7 Hz, 1F), -219.3 (d, J = 17.3 Hz, 1F). Data for α-anomer: δC (100 MHz, CDCl3) 91.9 (d,
J = 32.1 Hz , CH), 88.5–81.8 (m, CH), 66.1 (dd, J = 24.6, 2.8 Hz, CH), 61.5 (CH2); δF (376
MHz, CDCl3) -200.5 (dm, J = 44.2 Hz, 1F), -209.7 (dm, J = 45.4 Hz, 1F), -213.9 (dm, J =
174
48.7 Hz, 1F); δF{H} (376 MHz, CDCl3) -200.5 (dd, J = 17.7, 2.1 Hz, 1F), -209.7 (dd, J = 11.1,
2.1 Hz, 1F), -213.9 (dd, J = 17.7, 11.1 Hz, 1F).
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(S)-(1-Fluoroethyl)benzene (S)-214 (95% ee):20
F
(S)-214
N-(Trimethylsilyl)morpholine 226 (neat, 447 µl, 2.5 mmol) was added dropwise to a solution
of DAST (312 µl, 2.4 mmol) in dry CH2Cl2 (0.96 mL) at -78 °C, and was stirred at RT for 2.5
h. The reaction was further cooled to -78 °C and a solution of (R)-213 (90 µl, 0.7 mmol) in
dry CH2Cl2 (2.24 mL) was slowly added via cannula. The reaction was stirred at RT for 15 h.
The mixture was then slowly poured over sat. aqueous NaHCO3 solution (15 mL). The
organic layer was separated and the aqueous extracted into CH2Cl2 (3 x 1.5 mL). The
combined organic layers were dried over anhydrous MgSO4 and the solvent was evaporated
under reduced pressure. The residue was purified over silica gel (100% pentane) to afford
(S)-214 (65 mg, 71% yield) as a colourless oil. Chiral-phase GC/MS (EI) analysis of the
product, tR = 20.3 min for the major (S)-enantiomer and tR = 21.3 min for the minor (R)-
enantiomer, indicated that the ee was 95%.
[α]D22 +35.6 (c 1.0, CHCl3); max (NaCl)/cm-1 3083, 3064, 3034, 2980, 2926, 1451,
1211, 1063; δH (300 MHz, CDCl3) 7.43–7.29 (m, 5H), 5.64 (dq, J = 47.6, 6.4 Hz, 1H), 1.65
(dd, J = 23.9, 6.4 Hz, 3H); δC (75 MHz, CDCl3) 141.7 (d, J = 20.0 Hz, C), 128.6 (CH), 128.3
(d, J = 1.9 Hz, 2 x CH), 125.3 (d, J = 6.7 Hz, 2 x CH), 91.1 (d, J = 167.4 Hz, CH), 23.1 (d, J
= 25.3 Hz, CH3); δF (282 MHz, CDCl3) -167.5 (dq, J = 47.6, 23.9 Hz, 1F); δF{H} (282 MHz,
CDCl3) -167.5 (s, 1F); GC/MS (EI, +ve) m/z 124 [M]+, 109 [M-CH3]+; HRMS (EI, +ve)
C8H9F requires m/z 124.0688, found 124.0689.
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(S)-Methyl 2-fluoro-2-phenylacetate (S)-228:20
F
CO2Me
(S)-228
N-(Trimethylsilyl)morpholine 226 (neat, 298 µl, 1.7 mmol) was added dropwise to a solution
of DeoxofluorTM (50% in THF, 690 µl, 1.6 mmol) in dry CH2Cl2 (2.20 mL) at -78 °C. The
resultant solution was stirred at RT for 2.5 h. The reaction was further cooled to -78 °C and a
solution of methyl (R)-227 (248 mg, 1.5 mmol) in dry CH2Cl2 (4.48 mL) was slowly added
via cannula. The reaction was stirred at RT for 24 h. The mixture was then slowly poured
over sat. aqueous NaHCO3 solution (30 mL). The organic layer was separated and the
aqueous extracted into CH2Cl2 (3 x 3.0 mL). The combined organic layers were dried over
anhydrous MgSO4 and the solvent was evaporated under reduced pressure. The residue was
purified over silica gel (9:1 hexane:EtOAc → 4:1) to afford (S)-228 (48 mg, 19% yield) as a
colourless oil. Chiral-phase GC/MS (EI-SIM) analysis of the product, tR = 42.2 min for the
minor (R)-enantiomer and tR = 42.5 min for the major (S)-enantiomer, indicated that the ee
was 99%.
[α]D22 +117.5 (c 1.4, CDCl3); max (NaCl)/cm-1 3083, 3062, 3027, 2972, 2937, 2877,
1761, 1714, 1448, 1350, 1091; δH (400 MHz, CDCl3) 7.51–7.36 (m, 5H), 5.80 (d, J = 47.5
Hz, 1H), 3.78 (s, 3H); δC (75 MHz, CDCl3) 169.1 (d, J = 27.7 Hz, C), 134.3 (d, J = 20.6 Hz,
C), 129.8 (d, J = 2.1 Hz, 2 x CH), 128.9 (CH), 126.8 (d, J = 6.1 Hz, 2 x CH), 89.4 (d, J =
185.6 Hz, CH), 52.7 (s, CH3); δF (282 MHz, CDCl3) -180.3 (d, J = 47.5 Hz, 1F); δF{H} (282
177
MHz, CDCl3) -180.3 (s, 1F); GC/MS (EI-SIM, +ve) m/z 168 [M]+; HRMS (ESI, +ve)
C9H9FO2Na+ requires m/z 191.0484, found 191.0482.
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5.3) General procedures for dehydroxyfluorination of allylic alcohol
155a/155b:
5.3.1) Dehydroxyfluorination with TFEDMA:21
A solution of allylic alcohol 155a/155b (5.0 mmol) in CH2Cl2 (10 mL) was added to a
solution of TFEDMA (5.5 mmol) in CH2Cl2 (10 mL) at 0 °C placed in a polythene vessel.
After addition the reaction was brought to RT and stirred for 1 h and the progress of the
reaction was monitored by t.l.c. The reaction was worked up by adding sat. aqueous NaHCO3
solution and the product was extracted into CH2Cl2 (3 x 150 mL). Purification by
chromatography (6:1 hex:EtOAc → 3:1) gave 156a and an inseparable mixture of isomers
156b/157a/157b. Stereoisomer ratios (determined by 19F-NMR) and yields (after isolation by
column chromatography) are given in Table 2.1, Chapter 2.
5.3.2) Dehydroxyfluorination with DeoxofluorTM:22
A solution of DeoxofluorTM (7.5 mmol, 50% in THF) was added to a solution of 155a/155b
(5.0 mmol) in CH2Cl2 (20 mL) at 0 ºC placed in a round-bottom flask (standard glassware).
After addition the reaction was heated to 55 °C for 3.5 h and the progress of the reaction was
monitored by t.l.c. The reaction was allowed to cool to RT and was then worked up by adding
sat. aqueous NaHCO3 solution. The product was extracted into CH2Cl2 (3 x 150 mL) and was
purified over silica gel eluting with a hexane/ethyl acetate gradient (6:1 hex:EtOAc → 3:1). 
This gave 156a and an inseparable mixture of isomers 156b/157a/157b. Stereoisomer ratios
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(determined by 19F-NMR) and yields (after isolation by column chromatography) are given in
Table 2.1, Chapter 2.
5.3.3) Dehydroxyfluorination with DAST:23
DASTTM (neat, 7.5 mmol) was added to a solution of 155a/155b (5.0 mmol) in dry CH2Cl2
(20 mL) at 0 ºC placed in a round-bottom flask (standard glassware). After addition the
reaction was brought to RT and stirred for 4.5 h and the progress of the reaction was
monitored by t.l.c. The reaction was worked up by adding sat. aqueous NaHCO3 solution and
the product was extracted into CH2Cl2 (3 x 150 mL) and purified over silica gel (hexane/ethyl
acetate gradient (6:1 hex:EtOAc → 3:1). This gave 156a and an inseparable mixture of
isomers 156b/157a/157b. Stereoisomer ratios (determined by 19F-NMR) and yields (after
isolation by column chromatography) are given in Table 2.1, Chapter 2.
5.3.4) Dehydroxyfluorination with FluoleadTM:24
A solution of allylic alcohol 155a/155b (1.1 mmol) in dry CH2Cl2 (2.2 mL) was added to a
solution of FluoleadTM (1.2 mmol) in dry CH2Cl2 (2.2 mL) at 0 °C placed in a polyethylene
vessel. After addition the reaction was stirred at 0 °C for 40 min. The progress of the reaction
was monitored by t.l.c. The reaction was worked up by slowly adding sat. aqueous NaHCO3
solution and the product was extracted into CH2Cl2 (3 x 20 mL). Evaporation of solvents in
vacuo gave a product that was analysed directly by 19F NMR spectroscopy. Stereoisomer
ratios (determined by 19F-NMR) of 156a/156b/157a/157b are given in Table 2.1, Chapter 2.
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5.4) General procedures for dehydroxyfluorination of alcohols 213 and 227:
5.4.1) Dehydroxyfluorination without additive:
A solution of alcohol 213 or 227 (0.7 mmol, 1.0 equiv.) in dry CH2Cl2 (2.2 mL) was slowly
added via cannula to a solution of dehydroxyfluorination reagent (1.1, 2.2 or 3.3 equiv.) in
CH2Cl2 (1.4 mL) at -78 ºCa placed in a round-bottom flaskb. The solution was then allowed to
warm to RT and stirred for 15 h. The mixture was slowly poured over sat. aqueous NaHCO3
solution (30 mL). The organic phase was separated and washed with water (10 mL), dried
over MgSO4 and analysed by chiral GC-MS (see Paragraph 5.5).
a For reactions performed using FluoleadTM, addition of alcohol was performed at -20 °C.
b Reaction using FluoleadTM and TFEDMA were performed in a polyethylene vessel.
5.4.2) Dehydroxyfluorination with additive:20
Neat additive 226 or 229 (1.1, 2.2 or 3.3 equiv.) was added dropwise to a solution of
dehydroxyfluorination reagent (1.1, 2.2 or 3.3 equiv.) in dry CH2Cl2 (1.4 mL) at -78 ºCa
placed in a round-bottom flaskb. The solution was then allowed to warm to RT, stirred for 2.5
h and further cooled to -78 ºC. A solution of alcohol 213 or 227 (0.7 mmol, 1.0 equiv.) in dry
CH2Cl2 (2.2 mL) was slowly added via cannula at -78 ºC. The solution was allowed to warm
to RT and stirred for 15 h. The mixture was slowly poured over sat. aqueous NaHCO3
solution (30 mL). The organic phase was separated and washed with water (10 mL), dried
over MgSO4 and analysed by chiral GC-MS (see Paragraph 5.5.1).
a For reactions performed using FluoleadTM, addition of alcohol was performed at -20 °C.
b Reaction using FluoleadTM and TFEDMA were performed in a polyethylene vessel.
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5.5 GC analyses for determination of the enantiopurities and the %
conversions of products 214 and 228:
5.5.1) GC analyses for determination of the enantiopurities:
Analyses were run using a BetadexTM 120 fused silica capillary column (30 m x 0.25 mm i.
D., 0.25 μm film thickness). Different temperature gradients were used for the chiral 
separation of racemic-214 and racemic-228. The GC chromatogram of racemic-214 is
presented . It has two peaks of the same area at 22.66 and 23.71 min. The MS (EI) spectra of
the peak at 22.66 min (Figure 5.2) and of the peak at 23.71 min (Figure 5.3) show identical
fragmentation patterns for 214 (m/z = 124 [M]+, 109 [M-CH3]+), consistent with each peak
belonging to enantiomers of 214.
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Figure 5.1. Chiral-phase GC chromatogram of racemic-214: temperature-gradient oven (80 °C held for 30 min),
250 °C injector temperature, 100:1 split ratio, 0.9 mL/min flow, He carrier gas, BetadexTM 120 fused silica
capillary column (30 m x 0.25 mm i.d., 0.25 µm film thickness), MS (EI) detection.
Ret. Time
(min)
Area
(units)
22.66 9390996
23.71 9458053
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Figure 5.2. GC/MS (EI) spectrum of racemic-214, scan at 22.66 min.
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Figure 5.3. GC/MS (EI) spectrum of racemic-214, scan at 23.70 min.
Chiral-phase GC-MS allowed determination of the enantiomeric ratios of 214 prepared in this
study. GC/MS (EI) analysis of (S)-214 (95% ee, Entry 7 in Table 4.7, Chapter 4) allowed the
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individual (R or S) enantiomers of each peak to be assigned. The GC chromatogram of (S)-
214 (95% ee) is presented in Figure 5.4 and shows a major peak at 20.27 min which
corresponds to the (S) enantiomer, and a minor peak at 21.30 min corresponding to the (R)
enantiomer. The MS (EI) spectra for each peak are shown in Figures 5.5 and 5.6. In each case
they display a fragmentation pattern consistent with 214 (m/z = 124 [M]+, 109 [M-CH3]+).
Figure 5.4. Chiral-phase GC chromatogram of (S)-214 (95% ee): temperature-gradient oven (80 °C held for 30
min), 250 °C injector temperature, 100:1 split ratio, 0.9 mL/min flow, He carrier gas, BetadexTM 120 fused silica
capillary column (30 m x 0.25 mm i.d., 0.25 µm film thickness), MS (EI) detection.
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Figure 5.5. GC/MS (EI) spectrum of (S)-214, scan at 20.28 min.
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Figure 5.6. GC/MS (EI) spectrum of (R)-214, scan at 21.30 min.
A similar procedure was adopted for product 228. The GC chromatogram of racemic-228 is
presented in Figure 5.7 and has two peaks of the same area at 41.33 and 41.70 min. The MS
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(EI) spectra of the peaks at 41.33 min (Figure 5.8) and 41.70 min (Figure 5.9) show the same
expected fragmentation pattern for 228 (m/z = 168 [M]+, 109 [M-CH3]+), indicating that they
belong to the enantiomers of 228.
Figure 5.7. Chiral-phase GC chromatogram of racemic-228: temperature-gradient oven (start at 110 °C held for
40 min, then gradient at 20 °C/min to 150 °C held for 15 min), 250 °C injector temperature, 100:1 split ratio, 0.9
mL/min flow, He carrier gas, BetadexTM 120 fused silica capillary column (30 m x 0.25 mm i.d., 0.25 µm film
thickness), MS (EI) detection.
Ret. Time
(min)
Area
(units)
41.33 52577718
41.70 52044097
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Figure 5.8. GC/MS (EI) spectrum of racemic-228, scan at 41.33 min.
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Figure 5.9. GC/MS (EI) spectrum of racemic-228, scan at 41.70 min.
Chiral-phase GC/MS (EI) analysis of (S)-228 (99% ee, Entry 3, Table 4.9, Chapter 4) allowed
the individual (R or S) enantiomers of each peak to be assigned. The GC chromatogram of
(S)-228 (99% ee) is presented in Figure 5.10 and shows a small peak at 42.20 min which
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corresponds to the (R) enantiomer, and the main peak at 42.45 min which corresponds to the
(S) enantiomer. The MS (EI-SIM) spectra for the peak at 42.20 min and the peak at 42.45 min
are shown in Figure 5.11 and Figure 5.12 respectively. In each case they display the same
expected fragmentation pattern consistent with 228 (m/z = 168 [M]+).
Figure 5.10. Chiral-phase GC chromatogram of (S)-228 (99% ee): temperature-gradient oven (start at 110 °C
held for 40 min, then gradient at 20 °C/min to 150 °C held for 15 min), 250 °C injector temperature, 100:1 split
ratio, 0.9 mL/min flow, He carrier gas, BetadexTM 120 fused silica capillary column (30 m x 0.25 mm i.d., 0.25
µm film thickness), MS (EI-SIM) detection.
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Figure 5.11. GC/MS (EI-SIM) spectrum of (R)-228, scan at 42.20 min.
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Figure 5.12. GC/MS (EI-SIM) spectrum of (R)-228, scan at 42.45 min.
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5.5.2) GC analyses for determination of the % conversions:
In this study, the reaction conversions were determined by GC-FID using n-decane as an
internal standard. GC-FID analyses were run on a Hewlett Packard 1 column (30 m x 0.25
mm i.d, 0.25 µm film thickness). n-Decane was chosen as an internal standard as it does not
react or overlap with the other components of the reaction. In addition, its low volatility
allows for more accurate results. Two calibration curves for the two analytes (S)-214 and (S)-
228 were generated by GC-FID analyses of solutions containing a constant concentration of
n-decane. The amounts of analyte (number of mmol) were varied, covering the range of
levels expected. The two calibration curves, one for (S)-214 (Figure 5.13) and the other for
(S)-228 (Figure 5.14) were constructed by plotting the ratio of the area of the analyte to the
area of the internal standard (y axis) against the number of mmol (no. mmol) of the analytes
(x axis).
Figure 5.13. Calibration curve for ana
Area (S)-214
Area n-decane
y = 1.0705x – 0.0064
R2 = 1lyte (S)-214.
no. mmol (S)-214
190
Figure 5.14. Calibration curve for ana
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analyte to be determined, allowed the ratio of the analyte
area to be calculated. The corresponding no. mmol of p
from the graph, which allowed determination of the %
analysis (Figure 5.15) of the product mixture contain
determined (Entry 7, Table 4.7, Chapter 4), provided the
Area (S)-214 = 110486801 (units)
Area n-decane = 152916682 (units)
y = 0.5774x – 0.0085
R2 = 1
Area (S)-228
Area n-decanelyte (S)-228.
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ing the amount of (S)-214 to be
following areas:
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Figure 5.15. Gas chromatogram (GC-FID) of the quenched reaction mixture of (S)-214 (95% ee): temperature-
gradient oven (start at 50 °C held for 4 min, then gradient at 20 °C/min to 130 °C held for 2 min, then gradient
at 20 °C/min to 280 °C), 250 °C injector temperature, 100:1 split ratio, 1.0 mL/min flow He carrier gas, Hewlett
Packard 1 column (30 m x 0.25 mm i.d, 0.25 µm film thickness.
This allowed the ratio (y) of the (S)-214 area to n-decane area to be determined: y =
110486801 / 152916682 = 0.723. The corresponding no. mmol of (S)-214 formed is
determined from the calibration curve (Figure 5.13): x = 0.723 + 0.0064 / 1.0705 = 0.68
mmol. Considering that the mmol of alcohol starting material (R)-213 are 0.74, the
conversion is calculated as follows: % conversion = 0.68 / 0.74 · 100 = 92%
GC-FID analysis (Figure 5.16) of the product mixture containing the amount of (S)-228 to be
determined (Entry 3, Table 4.9, Chapter 4), provided the following areas:
Area (S)-228 = 130338322 (units)
Area n-decane = 306942672 (units)
Ret. Time
(min)
Area
7.21 110486801
8.55 152916682
F
(S)-214
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Figure 5.16. Gas chromatogram (GC-FID) of the quenched reaction mixture of (S)-228 (99% ee): temperature-
gradient oven (start at 50 °C held for 4 min, then gradient at 20 °C/min to 130 °C held for 2 min, then gradient
at 20 °C/min to 280 °C), 250 °C injector temperature, 100:1 split ratio, 1.0 mL/min flow, He carrier gas, Hewlett
Packard 1 column (30 m x 0.25 mm i.d, 0.25 µm film thickness).
This allowed the ratio (y) of the (S)-228 area to n-decane area to be determined: y =
130338322 / 306942672 = 0.425. The corresponding no. mmol of (S)-228 formed is
determined from the calibration curve (Figure 5.14): x = 0.425 + 0.0085 / 0.5774 = 0.75
mmol. Considering that the mmol of alcohol starting material (R)-227 are 1.48, the
conversion is calculated as follows: % conversion = 0.74 / 1.48 · 100 = 51%
Ret. Time
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5.6) X-ray crystallographic data
Table 1. Crystal data and structure refinement for sbdh5: 158a
Identification code sbdh5
Empirical formula C23 H22 N2 O9
Formula weight 470.43
Temperature 173(2) K
Wavelength 1.54178 Å
Crystal system Monoclinic
Space group P2(1)
Unit cell dimensions a = 11.1345(5) Å = 90°.
b = 11.5467(5) Å = 98.261(2)°.
c = 17.7582(7) Å  = 90°.
Volume 2259.42(17) Å3
Z 4
Density (calculated) 1.383 Mg/m3
Absorption coefficient 0.914 mm-1
F(000) 984
Crystal size 0.250 x 0.200 x 0.030 mm3
Theta range for data collection 4.01 to 67.97°.
Index ranges -13<=h<=13, -13<=k<=13, -21<=l<=21
Reflections collected 25733
Independent reflections 7204 [R(int) = 0.0327]
Completeness to theta = 67.00° 93.5 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.9148
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 7204 / 32 / 591
Goodness-of-fit on F2 2.976
Final R indices [I>2sigma(I)] R1 = 0.1662, wR2 = 0.5312
R indices (all data) R1 = 0.1718, wR2 = 0.5446
Absolute structure parameter 0.00
Extinction coefficient 0.0051(18)
Largest diff. peak and hole 1.883 and -0.887 e.Å-3
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Table 1. Crystal data and structure refinement for sbdh4: 159
Identification code sbdh4
Empirical formula C16 H23 F O5
Formula weight 314.34
Temperature 173(2) K
Wavelength 1.54178 Å
Crystal system Monoclinic
Space group P2(1)
Unit cell dimensions a = 8.0621(9) Å = 90°.
b = 5.9382(6) Å = 91.350(4)°.
c = 16.5465(17) Å  = 90°.
Volume 791.93(14) Å3
Z 2
Density (calculated) 1.318 Mg/m3
Absorption coefficient 0.877 mm-1
F(000) 336
Crystal size 0.200 x 0.200 x 0.080 mm3
Theta range for data collection 5.35 to 66.90°.
Index ranges -8<=h<=8, -6<=k<=7, -19<=l<=19
Reflections collected 9882
Independent reflections 2573 [R(int) = 0.0332]
Completeness to theta = 66.50° 93.0 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.9285
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2573 / 3 / 208
Goodness-of-fit on F2 1.058
Final R indices [I>2sigma(I)] R1 = 0.0296, wR2 = 0.0754
R indices (all data) R1 = 0.0298, wR2 = 0.0755
Absolute structure parameter 0.03(12)
Largest diff. peak and hole 0.117 and -0.148 e.Å-3
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Table 1. Crystal data and structure refinement for sbdh10: 162a
Identification code sbdh10
Empirical formula C16 H21 F O7 S
Formula weight 376.39
Temperature 93(2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group P2(1)
Unit cell dimensions a = 10.727(4) Å = 90°.
b = 6.988(3) Å = 98.075(17)°.
c = 11.271(4) Å  = 90°.
Volume 836.5(5) Å3
Z 2
Density (calculated) 1.494 Mg/m3
Absorption coefficient 0.241 mm-1
F(000) 396
Crystal size 0.150 x 0.100 x 0.030 mm3
Theta range for data collection 3.44 to 25.35°.
Index ranges -11<=h<=12, -6<=k<=8, -9<=l<=13
Reflections collected 4600
Independent reflections 2505 [R(int) = 0.0539]
Completeness to theta = 25.00° 97.1 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.9515
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2505 / 1 / 227
Goodness-of-fit on F2 1.097
Final R indices [I>2sigma(I)] R1 = 0.0538, wR2 = 0.1175
R indices (all data) R1 = 0.0608, wR2 = 0.1216
Absolute structure parameter 0.12(14)
Largest diff. peak and hole 0.259 and -0.406 e.Å-3
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Table 1. Crystal data and structure refinement for sbdh11: 193
Identification code sbdh11
Empirical formula C6 H9 F3 O3
Formula weight 186.13
Temperature 173(2) K
Wavelength 1.54178 Å
Crystal system Orthorhombic
Space group P2(1)2(1)2(1)
Unit cell dimensions a = 5.507(3) Å = 90°.
b = 7.525(4) Å = 90°.
c = 18.773(9) Å  = 90°.
Volume 777.9(7) Å3
Z 4
Density (calculated) 1.589 Mg/m3
Absorption coefficient 1.518 mm-1
F(000) 384
Crystal size 0.100 x 0.100 x 0.010 mm3
Theta range for data collection 6.34 to 66.27°.
Index ranges -6<=h<=6, -8<=k<=8, -20<=l<=21
Reflections collected 4650
Independent reflections 1101 [R(int) = 0.1393]
Completeness to theta = 66.27° 85.4 %
Absorption correction Multiscan
Max. and min. transmission 1.0000 and 0.8871
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 1101 / 2 / 118
Goodness-of-fit on F2 1.152
Final R indices [I>2sigma(I)] R1 = 0.1567, wR2 = 0.3500
R indices (all data) R1 = 0.1892, wR2 = 0.3752
Absolute structure parameter -1.1(16)
Largest diff. peak and hole 0.438 and -0.369 e.Å-3
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Table 1. Crystal data and structure refinement for SBDH13: 216
Identification code sbdh13
Empirical formula C6 H9 F3 O3
Formula weight 186.13
Temperature 93(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group P1
Unit cell dimensions a = 6.373(5) Å = 88.89(7)°.
b = 6.623(9) Å = 72.96(6)°.
c = 10.220(8) Å  = 75.90(5)°.
Volume 399.4(7) Å3
Z 2
Density (calculated) 1.548 Mg/m3
Absorption coefficient 0.164 mm-1
F(000) 192
Crystal size 0.15 x 0.15 x 0.03 mm3
Theta range for data collection 3.18 to 25.33°.
Index ranges -6<=h<=7, -7<=k<=7, -12<=l<=12
Reflections collected 3843
Independent reflections 2297 [R(int) = 0.0235]
Completeness to theta = 25.00° 98.0 %
Absorption correction Multiscan
Max. and min. transmission 1.000 and 0.930
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 2297 / 3 / 217
Goodness-of-fit on F2 1.157
Final R indices [I>2sigma(I)] R1 = 0.0345, wR2 = 0.0982
R indices (all data) R1 = 0.0345, wR2 = 0.0983
Absolute structure parameter -0.3(6)
Largest diff. peak and hole 0.347 and -0.349 e.Å-3
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